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ABSTRACT 
 
 
Nitric Oxide (NO) is a gaseous molecule that acts in a wide range of biological processes. 
NO can be produced by enzymatic and non-enzymatic pathways and, in this scenario, the 
enzyme Nitric Oxide Synthase (NOS) has a great importance for its exclusive role in de 
novo synthesis of NO. In the present study, the role of the NO in the embryonic 
development was investigated in the cephalochordate Branchiostoma lanceolatum 
(amphioxus) with the purpose of acquiring further knowledge on the ancestral role of 
animal Nos and the acquisition of new NO functions during evolution. Amphioxus has 
three different Nos genes (NosA, NosB and NosC) that are not orthologues of the three 
Nos of mammals (NosI, NosII and NosIII) deriving from an independent duplication 
occurred in the common ancestor of cephalochordates. The three amphioxus Nos genes 
showed a different temporal and spatial expression during development and a different 
susceptibility to be induced after immune stimulation. The study of the promoter regions 
of these genes can be very useful to identify possible diversities in regulation that can 
lead those peculiar expression features. In amphioxus larva, NO was mainly detected in 
the developing nervous system and in the pharyngeal area, before and after the mouth 
opening. The inhibition of NOS activity, and as consequence the enzymatic NO 
production, during amphioxus neurulation, resulted in the alteration of pharyngeal 
structures formation in the larvae, in particular opening of the mouth resulted 
compromised. Moreover, an alteration in larva locomotion was observed. Further studies 
will be necessary to reveal the exactly molecular mechanisms and the pathways in which 
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NO acts for establishment of the pharyngeal structures and the neuromuscular junctions 
early in development.  For this purpose, a differential transcriptomic analysis of NOS-
inhibited embryos was performed but the results are still very preliminary. 
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 NITRIC OXIDE: SIGNALING, BIOLOGICAL FUNCTION AND 
BIOSYNTHESIS 
Nitric Oxide (NO) is a highly diffusible gas molecule and its signaling effects are 
determined by its chemical reactivity. NO may act in the cells where it is produced or in 
the adjacent cells where it rapidly diffuses through the membrane (Goretski and 
Hollocher, 1988; Stamler et al., 1992), and so a concentration gradient occurs. Because 
of its free radical nature, NO is a very unstable molecule and its role as a direct signal 
mediator is limited to a short time window after its production (Martínez-Ruiz and 
Lamas, 2009). NO regulates a variety of processes ranging from the control of blood 
pressure and smooth muscle relaxation to immune activation and neuronal signaling 
(Moncada et al., 1991; Esplugues, 2002; Förstermann and Sessa, 2012). NO mainly acts 
through the cyclic guanosine-30,50-monophosphate (cGMP) pathway. NO binds the 
soluble guanylyl cyclase (Stamler et al., 1992) that, as result, increases the production 
of cGMP, a second messenger involved in several physiological functions (Ahern et al., 
2002). cGMP activates several targets including cGMP-dependent protein kinase, 
cGMP-gated channels and phosphodiesterases (Ahern et al., 2002) (Fig. 1.1A). NO 
interact with other molecules such as oxygen, oxygen-derived free radicals, glutathione, 
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and specific protein residues producing several types of post-translational modifications 
(Martínez-Ruiz and Lamas, 2009). In particular, NO reacts with thiol groups, mainly of 
cysteine residues, to produce S-nitrosylated proteins, through the intermediacy of 
dinitrogen trioxide, N2O3, which is formed by the reaction of NO with oxygen 
(Martínez-Ruiz and Lamas, 2009). NO also reacts with the phenolic ring of tyrosine 
residues to form a 3-nitrotyrosine residue in target proteins (Martínez-Ruiz and Lamas, 
2009). In this case the nitrating species is peroxynitrite, deriving by the reaction of NO 
with superoxide (O2-) to give peroxynitrite (ONOO-) (Fig. 1.1B). Considering the 
different nature of the chemical bonds, nitrosylation is generally considered a reversible 
process, whereas nitration an irreversible reaction. However, the existence in the cells 
of mechanisms accounting for a denitrating activity has been suggested. Indeed, 
dynamics of protein nitration in respiring mitochondria have been reported, showing 
that nitration is related to oxygenation and denitration to anoxia (Aulak et al., 2004). 
NO may be also involved in S-glutathionylation, the incorporation of glutathione (GSH) 
into the protein, through the reaction between the S-nitrosothiol, S-nitrosoglutathione 
(GSHNO), and protein sulfhydryls to produce the mixed disulfide P-SSG. This can be 
also formed by reaction of S-nitrosylated proteins with GSH.   
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Figure 1.1: Two different NO signaling pathway. (A) cGMP-dependent pathway (Ahern et al., 2002); 
(B) cGMP-independent pathway (adapted from Martínez-Ruiz and Lamas, 2009). 
 
Until recently protein nitration and nitrosylation were essentially considered as a 
footprint of oxidative damage, but it is now becoming clear from a series of evidences 
reported in the literature that these processes may represent new signaling pathways. In 
fact, protein nitration can affect the enzymatic activity of a variety of proteins (Schopfer 
et al., 2003) or it can mimic cell-signaling events such as adenylation (Berlett et al., 
1996). Thus, protein nitration has also been associated to some biological processes, 
such as cell maturation (Fiore et al., 2009) and larval development (Ercolesi et al., 
2012). Protein nitration can also modulate cytoskeletal organization that represents a 
signaling mechanism in neuronal differentiation (Cappelletti et al., 2004; Tedeschi et 
al., 2007).  
In mammals, including humans, NO is an important cellular signaling molecule 
involved in many physiological and pathological processes (Hou et al., 1999). It is a 
powerful vasodilator with a short half-life of a few seconds in the blood; its vasodilatory 
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action plays a key role in renal control of extracellular fluid homeostasis and is essential 
for the regulation of blood flow and blood pressure (Yoon et al., 2000). NO also serves 
as a neurotransmitter (Figure 1.1). Glutamate released from the presynaptic neuron 
binds to the NMDA receptor and causes the entrance of calcium ions. These ions bind 
to calmodulin which activates NOS to produce NO in the postsynaptic neuron. Unlike 
most other neurotransmitters that pass information only from a presynaptic to a 
postsynaptic neuron, NO widely and readily diffuses into cells and, so, it can act on 
several nearby neurons, even on those not connected by a synapse (Vizi et al., 2010). It 
has been associated with neuronal activity and various functions such as learning and 
memory through the maintenance of long-term potentiation (Taqatqeh et al., 2009). NO 
is also involved in immune response mediating macrophage cytotoxicity against 
microbes and tumor cells (Förstermann and Sessa, 2012).  
In non-vertebrates, NO is involved in a wide spectrum of physiological processes, as 
feeding, blood sucking, bioluminescence, neural transmission, immune response, 
apoptosis (Palumbo, 2005; Di Cristo et al., 2007; Krönström et al., 2007; Mattiello et 
al., 2010) and other processes listed in Table 1.1. NO is also necessary in sea urchins, in 
the first phases of life, as in male gametes development and in egg activation (Kuo et 
al., 2000), as well as in the duration of the calcium transient increase, in the NAD(P)H 
and H2O2 production and in the fertilization envelope hardening (Mohri et al., 2008). 
Moreover, NO was found to be implicated during settlement and metamorphosis in 
different marine organisms, such as C. robusta, Ilyanassa obsolete, Lytechinus pictus 
and Boltenia villosa (Table 1.1; Bishop and Brandhorst, 2001; Bishop et al., 2001; 
Leise et al., 2004; Bishop and Brandhorst, 2007; Comes et al., 2007).  
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Table 1.1: Physiological processes in which NO acts in invertebrates.  
 
In cells, NO is endogenously generated by a class of heme-dependent enzymes, called 
Nitric Oxide Synthase (NOS), that catalyze the conversion of L-arginine to L-citrulline 
and NO (Fig. 1.2).  
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Figure 1.2: NO biosynthesis. 
 
In mammals, there are three NOS proteins coded by three different genes: two 
constitutively expressed genes, the endothelial Nos (eNos, Nos-III or Nos-3) and the 
neuronal Nos (nNos, Nos-I or Nos-1); one inducible Nos (iNos, Nos-II or Nos-2). 
Neuronal and endothelial Nos genes are commonly associated with constitutive 
expression and are most commonly found in non-immunological cells e.g., neurons and 
endothelium (Knowles and Moncada, 1994). On the other hand, the inducible Nos 
expression has long been associated with immunological functions. Immune cells use 
NO, often in conjunction with reactive oxygen intermediates (ROI), to eliminate 
pathogens and cancer cells (MacMicking et al., 1997; Xu et al., 2002). NO acts non-
specifically on a variety of targets and can kill targets at micromolar concentrations 
(Wink et al., 2011). Despite their names indicate a tissue-specificity, all three Nos genes 
were indeed found in a wide variety of tissues and organs. Thus, for example, nNOS is 
also present in muscle, pancreatic islets, kidney, respiratory and gastrointestinal 
epithelia. The eNOS has been reported in cardiac myocytes, brain and kidney epithelia, 
whereas the iNOS in cardiac myocytes, glial cells, hepatocytes, keratinocytes (for a 
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review see Andreakis et al., 2011). nNOS and eNOS activity is calcium-dependent, 
whereas iNOS is fully activated at basal intracellular calcium concentration, so its 
activity is calcium-independent (Calabrese et al., 2007). Mammalian NOS are 
catalytically active when dimerized (Förstermann and Sessa, 2012); each monomer 
consists of a C-terminal reductase domain and an N-terminal oxygenase domain 
(Alderton et al., 2001). These two domains are connected by a calmodulin (CaM) 
binding sequence (Fig. 1.3). The oxygenase domain contains a non-catalytic zinc (Zn2+), 
heme, tetrahydrobiopterin (BH4), and the substrate (L-arginine) binding site, where 
catalysis occurs. The binding mode of L-arginine in the three NOSs is identical. The 
reductase domain, which contains NADPH (nicotinamide adenine dinucleotide 
phosphate), FAD (flavin adenine dinucleotide), and FMN (flavin mononucleotide) 
cofactors, is divided into an NADPH-FAD binding subdomain and a FMN binding 
subdomain (Fig. 1.3). Because these two subdomains are connected by a flexible 
dodecapeptide, they can perform a hinge movement when CaM, linked with calcium, 
binds to its binding site (Alderton et al., 2001; Andrew and Mayer, 1999). For all the 
three enzymes a conformational change, associated with CaM binding, is required for 
the electron transfer (Ghosh and Salerno, 2003). For both neuronal and endothelial 
NOSs, CaM binding takes place when the free intracellular calcium (Ca2+) levels up to 
specific micromolar concentrations. Conversely, the inducible NOS, thanks to a greater 
affinity, carry a permanently bound CaM, which does not dissociate even at low Ca2+ 
concentrations (Cho et al., 1992). Therefore, the iNOS expression is not regulated by 
intracellular Ca2+ and, in basal conditions, its activity is very low but its expression 
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could be regulated at the transcriptional level under certain conditions (Förstermann and 
Sessa, 2012). 
 
Figure 1.3: Schematic structure of mammalian constitutive NOS. It shows two domains separate by a 
calmodulin binding site and the flow of electrons from NADPH to heme-Fe (from Zhou and Zhu 2009). 
 
The structural features listed above are common to all three NOSs. In addition, nNOS 
has a PDZ domain (Fig. 1.4) through which it can interact with other adapter proteins 
containing PDZ binding domains influencing the subcellular distribution and/or activity 
of the enzyme (Brenman et al., 1996; Titheradge et al., 1998; Jaffrey et al., 2002). At 
the N-terminal part eNOS presents two post-translational modification sites: 1) glycine 
in positions 2 (Gly-2) is N-myristoylated after removal of the N-terminal methionine 
residue; 2) residues of cysteine in position 15 and 26 (Cys-15 and Cys-26) are N-
palmitoylated (Fig. 1.4). Myristoylation is highly stable and generally irreversible under 
physiological conditions, it allows weak protein-protein and protein-lipid interactions 
and plays an essential role in membrane targeting (Titheradge et al., 1998). In contrast, 
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palmitoylation is a reversible post-translational modification and, usually, it enhances 
the hydrophobicity of proteins, contributing to protein-membrane interactions 
(Robinson and Michel, 1995; Titheradge et al., 1998). Both the constitutive nNOS and 
eNOS are characterized by the presence of the so called “autoinhibitory loop”, that is 
responsible of the Ca2+ dependence interfering with the binding of CaM. This element 
inhibits intradomain electron transfer but, at specific Ca2+ concentrations, CaM acts by 
displacing the autoinhibitory element allowing the enzymatic activity (Nishida and 
Ortiz de Montellano, 1999). The autoinhibitory loop is about 52-55 aa long and is 
situated within the FMN binding domain located approximately 80 aa residues at 3’ of 
the CaM binding sequence (Fig. 1.4b).  
 
Figure 1.4: Human nNOS, eNOS and iNOS. a) Dimeric form of NOS protein. b) Human neuronal Nitric 
Oxide Synthase (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) domain structure. Peculiar 
characteristics of neuronal and endothelia NOS are reported, respectively PDZ domain and myristoylation 
and palmitoylation sites, at the N-terminal of the protein. The yellow stars in the nNOS and eNOS 
indicate the inhibitory loop inside the FMN domain (modified from Tengan et al., 2012).  
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Among metazoans, the NOSs amino acid sequence is highly conserved except for the 
N-terminal region containing the PDZ and the autoinhibitory loop. Moreover, Nos 
genes in animals show a similar genomic structure, i.e. intron positions and phases are 
highly conserved. At least 24 introns, in fact, are in the same position from placozoans 
to mammals, suggesting that these introns were already present in the ancestor NOS 
gene of metazoa (Andreakis et al., 2011) (Fig. 1.5).  
 
 
11 
 
Figure 1.5: Schematic representation of animal NOS organization. Functional domains are shown as 
colored boxes. The positions of the introns, relative to the protein structure, are depicted by arrowheads. 
Black arrowheads indicate overall conserved intron positions, numbered 1–24. Red arrowheads denote 
intron positions conserved in no bilaterian phyla. White arrowheads denote lineage-specific introns (from 
Andreakis et al., 2011). 
 
1.2 THE EXPERIMENTAL MODEL SYSTEM: AMPHIOXUS  
1.2.1 History of amphioxus and its anatomy 
Amphioxus was firstly described by the German zoologist Peter Simon Pallas in 1767 
as a mollusk of the genus Limax that he named “Limax lanceolatus”, having a 
streamlined body plan with both spear-shaped ends, characterized by transparent body 
and showing internal compartmentalized musculature (Pallas, 1767). However, Pallas’ 
examination was confined to the external anatomy of this animal on specimens 
preserved in spirit. Almost seventy years after this first description, in 1834 amphioxus 
was discovered for the second time in the Mediterranean sea by the Italian naturalist 
Gabriel Costa. A big amphioxus population was found near capo Posillipo in the north-
west of the gulf of Naples (Italy) and this allowed Costa to make observations on the 
living animal. He recognized its affinity to fishes allied to Cyclostomata, a group which 
include lampreys and hag-fish. In his book, Costa described amphioxus as an atypical 
fish without eyes and nasal neither gill openings, but he mistook the structures 
surrounding the mouth (oral cirri) were respiratory filaments, so he suggested the name 
Branchiostoma lubricum, referring with “lubricum” to the way in which this animal 
slips quickly through the fingers (Costa, 1834). Two years later, William Yarrell, in his 
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“History of British Fishes”, was the first to describe notochord in amphioxus as a 
cartilaginous vertebral column and he named it Amphioxus (from greek “pointed on 
both sides”, referring to its shape) lanceolatus (Yarrell, 1836). Years later the scientific 
community adopted Branchiostoma (from Costa) lanceolatum (from Pallas) as the 
definitive name of the specie, while amphioxus is still used as a common name. In 
1866, the embryologist Alexander Kovalevsky, looking at amphioxus and ascidian 
embryos, identified in both some chordates features, as the notochord, dorsal nerve cord 
and metameric muscle, as well as common developmental mechanisms (i.e formation of 
archenteron by invagination and development of nerve cord from neural folds). 
Therefore, he classified amphioxus and ascidians as invertebrate chordates, and this 
represents one of his most important contributions to chordate developmental biology.  
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Figure 1.6: Wall chart from a Karl Georg Friedrich Rudolf Leuckart collection, the famous German 
zoologist and parasitologist (1822-1898). This chart shows stages through development (1–12), small 
adult animal (14) and their transversal sections (15-20). By the longitudinal section of the adult (14) is 
possible to note the four typical chordate features: pharyngeal gill slits (SF), the hollow nerve cord (NC), 
notochord (N) and post-anal tail [posterior to anus (A)]. 
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Branchiostoma genus consists of about 25 species with a global distribution in shallow 
temperate and tropical seas close to the seashore from 0.5 to 40 m deep (Bertrand and 
Escriva, 2011; Desdevises et al., 2011). The most well-known species for their wide use 
in the scientific field are: the Mediterranean species Branchiostoma lanceolatum, which 
has been mentioned earlier, also present along Atlantic coasts of Europe; the Floridian 
species Branchiostoma floridae; the Asian species Branchiostoma belcheri and 
Branchiostoma japonicum, present mainly in China coast at Xiamen and Qingdao.  
Amphioxus is a filtered-feeding animal and its usual modus vivendi is to bury the whole 
of its body into the sand, leaving only the mouth outside with the expanded buccal cirri 
in order to capture food-particles through constant inflowing seawater current. 
Occasionally it emerges from its favorite position in the sand, especially during the 
reproduction period (see paragraph 1.2.3).  
The anatomy of adult amphioxus is vertebrate-like. It shows all the chordate prototypic 
features: the dorsal cord or notochord, a dorsal hollow nerve tube, a ventral gut, a 
perforated pharynx with gill slits, a post-anal tail, a segmented axial muscles and 
gonads, a pronephric kidney and homologues of the thyroid gland and adenohypophysis 
(the endostyle and pre-oral pit, respectively) (Bertrand and Escriva, 2011) (Fig. 1.7). 
However, it lacks some typical vertebrate-specific structures, such as paired sensory 
organs, paired appendages, neural crest cells and placodes (Schubert et al., 2006). 
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Figure 1.7: Adult amphioxus. a-b) Schematic representation of adult amphioxus anatomy; c) a picture of 
a small adult amphioxus.  
 
The notochord, cylindrical muscularized rod, runs dorsally along the full length of the 
animal, extending anteriorly beyond the end of the nerve cord (Schubert et al., 2006; 
Takahashi and Holland, 2004). Immediately above the notochord there is a dorsal 
tubular nervous system, with only a slight enlarged cerebral vesicle at its most anterior 
end (Lacalli, 2006). Under the notochord there is an endodermal-derived digestive tract 
connected anteriorly to a pharyngeal area with gill slits and ciliated gill bars. At the 
ventral part of the pharynx region is located the endostyle, a ciliated groove that 
produces mucous needed for the filter feeding mechanisms. Posteriorly to the digestive 
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tract there is the anal opening, beyond which occurs a short post-anal tail. The adult 
amphioxus possesses a laterally flattened cylindrical shape, usually not more than 6 cm 
in length and 0.5-1 cm in diameter. Through the transparent skin it is possible to see 
metameric muscle structures along the body length that enable them to swim and 
burrow into the sand. The sexes of amphioxus are readily distinguishable as they begin 
to develop their rows of testes or ovaries and it is possible to distinguish males and 
females by observing the gonads to the stereomicroscope (Fig. 1.8). 
 
Figure 1.8: Difference between male and female gonads in adult amphioxus. A) Adult ripe amphioxus; 
B) Magnification of mature ovary. C) Magnification of mature testis. D) Adult Branchiostoma 
lanceolatum transversal section with mature ovary. E) Adult B. lanceolatum transversal section with 
mature testis. Abbreviations: n: neural tube, ch: notochord, ms: muscles, g: gut o: ovaris, t: testis. Scale 
bar of b and c is 1 mm. 
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1.2.2 Phylogeny 
Branchiostoma is one of the genera of Cephalochordates subphylum which represents 
the most basal extant chordate lineage that diverged from olfactores (urochordates and 
vertebrates) half a billion years ago (Delsuc et al., 2006). Phylogenetic analyses based 
on morphological characters and rDNA 18S sequencing, placed cephalochordates as 
sister group of vertebrates within chordates, with tunicates basal in the phylum (Hecht 
et al., 1987; Winchell et al., 2002). But these analyses erroneously placed urochordates 
basal in chordates due to the fact that they are rapidly evolving, while cephalochordates 
and vertebrates are evolving much more slowly. However, more recent analyses of a 
large set of nuclear genes have established that cephalochordates represent the most 
basally divergent lineage of chordates (Blair et al., 2005; Delsuc et al., 2006, 2008) 
(Fig. 1.9). Therefore, cephalochordates occupy a key phylogenetic position for 
comparative and evolutionary studies in vertebrates (Yu and Holland, 2009). 
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Figure 1.9:  Phylogeny of deuterostomes. This phylogenetic tree shows the relationship of the major 
chordate and echinoderm groups (from Diogo et al., 2015).  
 
There are two other genera in Cephalochordates, Asymmetron and Epigonichthys, which 
are very similar to Branchiostoma except they have a series of gonads only on the right 
side of the body compared to both sides in Branchiostoma. A single species of 
Epigonichthys (Epigonichthys maldivensis) and two of Asymmetron (Asymmetron 
lucayanum and Asymmetron interferum) have been described so far; however, there 
may be additional cryptic species (Kon et al., 2007).  Nothing is known about any 
aspect of the Epigonichthys biology, while much more is known about Asymmetron 
lucayanum (Holland and Holland, 2010). A phylogenetic analysis with whole 
mitochondrial genome sequence revealed that Asymmetron diverged first, followed by 
Branchiostoma and Epigonichthys clades (Nohara et al., 2005; Kon et al., 2007; Igawa 
et al., 2017) (Fig. 1.10). The branching order within Branchiostoma showed a 
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monophyletic relationship between B. lanceolatum and B. floridae (Igawa et al., 2017; 
Fig. 1.10).  
 
Figure 1.10: Phylogenetic relationship within the Cephalochordata. The three genera are Asymmetron, 
Branchiostoma and Epigonichthys. The phylogenetic relationship within the Branchiostoma genus is also 
reported (from Igawa et al., 2017). 
 
The genome of B. floridae is approximately 520 Mb in size and estimated to contain 
approximately 21 900 protein-coding loci (Putnam et al., 2008). The amphioxus 
20 
 
genome exhibits considerable synteny conservation with the human genome, minimal 
gene losses and remarkably it has not undergone two-round whole genome duplications 
which occurred early in the evolution of vertebrates, known as the 2R hypothesis 
(Ohno, 1970; Dehal and Boore, 2005). Therefore, amphioxus generally possesses only a 
single paralogue (homologous genes that are derived by gene duplication from an 
ancestral gene) of the two to four paralogues of vertebrate genomes (Brooke et al., 
1998; Wada et al., 1999; Cañestro et al., 2007; Pascual-Anaya et al., 2008; Garcia-
Fernàndez et al., 2009; Pascual-Anaya et al., 2012; Pascual-Anaya et al., 2013). 
Moreover, the “pre-duplicative” amphioxus genome possesses one representative of all 
the gene families that presumably existed in the ancestor of chordates, in contrast to the 
situation in the two other chordate subphyla, urochordates and vertebrates, which have 
specifically lost different members of several gene families (e.g. the homeobox-
containing genes, tyrosine kinases or nuclear receptors) (D'Aniello et al., 2008; Takatori 
et al., 2008; Bertrand et al., 2011). Thus, the morphological and genomic simplicity of 
amphioxus, together with its key phylogenetic position, make it an invaluable animal 
model for understanding the invertebrate to vertebrate evolutionary transition. 
 
1.2.3 Reproduction and embryology: early and late amphioxus development 
All amphioxus species have separate sexes. The reproductive period of amphioxus 
ranges from April to August, with slight variations depending on the species and the 
environmental conditions. In field, after sunset, animals move along the water column 
and release millions of gametes simultaneously. Zygotes develop inside their 
fertilization envelopes, which protect them from external aggressions during early 
21 
 
development. By the end of gastrulation, they begin to rotate anti-clockwise within their 
fertilization membrane and soon after they become neurula. At this stage, they join the 
planktonic community and live in it from one month to several months, depending on 
the species and environmental conditions (Stokes and Holland, 1995; Fuentes et al., 
2007). After this pelagic life period, they undergo a metamorphosis (see later in this 
paragraph) and slowly develop into juveniles and return to burrows in the benthic 
ground (Fig. 1.11). The embryology of amphioxus was first described by Kowalevsky, 
in 1867, who raised embryos of B. lanceolatum obtained in Napoli (Italy) from plankton 
tows. At the beginning, the major difficulty for studies of early amphioxus development 
was that researchers had to rely on natural spawning of the animals and rarely they 
obtained eggs and sperm separately in order to control the fertilization. Many 
misconceptions about amphioxus development arose due to the small size of amphioxus 
embryos and the limitations of light microscopy of that era. These errors were corrected 
thanks to electron microscopy studies carried out in the late 1980s. In those years, a 
huge amphioxus population, first described in 1980 by Wright, was rediscovered in 
Tampa Bay (Florida, USA) and it was found that animals could be induced to spawn in 
the same period that they normally spawn in field. These events have led to obtain more 
easily a controlled fertilization allowing the events surrounding fertilization and very 
early development to be studied in detail (Holland and Holland 1989, 1990, 1991, 1992, 
1993).  
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Figure 1.11: Amphioxus life cycle (Adapted from Stokes and Holland 1998) 
 
Fertilization, cleavage and gastrulation 
Amphioxus eggs are microlecithal, spherical and 100-130 µm in diameter. The 
spermatozoa are very small, more or less 15-20 µm in length with a rather spherical 
head of about 1 µm in diameter. During sperm and egg fusion, as the sperm nucleus 
migrates to the vegetal pole, the fertilization envelope rises (Fig. 1.12a). The egg 
completes the second meiotic division, the second polar body is formed and the mature 
egg nucleus established. In B. floridae, first equal cleavage starts at the animal pole 
more or less 60-90 minutes after fertilization, the second one occurs one hour after the 
first (Holland and Onai, 2012). The third cleavage divides the embryos into an animal 
half and a vegetal half, the animal pole of the egg becomes antero-ventral, the vegetal 
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pole postero-dorsal. Blastomeres are usually roughly equal in size, but sometimes 
vegetal blastomeres are slightly larger than animal ones (Fig. 1.12d).  
 
 
Figure 1.12: Branchiostoma lanceolatum cleavage phases. a) Fertilized egg with fertilization envelop; b-
c-d) Zygotes at early cleavage stages, 2, 4 and 8 blastomeres respectively. 
 
A central space among the blastomeres is formed. Virtually present in the four-cells 
stage, it becomes real at eight-cells stage: it is the blastocel. The first indication of 
gastrulation is the flattening of the vegetal pole of the blastula. Thanks to the 
invagination of vegetative blastomeres, a second cavity also forms, the archenteron, 
which is not a true body cavity but it is considered outside and its opening is the 
blastopore. The blastopore constricts with the tissue at the ventral side elongating more 
than the dorsal side. We may now speak of the invaginating and non-invaginating layers 
as, respectively, endoderm (hypoblast) and ectoderm (epiblast) and of the whole 
structure as gastrula. After gastrulation begins, a center of very rapid division appears in 
the lip of the blastopore mainly on the dorsal side, this region is called germ ring. This 
great proliferative region contributes to add cells both to endoderm and ectoderm layers. 
At the late gastrula, each ectodermal cell develops a cilium and the gastrula begins to 
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rotate within the fertilization envelope and start to secrete hatching enzymes. At the end 
of gastrulation, the embryo is bilaterally symmetric, quite elongated antero-posteriorly, 
flattened dorsally, rounded ventrally as well as anteriorly, while at the postero-dorsal 
side the archenteron opens directly to the outside by a narrow blastoporal opening (it 
will correspond to the final anal opening in chordates). EvoDevo studies have indicated 
that different parts of the fertilized egg are destined to give rise to certain specific 
domain in adult animal in the course of a normal development (Holland and Holland, 
2007; Fig. 1.13). The vegetal half of the egg and blastula is destined to became 
mesoderm and endoderm while the animal half ectoderm. As gastrulation progresses, 
the blastopore lips close bringing together the future posterior end of the embryo. 
During gastrulation, the animal pole shifts towards the ventral side and the future 
mesoderm is entirely dorsal (Holland and Holland, 2007; Holland and Onai, 2012). 
 
 
Figure 1.13: Fate map of amphioxus gastrula stage. The second polar body is at the animal pole (see 
circle by ectoderm). The future anterior and posterior ends of the embryo are indicated by asterisks 
(adapted from Holland and Holland, 2007). 
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Neurulation 
Neurulation in amphioxus occurs in a different manner compared to those in general 
Vertebrates. Along the dorsal flattened surface of the late gastrula, a median strip of 
ectodermal cells becomes delimitated from the adjacent cells that grow over it. This 
strip of cells is the neural plate (Fig. 1.14d-e-f). The ectoderm bounds the neural plate 
and it becomes elevated forming the neural folders. After ectoderm covers the neural 
plate, this rounds up to form a tube and the original space between the neural plate and 
the covering ectoderm becomes the cavity of the neural tube. At the end of neurulation, 
the neural plate becomes completely closed except at its anterior extremity where it 
remains open to the exterior in the mid-dorsal line by an opening known as neuropore 
(Fig. 1.14b).  
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Figure 1.14: Amphioxus neurulation. a) 2 somites neurula before hatching. b) middle neurula at 5 
somites stage, lateral view. c) the same neurula in b, dorsal view. d-e-f) schematic representation of 
neurulation process in cross-section. The territories are marked in different colors; blue: ectoderm, both 
neural and non-neural one; green: chorda-mesoderm; pink: somitic mesoderm; yellow: endoderm 
(adapted from Conklin, 1914). 
 
Recent molecular studies performed on B. lanceolatum neurula stage, revealed that the 
amphioxus incipient neural tube is very complex with several anteroposterior (AP) and 
dorsoventral (DV) molecular partitions, according to axial references (Albuixech-
Crespo et al., 2017). Two major AP regions are observed in amphioxus neural tube: the 
archencephalon (ARCH) that is regionalized in a rostral hypothalamo-prethalamic 
primordium (HyPTh) domain (Fezf and Otx positive) and in a caudal Di-Mesencephalic 
primordium (DiMes) domain (Fezf negative and Otx positive); the deuteroencephalon 
(DEU), located posteriorly to the DiMes and containing a Rhombencephalo- Spinal 
primordium (RhSp) domain (Albuixech-Crespo et al., 2017; Fig. 1.15).  
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Figure 1.15: Schematic representation of the three major AP subdivisions in the amphioxus central 
nervous system at neurula stage and the relative expression of their key markers (Modified from 
Albuixech-Crespo et al., 2017). 
 
The blastopore becomes converted into the neurenteric canal, joining the lumen of the 
central nervous system with the lumen of the gut. This canal remains open throughout 
the embryonic period, until the mouth is formed. The chorda develops more slowly than 
the nervous system. The rudiment of this structure is a median strip of endoderm 
forming the roof of the archenteron, in contact with lower surface of neural plate. The 
chord rudiment pushes down into the archenteric cavity and appears in section 
concavely arched (Fig. 1.14d-e-f). At nine or ten somite formed stages, the notochord 
becomes completely cut off from the endoderm and close to forming a cave tube. At the 
neurula stage, a third intermediate layer, the mesoderm, appears. The formation of 
somites in amphioxus begins very early, before hatching, when mesoderm first 
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separates from endoderm as a pair of longitudinal band that later become divided into 
the first two somites in the anterior part (Fig. 1.14a). The portion of archenteric space 
that remains inside the forming somites it is called enterocelic cavity (Fig. 1.14c). After 
hatching, mesodermal somites posterior to the two formed before, continue to form 
successively in the elongating mesodermal folds until the formation of fourteen pairs of 
somites (Fig. 1.14c). Posterior to these, in the tail bud, undivided regions of mesoderm 
remain from which additional somites will be formed during the larval period. By the 
time five or six pairs of somites are formed, they begin to show alternation that is 
characteristic of the adult, in particular, left member comes to lie in advance of the 
right.  
 
Larvae and metamorphosis 
The duration of the larval period in B. lanceolatum is roughly about three months 
during which the larva is free swimming. Development is very slow and consists largely 
in the elaboration and modification of structures appeared before. The dorsal organs 
such as the neural tube, the notochord and the muscular lamella do not much change 
morphologically but become structurally more complex (Hirakow and Kajita, 1994). 
The central nervous system (CNS) of lancelets consists of a tubular nerve cord, located 
directly above the notochord and that extends from the anterior cerebral vesicle (CV) to 
the to the tip of the caudal fin. Comparisons of developmental gene expression together 
with three-dimensional reconstructions from serial TEM have shown that the 
amphioxus brain has homologues of most of the features of the vertebrate brain (Lacalli, 
1996; Candiani et al., 2012; Albuixech-Crespo et al., 2017). These include a 
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diencephalic forebrain with a pineal homologue, a small midbrain (tectum), a hindbrain 
and a spinal cord (Lacalli, 1996; Candiani et al., 2012; Albuixech-Crespo et al., 2017) 
(Fig. 1.16). Forebrain and midbrain together form the CV that is extended almost to the 
boundary between somites 1 and 2 (Candiani et al., 2012). The anterior landmark of the 
CV is the frontal eye, which has been proposed to be homologous to paired eyes of 
vertebrate. This structure consists of a pigment cup with four rows of neurons: sensory 
neurons, probably photoreceptor cells, that are closely related with nerve cells that 
communicate with the dendrites of neurons involved in the locomotory control center 
(Wicht and Lacalli, 2005). In the forebrain, an important structure is the lamellar body 
of the infundibular region. The lamellar body is generally accepted as a homolog of the 
vertebrate pineal organ and so, it is may responsible of the circadian rhythm. The 
posterior landmark of the CV is the primary motor center (PMC) that contains the 
anterior most motoneurons in the nerve cord and a number of large premotor 
interneurons. 
 
Figure 1.16: Schematic representation of the amphioxus larval nervous system. The different regions in 
which the amphioxus nervous system has been subdivided have been highlighted. FB: forebrain; MB: 
midbrain; HB: hindbrain; SC: spinal cord; PS, first pigment spot; S, somite; N, notochord; M, mouth; FE: 
frontal eye; IO: infundibular organ; LB: lamellar body; PMC: primary motor center; CV: cerebral vesicle 
(from Candiani et al., 2012), 
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A hindbrain-like region extends from the posterior margin of the PMC to the boundary 
of somites 7 and 8; beyond this region there is a territory corresponding to the 
vertebrate spinal cord (Candiani et al., 2012). The peripheral Nervous System (PNS) of 
amphioxus is composed of several types of neurons, and at least two types of epidermal 
sensory cells, widely distributed along the epithelium surface. The Type I receptors are 
primary sensory neurons having axons projecting to CNS, whereas the Type II receptors 
are axon-less secondary sensory neurons, putative chemoreceptors, with synaptic 
terminals arising at short distances from the cell body (Wicht and Lacalli, 2005; 
Candiani et al., 2010). 
The embryos continue to elongate and showing marked asymmetry in particular in the 
pharyngeal region (Fig. 1.17). The end of the larval period is marked by an extensive 
metamorphosis that leads to a “symmetrization” of the anterior portion of the body. The 
gill slits of the right and left sides develop independently, those of the left side first. The 
first twelve-fifteen gill slits are called “primary gill slits” and, at this stage, they are 
metameric and correspond with the somites. Then, the “secondary gill slits” appear also 
on the right side of the pharynx and dorsal to the primary series. The rudiment of the 
gill slits enlarges and become perforated. The dorsal margin of the gill slits moves to the 
ventral part and, as this migration is going on, gill slits become divided by a downward 
extension that forms the tongue bar of the completed structure of the adult. One of the 
characteristic organs of the larval stage is the club-shaped gland that is limited to this 
developmental stage (Goodrich, 1930). This structure arises as an evagination from the 
pharyngeal endoderm in late embryos and soon develops into a tube connecting the 
pharyngeal lumen with the external environment; the external opening is a pore in the 
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epidermis, near the anteroventral edge of the mouth (Hatschek, 1893). Different theories 
about club-shaped gland function were proposed during the years (Olsson 1983; 
Gilmour 1996; Holland and Yu 2002), but what seems to be the most accepted one is 
that this gland, together with the endostyle (see later in this paragraph), produces a thin 
vertical curtain of mucus to capture ingested particles and then transport them toward 
the most posterior gut regions (Holland et al., 2009). Following the apoptotic 
destruction of the club-shaped gland during metamorphosis, the endostyle of juvenile 
and adult amphioxus presumably becomes the major (or even exclusive) source of 
mucus for capturing food particles in the pharyngeal lumen. The endostyle is an organ 
that originates as a thickening of the pharyngeal wall and it is located in front of the 
club-shaped gland. As well as producing mucus, it selectively binds iodine, and 
synthesize and release thyroid hormones and for this reason it was compared with 
vertebrate thyroid (Fredriksson et al., 1984). This organ persists in adults as a major site 
for iodination (Ericson et al., 1985), possibly because of the continued synthesis of 
thyroid hormones influencing tissue growth and maintenance in the juvenile and adult 
amphioxus. After metamorphosis, the endostyle moves from the right side of the 
pharynx to the ventral floor and expands longitudinally (Wlllcy, 1891; Paris et al., 
2008; Paris et al., 2010; Kaji et al., 2013). 
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Figure 1.17: Schematic representation and morphology of amphioxus larva with one gill slit, seen from 
right side and left side. Abbreviations: dkk, intestinal opening of the club-shaped gland; hkk, cutaneous 
opening of the club-shaped gland; kk, the club-shaped gland; ko, first gill pouch; lp, left post-oral papilla; 
m, mouth; md, mid-ventral line of intestine; mh, ventral median line of epidermis; op, unpaired papilla; 
po, pre-oral pit; rp, right papilla; th, endostyle (adapted from Barrington, 1965). 
 
Unlike in other animals, the mouth in amphioxus larva develops on the left side. Kaji 
and collaborators suggest that amphioxus mouth develops from the first postero-ventral 
outgrowth of the left somite, as a pocket, called ‘oral mesovesicle’, that opens initially 
into the pharynx and then into the outside environment (Kaji et al., 2016) (Fig. 1.18). 
This process is different from what happens in other deuterostomes (Soukup et al., 
2013) but the involvement of mesodermal vesicles or their derivatives was found during 
development of other amphioxus organs such as pre-oral pit and gill slits. Moreover, the 
development of the oral mesovesicle is under control of the Nodal-Pitx signaling 
pathway, which governs asymmetric development of the whole larval body in 
amphioxus (Soukup et al., 2015). 
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Figure 1.18: Amphioxus mouth development hypothesis according to Kaji and collaborators (2016). LD: 
left structures; RD: right structures; OMV: oral mesovesicle. Red arrow indicates mouth opening 
(adapted from Soukup and Kozmik 2016). 
 
1.3 NITRIC OXIDE AND NITRIC OXIDE SINTHASES IN AMPHIOXUS 
Andreakis and collaborators, in 2011, have demonstrated the existence in B. floridae 
genome of three distinct amphioxus genes coding for three different NOS proteins, 
called NosA, NosB and NosC (Andreakis et al., 2011) (Fig. 1.5). NOSA and NOSC 
contain the PDZ domain and the autoinhibitory loop (Fig. 1.5), so they were identified 
as neuronal NOSs. NOSB does not contain both elements, thus indicating its inducible 
feature. Evolutionary analysis showed that there is not a direct relationship between the 
three amphioxus NOS and the vertebrate eNOS, nNOS and iNOS but they resulted to be 
the product of a lineage-specific duplication event (Fig. 1.19) (Andreakis et al., 2011).  
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Figure 1.19: Evolutionary events regarding NOS genes in chordates. There are two different evolutionary 
events: whole-genome duplications (R) and lineage-specific duplications (D). Inferred gene losses during 
vertebrate evolution are depicted in gray (adapted from Andreakis et al., 2011). 
 
Nevertheless, before these structural evidences, some studies about NOS genes and 
proteins in amphioxus were performed. In 2006, Godoy and collaborators performed an 
immunostaining experiment on B. floridae larvae using a universal anti-NOS antibody 
directed against the C-terminal epitope DQKRYHEDIFG that is highly conserved 
among the different NOS proteins in vertebrates, insects and crustaceans (Pollock et al., 
2004). Immunostaining analyses revealed NOS presence in the larval intestine that 
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seems to be the major organ for NO synthesis and in the dorsal region of the club-
shaped gland (csg) (Godoy et al., 2006) (Fig. 1.20). 
 
Figure 1.20: Whole-mount immunostaining of 48 hpf Branchiostoma floridae larvae with a universal 
anti-NOS antibody. (A) Right-sided view; (B) Left-sided view; (C-E) Magnified view of the right side, 
right and left side of the gut NOS localization; (F) Detail of the NOS staining in the dorsal region of the 
club-shaped gland; G) Western blot analysis of larval protein extract with the same universal NOS 
antibody used for immunostaining (from Godoy et al., 2006). 
 
Other studies were performed on adult specimens. Chen and collaborators, in 2008, 
investigated the expression of dimethylarginine dimethylaminohydrolase (DDAH) and 
Nos genes in adult amphioxus Branchiostoma belcheri tsingtauense (Chen et al., 2008). 
Both genes were detected in the neurons lining the central canal of the neural cord, in 
the wheel organ, in the epithelial cells of gut and midgut diverticulum, in the ciliary 
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epithelial cells on the inner side of branchial lamellas, in the endostyle, in the ovary and 
in the epidermis cells of metapleural fold and in the macrophages in the lymphoid 
cavities of metapleural fold (Fig. 1.21). The authors hypothesized that this co-
expression may be due a conserved role of DDAH in the regulation of NO synthesis 
(Chen et al., 2008). 
 
Figure 1.21: NOS expression pattern in different tissues of adult amphioxus (from Chen et al., 2008). 
  
In 2011, in a study aimed to understanding the evolution of the primordial adaptive 
immune system, Lin and collaborators reported the expression pattern of Nos in 
amphioxus B. belcheri after stimulation of the immune system by Staphylococcus 
aureus injection. Nos expression was detected in gill epithelium and branchial coelom 
macrophages, in the intestinal epithelium and perienteric coelom macrophages, in the 
metapleural fold epidermis and in metapleure coelom macrophages (Fig. 1.22) (Lin et 
al., 2011).  
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Figure 1.22: Amphioxus Nos expression pattern by in situ hybridization experiments in adult tissues. E-
F) gill epithelium and branchial coelom macrophages; K-L) intestinal epithelium and perienteric coelom 
macrophages; Q-R) metapleural fold epidermis and metapleure coelom macrophages (adapted from Lin 
et al., 2011). 
 
Recently, the B. lanceolatum NOS genes expression pattern during embryonic and 
larval development were described. The whole-mount in situ hybridizations (WISH) 
presented by Annona et al. (2017) showed that NosB was expressed early in 
development in endoderm (Fig. 1.23b-d) while later on, and following NosB turning off. 
NosC expression was detected in nervous system and in the club shaped gland, from 
mid-neurula stage in few cells in the anterior part of the neural plate, slightly posterior 
to the neural pore (Fig. 1.23e); at pre-mouth larva in neural tube until the pigment spot  
(Fig. 1.23f); at 3 days post fertilization (dpf) larvae the NosC expression in the neural 
tube disappeared almost completely, remaining in few cells located in the most ventral 
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and posterior part of the cerebral vesicle and, also, expression in the club-shaped gland 
was found (Fig. 1.23g). NosA was not expressed during embryonic development 
(Annona et al., 2017).  
 
Figure 1.23: Branchiostoma lanceolatum NosB and NosC expression during embryonic development. a) 
Fate map of amphioxus gastrula stage; b) NosB expression at early gastrula, lateral view; c-d) NosB 
expression at mid-gastrula stage, respectively lateral and blastopore view. Arrowheads indicate the limits 
of the positive signal e) NosC expression at neurula in neuropore (arrowhead), lateral view; f) NosC 
expression at pre-mouth stage in brain vesicle (arrowhead) and in neural tube (posterior limit, arrow); g) 
NosC expression at 3 dpf larva in the brain vesicle (arrowhead) and club-shaped gland (arrow). Scale 
bars: 50 μm (adapted from Annona et al., 2017). 
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1.4 NEURONAL NOS GENE TRANSCRIPTIONAL REGULATION 
The control of NOS activity is mediated by allosteric enzyme regulation, post-
translational modification and subcellular targeting of the enzyme. Nevertheless, it is 
more important to note that NOS levels are dynamically regulated by transcriptional 
activity. The iNOS gene is predominantly regulated at the level of transcription by 
synergistic combinations of proinflammatory cytokines and bacterial wall products. 
Changes in eNOS mRNA levels following endothelium activation are mediated by 
altered rates of transcription as well as by the intriguing process of changes in mRNA 
stability. Instead, the nNOS mRNA is structurally diverse as a consequence of 
alternative promoters and alternative splicing occuring in a cell-type- and stimulus-
dependent manner in various tissues (Boisesl et al., 2003; Bros et al., 2006). In 
vertebrates, several different NOS1 exon 1 variants were described (Fig. 1.24A; 
Oberbaumer et al., 1998; Sasaki et al., 2000; Bachir et al., 2001; Boissel et al., 2003). In 
human, the brain shows a predominant presence of exons 1c-d, 1f, and 1g while in 
brain-derived cell lines the 1a isoform show the higher activity (Saur et al., 2002; Bros 
et al., 2006). In skin, exons 1d, 1b and 1f are expressed at significant levels while in 
skeletal muscle and heart there is a marked expression of the exon 1d (Bros et al., 
2006). Computational analyses revealed the presence of several potential transcription 
factor’s binding sites (TFBS) in the 5′ flanking genomic regions of different exon 1 
(Fig. 1.24B; Jeong et al., 2000; Bros et al., 2006).  
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Figure 1.24: Organization of the 5′ end of human NOS1 gene. A) Schematic representation of the 5′ end 
of the human NOS1 gene showing the localization of the 12 distinct first exons (1a to 1l in grey) and of 
exon 2 (in black). The position of the translation start codon (ATG) on exon 2 is indicated. B) Scheme of 
potential transcription factor binding sites within the 5′ flanking genomic regions of the various NOS1 
promoters. Included exonic sequences are indicated by gray boxes. Potential transcription factor binding 
sites are indicated by black boxes and labeled (Adapted from Bros et al., 2006). 
 
A number of studies proved that transcription factors of stimulatory protein (Sp) and 
zinc finger (ZNF) families transactivate the nNOS exon 1c promoter (Saur et al., 2002). 
It was described, in particular, the presence of a conserved cAMP response elements 
(CREs), within nNOS promoter, of potential functional importance. This was 
demonstrated thank to experiments using dibutyryl-cAMP, or others cAMP-activating 
agents, that increased the activity of the human NOS1 promoter related to exons 1f and 
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1g (Wang et al., 1994; Hall et al., 1994; Zhao et al., 1999; Bachir et al., 2001; Boissel 
et al., 2003; Bros et al., 2006). Moreover, Ca2+ influx also dynamically regulates nNOS 
expression through the binding of cAMP response element binding protein (CREB) to 
these CREs (Sasaki et al., 2000). In brain cells, it was demonstrated that nNOS 
expression was induced by nerve growth factor (NGF). Deletion studies indicated that 
six potential ETS binding sites as well as four potential AP1 binding sites are present in 
the alternative promoters 1f and 1g and the activation of ETS and/or AP1 transcription 
factors by the RAS-RAF-MAP kinase cascade can contributes to the NGF-mediated 
induction (Rife et al., 2000). It was also identified an active NF-κB responsive element 
in nNOS 1f promoter (Fig. 1.25) using chromatin immunoprecipitation assay with p65 
or p50 antibody; this NF-κB responsive element was crucial for the high activity of 
nNOS 1f promoter in neurons (Li et al., 2007). 
 
42 
 
 
Figure 1.25: Putative cis-acting elements within neuronal Nitric Oxide Synthase (nNOS) 1f promoter. A 
typical TATA-box motif is shown to be located between -28 and -20, and several potential transcription 
factor-binding sites were revealed. NF-kB: nuclear factor kB; C/EBP: CCAAT/enhancer-binding protein; 
GR: glucocorticoid receptor; Sp1: stimulatory protein 1; YY1: Yin (From Li et al., 2007) 
 
1.5 TRANSCRIPTIONAL GENE REGULATION 
1.5.1 Conserved non-coding regions and their gene regulatory function 
Both vertebrate and invertebrate genomes contain regions that do not codify for a gene 
product and, nevertheless, have remained highly conserved across millions of years of 
evolution. Cross-species sequence comparison was shown to be an efficient approach to 
identify putative functional regions in non-coding DNA. Functional sequences generally 
stand out as more “conserved” than non-functional sequences that are subject to genetic 
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drift and become increasingly different between species with increasing phylogenetic 
distance. These regions are called conserved non-coding elements (CNEs) and are often 
highly associated with transcription factor binding sites (TFBSs). Several studies have 
also demonstrated that CNEs can function as enhancers in various developmental 
contexts.  Both these evidences have led to the view of CNEs as cis-regulatory elements 
(CREs) driving spatial-temporal gene expression, especially during embryonic 
development (Nobrega et al., 2003; Johnson et al., 2004; Teng et al., 2004; Woolfe et 
al., 2005; Pennacchio et al., 2006; Li et al., 2010). Therefore, these sequences may be 
conserved because of a consistent gene regulatory function. These regulatory regions 
can lay: 1) upstream or downstream the target gene, 2) inside the introns of the target 
gene, 3) inside the introns of unrelated bystander genes (Fig. 1.26).  CNEs driving the 
expression of these target genes without affecting unrelated bystander genes and they 
are all maintained in syntenic blocks due to the requirement for regulatory elements to 
remain in cis with their target genes. 
 
Figure 1.26: Schematic representation of a target gene regulatory input by CNEs. The dashed lines 
indicate the long-range interactions between CNEs (green) and the target gene (red). Bystander genes are 
indicated in gray and are not affected by CNEs regulatory effects (Modified from Polychronopoulos et 
al., 2017) 
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A number of tools are available to identify conserved non-coding elements in genome 
sequences i.e PhastCons (Siepel et al., 2005), Percent identity plot (PiP) (Schwartz et 
al., 2000), and Gumby (Prabhakar et al., 2006). These tools are available on different 
browser and are based on a two-step process: 1) homologous regions of two or more 
different genomes are aligned (local or global) and the best fit for each nucleotide 
position is determined; 2) using a statistical method, regions where the sequence is more 
constrained (i.e. similar between the different organisms) than what would be expected 
for neutrally evolving DNA are identify. In this type of analysis, the choice of the 
species being compared can be used to roughly calibrate sensitivity versus specificity. 
The comparison of close species increases the sensitivity while that of distant species 
favors greater specificity. 
Once identified a CNE, in order to test if it acts as enhancer, it ideally need to be fuse 
with a reporter gene (e.g. GFP, luciferase, LACZ) with a minimal promoter and 
introduce it into a living model system, essaying the reporter gene expression during 
development (Fig. 1.27) or in in vitro cell lines. In general, transgenic approaches have 
been very successful in identifying enhancer properties of conserved non-coding 
sequences, with substantial overlap between the known endogenous pattern of 
expression of a gene and its associated CNEs.  
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Figure 1.27: Experimental design. Identification (example alignment displayed as PhastCons diagram), 
cloning and transgenic testing of candidate enhancer sequence. 
 
1.5.2 Ciona robusta as model organism for transgenic experiments 
Ascidians, together with thaliaceans and appendicularians, are grouped as Tunicates 
(Lamarck, 1816) or Urochordate (Lankester, 1877) (Fig. 1.9). Only after Kowalevsky 
had described the tailed larval form of ascidians in 1866, containing a dorsal neural 
tube, the notochord and lateral muscle cells, zoologists realized that tunicates should be 
placed within the chordates (Fig. 1.9). Because cephalochordates shared more 
morphological feature with vertebrates, the tunicates were initially placed at the base of 
Chordata (Hecht et al., 1987; Winchell et al., 2002) but, a more recent analysis 
established that cephalochordates, and not tunicates, are the most basally divergent 
lineage of chordates (Blair et al., 2005; Delsuc et al., 2006, 2008). The ascidian Ciona 
robusta is an important model organism for the study of developmental gene regulation, 
in part because transient transgenic embryos can be produced rapidly and reliably using 
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electroporation of fertilized eggs (for electroporation protocol in C. robusta see the 
chapter of Methods) (Davidson et al., 2005, 2006; Vierra et al., 2012). C. intestinalis    
transgene electroporation was first reported by Corbo et al. (1997). This type of 
transgenesis is considered to be transient and observed only in the electroporated 
embryos. However, it has been reported that stable transgenic lines can be produced as 
well (Matsuoka et al. 2005). The Ciona specimen originally described by Linnaeus 
(1767) was called Ciona intestinalis and for long time this name was used for 
specimens used in all the laboratories in the world. But now it is known that two closely 
related species were wrongly called with the same name. These two species are 
currently referred as C. intestinalis or type B (i.e. Northern Europe) and C. robusta or 
type A (i.e. Southern Europe) (Brunetti et al., 2015). The animals used for the 
experiments described here come from the Mediterranean sea.  
Many characteristics make C. robusta a highly tractable model: they have only 2,500 
cells in the late larva; cell fates are determined very early in embryogenesis compared to 
those of other animals, and developmental genes have concomitantly altered functions 
in patterning the embryo. 
Ciona robusta larval anatomy and nervous system   
The tadpole larva is mostly divided into two parts, the “trunk” (or head) and the “tail” 
(Fig. 1.28). The head is composed by: the anterior central nervous system (CNS); the 
peripheral nervous system (PNS); an undifferentiated endoderm that will form the 
endostyle and the anterior part of the gut; an undifferentiated mesoderm from which 
will derive the muscles, the heart and the blood, the tunic cells. The tail is mostly 
composed by the caudal CNS and PNS, the notochord (axial mesoderm), the muscles 
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(paraxial mesoderm), a ventral endoderm that give rise to the adult intestine and a vary 
caudal undifferentiated endoderm. 
 
 
Figure 1.28: Ciona robusta larva. The two parts of the larva, trunk and tail, are indicated. 
 
C. robusta larva CNS is divided, along the antero-posterior axis, in five compartments 
(Fig. 1.29A). Most anteriorly there is the sensory vesicle (SV), in which two pigmented 
cell-containing sensory structures are present: the anterior geotactic otolith and the 
posterior photoreceptive ocellus (Fig. 1.29B). Then there is the posterior sensory vesicle 
(PSV) also known as larval “brain”, containing neurons, photoreceptors and other 
sensory cells associated with the SV. This anterior CNS region is marked by Otx 
expression that is absent in the remainder (Ikuta and Saiga 2007). Posterior to the PSV 
is the neck, which is a mass of undifferentiated neuronal progenitors that express 
Pax2/5/8 and Phox2, supporting the homology of this region with the vertebrate 
hindbrain (Dufour et al., 2006).  Caudally there is the motor ganglion (MG) composed 
by neurons and interneurons that drive the swimming behavior of the larva (Bone et al., 
1992; Horie et al., 2010). The motor ganglion progenitors express specific spinal cord 
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motor neuron specification genes of vertebrates that support the homology of this region 
with the vertebrate spina cord. Most posteriorly, along the tail, there is the nerve cord 
(Fig. 1.29A). 
The peripheral nervous system (PNS) of the C. robusta tadpole larva comprises a 
distributed population of isolated receptor neurons, most of unproved function, 
organized along the trunk and the tail epithelium (Fig. 1.29B; Imai et al., 2007; Ryan et 
al., 2016). In the head, these neurons are dispersed only in the anterior and dorsal 
regions (Imaia and Meinertzhagen, 2007). In the tail, the neurons of the PNS, called 
caudal epidermal sensory neurons (CESN), are regularly distributed on the dorsal 
(DCEN) and the ventral (VCEN) side. The dorsal neurogenetic epidermis is induced by 
FGF signaling while the ventral is induced by ADMP/BMP signaling (Pasini et al., 
2006).  
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Figure 1.29: Ciona robusta larva nervous system. A) The five major anatomical subdivisions of the CNS 
are demarcated. SV: sensory vesicle; PSV: posterior sensory vesicle; N: neck; MG: motor ganglion; NvC: 
nerve cord. The CNS is fluorescently labeled with the vesicular acetylcholinesterase transporter (adapted 
from Stolfi et al., 2011). B) Diagram of larva nervous system sections and cells type. Abbreviations: Pap: 
papilla neuron: RTEN: rostral trunk epidermal neurons; ATENa: anterior apical trunk epidermal neurons; 
ATENp: posterior apical trunk epidermal neurons; Oc: ocellus; Ot: otolith; Ant: antenna neuron; Cor: 
coronet cell; PR: photoreceptor; ddN: descending decussating neuron; AMG/Ascending MG IN: 
ascending motor ganglion interneuron: MGIN: motor ganglion interneuron; MN: motor neuron; DCEN: 
dorsal caudal epidermal neuron; VCEN: ventral caudal epidermal neuron; BTN: bipolar tail neuron; Mu: 
muscle; pnsRNs: PNS relay neurons; PRRNs: photoreceptor relay neurons; AntRNs: antenna relay 
neurons; BV: brain vesicle; MG: motor ganglion; CNC: caudal nerve cord; Not: notochord; IN: 
interneuron; BVINs: brain vesicle interneurons (adapted from Ryan et al., 2016). 
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CHAPTER 2 
MATERIALS AND METHODS 
 
 
2.1 ANIMALS CARE AND GAMETES COLLECTION 
2.1.1 Branchiostoma lanceolatum sampling and ethics statement 
Adult amphioxus specimens (Branchiostoma lanceolatum) were collected from an 
endemic population of the Gulf of Naples (Italy) (40°48'33'' N - 14°12'55'' E) at a 
location that is not privately owned or protected in any way, according to the 
authorization of Marina Mercantile (DPR 1639/68, 09/19/1980 confirmed by D. Lgs. 
9/01/2012 n.4). All procedures were in compliance with current available regulation for 
the experimental use of live animals in Italy. The animals were caught using a drudge 
on the soft bottom, with the support of the SZN vessel "Vettoria", and collecting 5-10 
cm of sand. After the sand collection between 7 and 15 meters deep, it was sifted 
directly on boat using a net with a 1.25 mm mesh (Fig. 2.1).  
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Figure 2.1: Adult amphioxus sampling. (A) Drudge used to bring sand onboard; (B) Sorting of the sand; 
(C) Ripe adult amphioxus specimens. 
 
2.1.2 Branchiostoma lanceolatum culturing 
Animal care is entrusted to the “Marine Resources for Research Unit (MaRe)” at the 
Stazione Zoologica Anthon Dohrn of Naples. Animals were kept in an open seawater 
circulating system reproducing natural thermal and light conditions with continuous 
aeration (Fig. 2.2). During the period of gonad maturation (April to July) the 
temperature was maintained at 17°C, slightly lower than the field, to avoid the natural 
emission of sperm and eggs in the tank. Animals were fed daily with a 1:1 mix of 
Isochrysis galbana and Rhodomonas sp microalgae. 
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Figure 2.2: Amphioxus facility at the Stazione Zoologica Anton Dohrn of Naples. 
 
2.1.3 Branchiostoma lanceolatum spawnings 
B. lanceolatum gonads development starts in winter and between the late spring and the 
beginning of the summer arrive to maturation. As mentioned above, to avoid the natural 
emission of sperm and eggs, the animals were kept at a low temperature (17°C). The 
induction of artificial spawning was performed applying a heat shock to ripe animals. 
Selected animals, with visible mature gonads, were placed in a water bath with a 6 
degrees higher temperature than the culturing system; the day after before sunset the 
animals were singularly separated in glass beakers containing 100 ml of filtered sea 
water to avoid the uncontrolled fertilization. After approximately 30 h of exposure to 
the temperature stress, precisely after sunset, the animals would start to spontaneously 
release gametes (resembling the natural spawning) (Fig. 2.3). Upon release of gametes, 
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the adult animals were removed from the glass beakers, the sperm from several males 
was mixed to increase the fertilization percentage and kept on ice. 200-300 eggs were 
distributed into petri dishes with scratched bottom to avoid that they would attach to it, 
then they were fertilized with some drops of sperm’s mix. After approximately 10 min 
the percentage of fertilized eggs were checked by the elevation of the fertilization 
membrane and if less than 65% of the eggs were fertilized, another drop of sperm would 
be added. Subsequently, embryos were washed twice with filtered sea water (FSW) and 
left to grow until desired developmental stage at 18°C.  
 
 
Figure 2.3: Schematic timing representation of induced spawning in B. lanceolatum. Dark (night) period 
are represented by black area. The red line indicates the thermal shock from 17 to 23°C. Abbreviations: 
temperature (T), hours (h). 
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2.1.4 Ciona robusta sampling, care and gametes collection 
C. robusta is a hermaphroditic broadcast spawner that is widely distributed along 
Mediterranean and worldwide temperate costs. The animals used for the transgenic 
experiments shown in this thesis were fished by the crew of the SZN vessel “Vettoria” 
in the southern coastal regions of Italy, mainly in Taranto (Puglia, Italy). Once they 
were brought to the SZN, animals spent at least a week in an open circulating seawater 
tank at a temperature similar to that in the field in order to acclimate them to the new 
conditions. Animals care was entrusted to “Marine Resources for Research Unit 
(MaRe)” at Stazione Zoologica Anthon Dohrn of Naples. The spawning period is 
restricted from early autumn to late spring. In order to obtain gametes in the laboratory 
it was unfortunately necessary to kill the animals, so a continuous supply of adults was 
necessary. Tunic and muscles were splitted by scalpel trying not to damage the 
gonaducts to avoid uncontrolled fertilization. Sperm and eggs were therefore separately 
collected until the fertilization was carried out in in petri dishes of 6cm diameter with an 
agarose bottoms.  
 
2.2 IN VIVO EMBRYONIC MANIPULATION 
2.2.1 TRIM and L-NAME treatments in amphioxus 
In order to understand the role of NO during amphioxus embryonic development, we 
decreased the NO production using two types of soluble drugs that alter the NOS 
activity: an analog of L-arginine, the Nω-Nitro-L-arginine methyl ester hydrochloride 
(L-NAME, Sigma Aldrich, stock solution in filtered sea water, FSW) and a NOS 
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inhibitor, the 1-(α,α,α-trifluoro-o-tolyl)-Imidazole (TRIM, Cayman Chemical, stock 
solution in DMSO), which interfere with the binding of both L-arginine and 
tetrahydrobiopterin to their respective sites on NOS enzymes. Different drug 
concentrations and timing were tested. The L-NAME treatments were performed with 
100 µM, 1 mM and 10 mM of drug as pilot experiments. The in vivo experiments were 
performed at 50, 75 and 100 µM TRIM. Treatments were performed in petri dishes of 
3cm diameter with scratched bottoms at 18°C. Embryos developed in FSW or 
FSW+DMSO and in parallel embryos in the same developmental conditions but in 
absence of the drugs were used as control. For L-NAME treatment, we used an 
additional control: the inactive enantiomer Nω-Nitro-D-arginine methyl ester 
hydrochloride (D-NAME, Sigma Aldrich). Larvae at 72 hpf were fixed in 4% 
paraformaldehyde (PFA), dehydrated and stored in 70% ethanol. The larvae 
morphology was analyzed initially using a stereoscope and then, for image acquisition, 
a Zeiss EVO MA LS Scanning Electron Microscope.    
 
2.2.2 LPS treatment in amphioxus 
Lipopolysaccharides (LPS) are component of Gram negative bacterial wall and is 
usually used as a stimulator of the immune system. In this thesis, LPS treatment was 
used to investigate the possible inducible nature of at least one of the amphioxus Nos 
genes (NosB). 72 hpf larvae were stimulated with 10 µg/ml of LPS from Escherichia 
coli (O26:B6, Sigma Aldrich) for 1, 2, 4, 6 and 8 hours. The LPS was dissolved in 
FSW. Plates in which treatment was performed, were silanized (SIGMACOTE®, Sigma 
Aldrich) in order to avoid LPS binding to plastic plate walls and the consequent 
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reduction of its concentration in solution. As control of successful stimulation of the 
immune system, an amphioxus Intelectin gene (AmphiItln239631) was used (Yan et al., 
2013). Intelectins are lectins (carbohydrate-binding proteins) that bind specifically 
soluble galactofuranose and are involved in innate immunity. In particular, 
AmphiItln239631 contains a conserved fibrinogen-related domain (FReD), an intelectin 
domain and a putative collagen domain. The experiments were carried out in biological 
triplicates, each of which consisted of about 300 larvae for both control and treated. The 
fold change between control and LPS treated conditions were analyzed by qPCR.  
 
2.2.3 Transgenesis in Ciona robusta 
Before proceeding with the external introduction of DNA constructs via electroporation 
it was necessary to deprive the eggs from the chorion. A chemical dechorionation has 
been performed in a petri dish covered by a thin layer of 1% agarose in filtered sea 
water (FSW) containing a solution of Thioglycolic acid (1%, pH 10) and Proteinase E 
(0.05%) in FSW. The eggs were incubated in this solution for 5-6 minutes, shaking 
continuously using a glass pipette to remove the chorion and the follicular cells 
surrounding the eggs. In the next step, the eggs were washed several times in FSW to 
remove the dechorionation solution and then they were fertilized with sperm collected 
from two or more individuals to avoid self-sterility problems. After 10 minutes, 
fertilized eggs were washed 2-4 times to eliminate the exceeding sperms and then used 
for transgenesis experiments. The dechorionated and fertilized eggs have been 
transferred in a solution containing 0.77 M Mannitol containing 50-150 μg of DNA 
construct. The electroporation has been realized in 0.4 cm Bio-Rad Gene Pulser 
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cuvettes, using a Bio-Rad Gene Pulser II electroporator, at constant 50 V and 500-800 
μF, to have a time constant of 14-20 m/seconds. Afterwards, the embryos have been left 
to grow until desired developmental stage, at 18-20°C and then analyzed in vivo at the 
fluorescent microscope with a GFP filter and fixed for immunostaining. 
 
2.3 AMPHIOXUS EMBRYOS COLLECTION AND FIXATION 
Embryos at different developmental stages were collected and pelleted with a light 
centrifugation (1500-3000 rpm for 2-4 min) in order to remove much as possible sea 
water. For RNA extraction, they were stored at -80°C or kept in Eurozol (EuroClone) 
and stored at -20°C until the RNA extraction. For NO quantification (Griess assay), 
embryos after collection were frozen at -80°C in eppendorf tubes. For in vivo 
experiments such as NO localization or drug treatments, the embryos were kept in the 
petri dishes in FSW at 18°C until they reached the desired stage of development. 
 
2.4 BASIC MOLECULAR BIOLOGY PROCEDURES 
2.4.1 RNA purification 
To eliminate RNAase contaminations all the procedures were carried out in sterile 
condition. Samples, already kept in Eurozol, were homogenized using a pestle. Then 0.1 
volume of chloroform was added, mixed vigorously and centrifuged at 14.000 rpm at 
4°C. The aqueous phase was collected and precipitated over night with an equal volume 
of isopropanol. After precipitation, the sample was then centrifuged for 30 min at 
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14.000 rpm at 4°C. The obtained pellet was washed with 70% Ethanol, centrifuged, air-
dried and resuspended in DEPC H2O. The sample’s concentration was measured with a 
“NanoDrop 1000” spectrophotometer (Thermo) and RNA integrity was checked on a 
1% agarose gel. The total RNA was kept at -80°C until use. For differential 
transcriptomic analyses, RNA was purified with the RNeasy Mini Kit from QIAGEN 
following the protocol supplied by producer. 
 
2.4.2 Reverse transcription of RNA 
cDNA was obtained by in vitro reverse transcription using 0.5-1 μg of total RNA. This 
enzymatic reaction leads the synthesis of the DNA strand complementary to the RNA 
template using an RNA polymerase. The reaction was carried out with the SuperScript 
VILO cDNA Synthesis kit (Invitrogen). Reaction was performed, in a final volume of 
20 μl, in a thermocycling according to the following setting program: 25°C for 10 min, 
42°C for 60 min, 85°C for 5 min. The cDNA obtained was kept at -20°C until use. 
 
2.4.3 DNA and RNA gel electrophoresis 
In order to evaluate the RNA integrity or to separate DNA fragments on the base of 
their length, a horizontal agarose gel electrophoresis was performed. The concentration 
of the agarose was chosen according to the length of the expected DNA fragment. The 
gel was prepared with 1X TBE buffer (1.1 M Tris; 900 mM Borate; 25 mM EDTA; pH 
8.3) and 0.5 μg/ml Ethidium Bromide. DNA samples were mixed with Loading Buffer 
1X (0.25% Bromphenol Blue; 15% Ficoll 400, 120 mM EDTA, 0.25% Xylene Cyanol) 
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and the appropriate molecular marker. Electrophoresis was normally settled at the 
voltage of 90-100 V. For RNA, the procedure was similar to that used for DNA with 
slight modifications to avoid RNA degradation, but it was not prepared in denaturation 
conditions: the electrophoresis camera was RNAse-free, the running buffer was fresh 
prepared. The samples were boiled before the electrophoretic run in order to remove 
secondary structures.   
 
2.4.4 Genomic DNA preparation 
Genomic DNA was isolated from whole adult animals or from their caudal fin, in 20 µl 
of 50 mM NaOH. The samples were heated for 5 minutes at 95°C in a thermos-block, 
followed by cooling to 4°C. 100 mM Tris-HCl pH 8.0 was added in a 1:10 ratio. The 
samples were briefly centrifuged to collect the lysate in the bottom and 2 µl of the 
supernatant, containing the DNA, used for PCR reaction. 
 
2.4.5 Molecular cloning 
Molecular cloning is a technique used to insert recombinant DNA into a vector that will 
be replicate in host organisms. It consists of three phases: DNA ligation, transformation 
and hosting bacterial growth. 
DNA ligation: T4 DNA Ligase catalyzes the formation of a phosphodiester bond 
between juxtaposed 5'-phosphoryl and 3'-hydroxyl termini in duplex DNA. The PCR 
fragments were ligated with the commercial plasmids p-GEM-T Easy vector (Promega). 
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Each ligation reaction was carried out in a final volume of 20 μl in distilled H2O and 
containing 50-100 ng of vector DNA linearized. The moles of insert DNA were added 
in 3-5 fold vector moles and 2 μl of ligation buffer (10X T4 DNA Ligase buffer: 500 
mM Tris-HCl pH 7.5, 100 mM MgCl2, 100 mM dithiothreitol, 10 mM ATP, 250 μg/ml 
bovine serum albumin) and 1 μl of T4 DNA Ligase (1 unit/μl) (Promega). The reaction 
mix was incubated at 4°C overnight or two hours at room temperature, and used to 
transform competent bacteria. 
Bacterial transformation and growth: The transformation of vectors containing DNA of 
interest was performed by electroporation in bacterial cells Escherichia coli DH5α 
provided by the Molecular Biology Service of SZN and stored at -80°C. When needed 
the cells were gently defrosted on ice for 10 min, and the 40 μl were mixed with 4 μl of 
dialyzed vector (more or less 40 ng), then the mix was transferred quickly into electro-
cuvette. The electric shock was performed in a “Bio-Rad Gene Pulser” applying a 
constant voltage of 1.7 V. The cells transformed were placed in 800 ml of Luria Bertani 
(LB) medium shaking at 270 rpm at 37 °C for 1 hour, then the bacterial cells were 
plated on LB solid medium (NaCl 10g/l, tryptone 10 g/l, yeast extract 5 g/l, agar 15 g/l) 
in the presence of ampicillin (50 μg/ml) to which the plasmids were resistant. IPTG and 
X-gal (40 μl + 40 μl, respectively) were added for the blue-white screening technique 
and grown overnight at 37°C. 
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2.4.6 Isolation of plasmidic DNA from Escherichia coli 
Escherichia coli positive colonies were picked from the plates and grown overnight at 
37°C by shaking in 3 ml of LB medium containing 0,1 mg/ml of ampicillin. In order to 
reduce the number of colonies to purify, PCR colony screening was used to detect 
positive colonies. The colonies were individually picked using a sterile plastic tip and 
dissolved into 12,5 µl of PCR reaction mix. M13 forward and M13 reverse primers, that 
are more or less 60 bp up- and downstream the insert on the vector, were used for the 
amplification (primers sequences are listed in Table reported in section 2.16).  Mini or 
Maxi plasmid DNA isolations (Mini-prep or Maxi-prep) were carried out according to 
the protocol supplied of GenElute™ Plasmid Miniprep Kit (Sigma) and GenElute™ 
Plasmid Maxiprep Kit (Sigma). The elute DNA was quantified with the “NanoDrop 
1000” spectrophotometer (Thermo) as absorbance at 260 nm.  
 
2.4.7 Polymerase chain reaction (PCR)  
Polymerase chain reaction (PCR) is a method that allows exponential amplification of 
short DNA sequences within a longer double stranded DNA molecule. Each 
amplification reaction was conducted in a volume of 12,5 to 100 μl of reaction mix 
depending on the purpose of the experiment and it was composed by sterile H2O, 1X 
reaction buffer, 1.75 mM MgCl2, 0.2 mM dNTP, 50 pM of each primer, 1 U/μl of 
GoTaq DNA polymerase (Promega) and 1 ng of DNA template for each μl of final 
reaction. The amplification cycles were conducted by means of Thermal Cycler Perkin-
Elmer-Cetus. After denaturation at 95ºC for five min, 30 amplification cycles were 
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performed as follows: denaturation at 94 ºC for 30 sec, annealing at 55-65°C for 30 sec 
(depending on the primers), extension at 72°C for 0.5-1.5 min (considering 1 min to 
synthesize 1 kb). An extra extension cycle of 10 min was carried out at 72 ºC to 
complete all DNA strands. To purify the amplified DNA from the excess of buffer and 
dNTPs, the PCR Purification kit (Invitrogen) was used according to the protocol’s 
instructions. The concentration of the obtained DNA was measured using a “NanoDrop 
1000” spectrophotometer (Thermo) and checked on a 1-1.5% agarose gel with the 
appropriate molecular marker. 
 
2.4.8 DNA sequencing of individual plasmids 
The DNA sequencing was carried out at the Molecular Biology Service of SZN using 
Automated Capillary Electrophoresis Sequencer 3730 DNA Analyzer (Applied 
Biosystems) using a BigDye® Terminator v3.1 Cycle Sequencing Kit (Life 
Technologies). 
 
2.4.9 Oligonucleotides 
The following table (Table 2.1) shows all the primers used for the experiments reported 
in the present thesis. 
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Primer name Sequence (5’        3’) Product length 
Digital Droplet PCR and qPCR 
Bl_NosA_Fw AGTACAGTCATCTCCAGAAC 221 bp 
Bl_NosA_Rv TCTTGCAAGCGCTTCTATCTG 
Bl_NosB_Fw AGTTTACTCCCGGCGATCA 191 bp 
Bl_NosB_Rv AGAACATGGCGGCAAACGC 
Bl_NosC_Fw CAGGATTCTGCGCGTTTGC 197 bp 
Bl_NosC_Rv GGAGCTAGCCTCGCTCATG 
Bl_L32_Fw GGCTTCAAGAAATTCCTCGTC 117 bp 
Bl_L32_Rv GATGAGTTTCCTCTTGCGCGA 
Bl_ITLN_Fw CTTCTGGAGCGTGTGGCAG 183 bp 
Bl_ITLN_Rv CCTCTTTGGCCTCATTCTGGG 
Sequencing 
T3 ATTAACCCTCACTAAAGGG 
T7 AATACGACTCACTATAGGG 
SP6 GATTTAGGTGACACTATAG 
M13Fw CGTTGTAAAACGACGGCCAGT 
M13Rv TTTCACACAGGAAACAGCTATGAC 
Amphioxus CNRs amplification and cloning - NosC, Intron 1 - 
CNRs 2-3 Fw CTACCCATACCTCTAGGTATGG 1571 bp 
CNRs 2-3 Rv CTAATATTGCTTGGCCGGTTTC 
CNRs 6-9 Fw CCTTGCCGGTTGTAGAGTG 1617 bp 
CNRs 6-9 Rv GTCATGGGTCTATGGCGATG 
CNRs 14-15 Fw CATGTGAGGGCTAGCTAGGCAC 1301 bp 
CNRs 14-15 Rv GTTGTGTCCCTATTGTCCTTG 
CNRs 17-18-19 Fw GGAATAGCAACTCCTCGCTG 1741 bp 
CNRs 17-18-19 Rv GAAAGACAGGTGCAGCCCTAAC 
Amphioxus CNRs amplification and cloning - NosC, Intron 2 - 
CNR 30 Fw CCAATGTACCCGAGCACTAAC 509 bp 
CNR 30 Rv CGGGTTCGTCCTTAGTAATAGC 
CNR 33 Fw CCTCACCGACAAAGACCAAG 453 bp 
CNR 33 Rv GTGACTTGTGAGTGCAGGTGG 
CNR 34 Fw GAGAGGAATAGTTGTGGCCG 613 bp 
CNR 34 Rv GTCGTATGACGGATGTGATCAG 
CNRs 39-40-41 Fw CATTGCCTGTGATGTACATTG 1364 bp 
CNRs 39-40-41 Rv GACAAACTCTCTGGTCGATAGG 
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CNR 45 Fw GACTTACCAACCTGAGGAAGC 742 bp 
CNR 45 Rv CATACTGTCAATGAGTCACTGTAG 
 
Table 2.1: List of primers used for PCR experiments. For each pair of primer, the amplification product 
length is reported. 
 
2.5 QUANTITATIVE GENE EXPRESSION  
2.5.1 Quantitative real-time PCR (qPCR) 
mRNAs expression profile was monitored using quantitative real time PCR (qPCR). 
Optimal cDNA concentration to use was established empirically, through serial 
dilutions. The qPCR was carried out in triplicate with a ViiATM 7 Real-Time PCR 
System (Applied Biosystems) in a 384-multi-well plate. Each reaction was performed in 
a final volume of 10 μl containing 0.7 pmol/μl of each primer, 5 μl of SYBR Green mix 
with ROX (Applied Biosystems) and 1 μl of diluted cDNA. Thermal cycling parameters 
were: 95°C for 15 sec, 40 cycles at 60°C for 1 min followed by a denaturation step from 
60°C to 95°C with a continuous detection at 0.015°C/sec increment for 15 min to verify 
the presence of a single product. The results were analysed using the ViiA™ 7 Software 
and exported into Microsoft Excel for further analysis. Quantification results were 
expressed in terms of cycle threshold (Ct). The Ct values were averaged for each 
triplicate. Amphioxus ribosomal protein L32 gene was used as endogenous control for 
the experiments (Kozmikova et al., 2013). Differences between the mean Ct values of 
the tested genes and those of the reference gene were calculated as ΔCtgene = Ctgene - 
Ctreference. Relative expression was analyzed as 2-ΔCt. Relative fold changes in 
expression levels were determined as 2-ΔΔCt. 
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2.5.2 Digital droplet PCR (ddPCR) 
ddPCR is a method for performing digital PCR that utilizes a water-oil emulsion droplet 
system using a combination of microfluidics and proprietary surfactant chemistries. 
Droplets are formed in a water-oil emulsion that partitions the nucleic acid samples into 
20,000 nanoliter sized droplets, with background and target DNA randomly distributed 
among the droplets. Sample partitioning is key to ddPCR. Following PCR, each droplet 
is analyzed or read to determine the fraction of PCR-positive droplets in the original 
sample. These data are then analyzed using Poisson statistics to determine the target 
DNA template concentration in the original sample. The benefits of ddPCR technology 
are different, in particular it allows to accurately evaluate very low gene expression, like 
that of Nos genes. Nos genes expression were evaluated at gastrula (10hpf), middle 
neurula (24 hpf), pre-mouth larva (48 hpf), open-mouth larva (72 hpf) and small adult 
(1,2 cm length). Amphioxus ribosomal protein L32 was used as the reference gene 
(Kozmikova et al., 2013). Experiment was performed in biological triplicates. For my 
experiments, approximately 550 ng of total RNA, from each developmental stage 
analyzed, were reverse transcribed. For each sample, 3 ng of cDNA was mixed with 10 
µl of 2X ddPCR Evagreen Supermix, 0.5 pM of each primer and nuclease-free water to 
a total reaction volume of 20 µl. The entire reaction mix of 20 µl was then loaded into a 
sample well of a DG8 Cartridge for the QX200/QX100 droplet generator. This was then 
followed by adding 70 µl of droplet generation oil for probes into the oil wells of the 
cartridge, according to the QX200/QX100 Droplet Generator Instruction Manual. The 
cartridge was then inserted into the Automated Droplet Generator. After droplet 
generation, the droplets were transferred to a 96-well plate and then sealed with foil 
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using the PX1 PCR plate sealer.  Thermal cycling was performed according to the 
following protocol: enzyme activation at 95°C for 10 min (1 cycle), denaturation at 
94°C for 30 sec followed by annealing/extension at 60°C for 30 sec (40 cycles), enzyme 
deactivation at 98°C for 10 min (1 cycle) followed by hold at 4°C. After thermal 
cycling, the sealed plate was placed in a QX200 droplet reader and the absolute gene 
expression level per well for the probes and reference genes were quantitated using 
QuantaSoft software. The gene expression values for each sample were normalized to 
the housekeeping gene. The values for the absolute level of gene expression as obtained 
by ddPCR were then subjected to the t-test for each gene under the triplicate conditions, 
with a resulting P-value. A P-value of less than 0.05 was considered significant.  
 
2.6 CONSTRUCTS PREPARATION FOR TRANSGENESIS 
2.6.1 Amphioxus enhancers 
Amphioxus putative enhancer fragments, included in the non-coding region of the 1st 
and 2nd intron of NosC gene, were cloned from B. lanceolatum genomic DNA. 
Conserved sequences were retrieved from an alignment between three different 
Branchiostoma species (B. lanceolatum, B. floridae and B. belcheri; see Results). 17 Kb 
upstream the translation start codon ATG (intron 1) and the entire intron 2, downstream 
to the ATG, were considered for analysis. Sequences were taken from genome draft 
version Bl71nemr, kindly provided by the “Branchiostoma lanceolatum genome 
consortium”. The primers used to amplify these regions, are reported in the Table 2.1 in 
section 2.4.9. These regions were tested in vivo in C. robusta to verify the possible 
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presence of enhancers. The sequences of genomic DNA fragments cloned and tested in 
vivo are listed below and the localization of each fragment on B. lanceolatum scaffold 
Sc0000060 is indicated by numbers. The sequences in red correspond to conserved non-
coding regions (CNR).  
 
 
Sc0000060:252628-253878 (CNRs 2-3, intron 1) 
GACGTTTGAGTTGGGCCAGGCTGGTACCTTTTTGGTTTTAGGTTTCTGTATGCGTTTGTCTGTCTTGGTGTGTGTCAGTAGTTATTATCTCCATGGAAAATGGAGA
TATTGTTTTGGGTGTGTCTGTGTGTCTGTCTGTCTGTTTGTCTGTCTGTTTGTGTTTCCGGACTACTGTAGTCAGCATAACTCAAGAGCCTCTTGATGGATTACAAT
GATATTTGGTATGTGGGCGGGTGTTGTGAAGCCGAAATTCAAGGTCGATTTTGGGCCCCCTGGTATGTGACCTTGGTACTGCAGTAGAACTTCAATTTTTGTATC
TTTTGACCTGGACGTGCTGTGGTCTTGATATTTGGGTGGCAGATAGCTTGTGATGTAATAAAGAAGTGGAGTAGGTTAGGGCCCCCTAGCAGCTTCCTCTGGAA
CTGCAGGGGCGTTTTTTAAATATTGTTGAGTGACAATATGGGAGGCGGAAAATGGTGTAACGGAAGATTGCTTGGCCCGCGCCGGGTCCAGAGTTGGTCCCGC
TGACTGGCAGGAAGGGAAGATTTTTTGGCCTGGGTCCAAAGTTGGTCGCTGGCTGACAGGAAAATGCATAAACAGAATTAGAGAGAAACTCACAATAATGAAT
AAAAAAAGAAATTCACAAAAACTCTCCAATAGAGAAAGTATATCATTGAGATGTGAGATTTTTGATTTCTTGTATACTAATGCGTACGTCTTATCGCTGCATCTTC
CGACAACATCCGTACCCTAACAGCCGAAAGAGTCAAAGAACAAATTTAACCAACTTTTGAAGGGTAAAGTCAAACGTAGTGACTTTATCATGTTGCACGTTTCAT
GTTGCGTGACAGAACGTGGCATTCTGCACGTATCCGGAGTCATTTGTTTCAGTTTTTATTACCGATACGAGCAGGGAGACAGAACTAGGTTATTATGAGATTAAT
AACTCATTTTTGAGATTAATAACTCTGACAAAACGCAAAATTCCTCATACTCTAGACATGATACAATCGAAACAGCGTATTCAACAGGTTTAATTTCTAACCCAAA
CTTTTGATATCCATAAAATTGACATCGTTTTACATCAAAATGCTAATGCCATTTTCATAATCATCAGAGGTCATCAAAAACAAATATGTTCGGTTAAAAGATTCTGC
GCTGTTCGTCATAGTGCGACATAGATTGTTACGATCCAATTATCATTTCCAGAGATACCGGGGTAATTTTTCCTCAAGGTGACTCCGTCCTATTGCAAGTGTGTCC
GTTTTCAGATCTANGACTCCGTCCTATTGCAAGTGTGTCCGTTTTCATGTCTACATGTCCTTAGTTAGTTTTTACCTTCGGGAGGGAGGGTCGCCTCCGACGGGAG
GTATTGTTTTTGGTTGCGTGTTTGTGTGTCCGCACCCATAACTCAATATCCATTGGATGGACTGTTATGTTTTTGGTATGCGGGTAGGTATTAAAAGAAACCGGCC
AAGCAATATTAG 
Sc0000060:254561-255958 (CNRs 6-9, intron 1)  
CCTTGCCGGTTGTAGAGTGGTATATACGTGTCAAACTTTTTCGCTGGCTTCGTTTTCGAGATATTCACCTCCCTAGTATTGGCGTAAAGCCTGAGGTCTATACCAC
TAAGGCCAATTATAAGATCTTGGCGACTGTATCACATAGTATTTCTGTAGAACATGTTATCAAAGTATCATACATGGTTTGCCATTCTTGGAGTGAAAAAAAGAA
GAAAATTTCCTTTCACATGGAGTAGCTTGATACCACTGTTAAGATTGGACCAAGGAGTTTTAAACCTCCTTGATTGGACAGACCTGTGAATATCAACTGGGACCC
TAACAGAGCCCTCTATCAGGTACTGTTGGTACTGCAACATCCTCACTGGACCCCTTATTTTGCGCAAGATTAGAGAGGACTATTAAAAACTTTCTCCTCGCTTTAT
GGCAGCGCCGAACCACCGTGCACTTGACCCTTTCGTCCTACCGCACTCACAAGGGCAAAAATGCTGACGGGCTCTCCAAGTTCAAAGGCTATATCTCACTTTCCT
GCGTCTTTGTGAAACTTGCTCACGCTATCCTAATTAAATCTTCCCTCTGTCGAGTCTGAGTGATATTCACTCCCTTTGTACCACAAGGCCTATTGAACACGCTGTGT
AGATGAATAAATGCCCTTCACGAGTGCCCTTTGGGTCAGACCTGCGTCTATTGGCCCCTGACTTAACACAATCAAACAATCACAAGAGCGACTTTGTACTCTATA
CACTAATAACCTTGTTCGTACTTCTGTGACTAGGTTATCATGATTATAGGTTCTCGATGGAAGTTTTCTTCTAATAATGTCATGACGCTCCTTTGTAGTCTAGTTAA
GTGCTGTGTGGCAAGGTAGGATGTTGAAGAATTCAACAATAACTCAAAGGCGTTCGATTCAATTAACTGATATTGCACGGACTTTGGTGACTAGGTTACCATAA
CAGTAGCTCTTTCAAAGGTCTTCTTTCTACCTAAAGTAATAACCTAAGCTTCCTCTCGGAGTAGTAGCTGGTAAAAATGGTGGAGGTTTTAAGGAGGCAACAACT
AAAAGACACAGCCTTCGTTGAATAGTCGTACCATCGTCGTACCATCGTCGTACCATCGTCGTACCATCGTCGTACCATCGTCGTACCATCGTCGTACCAACTTCGT
ACCAACGTGGTACGATCGCGAACTGTGGACGCTCTTGGGAGAGTAGTTCATCTTTCTTATAAAATTCAGCTGTCTTGTTACGAAAAGGGCTGTAATAAATCCTTG
TCGGTGGTTGGTTCTGTCACAGCCTGCTTGAAAATCGTACGACATTAACAAAATCGCACGACGACCGACTACGAATGTGACCGCACCAGAATTGAGGTGTTCTA
ACATGAAAACAAGGCAGAGAAAGGAATGAAAACTTTTGCCCTAACAAAATATAGTAATTTCAACTATAGCTAGCATCAACACACTCCTTATTGTTTGTACTTCTTT
TTAGAAGCTGTACCGTAGTAAGAAACGACTTTAATTGACTTCAGTGATAACTTACACATAGAATGGGTATCAAAAAAGACTTTATCAGGTTGCTACTTAATCCTTA
GTACTACAGGGATCCCATCGCCATAGACCCATGAC 
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Sc0000060:259006-260100 (CNRs 14-15, intron 1)  
CATGTGAGGGCTAGCTAGGCACGCCATACCCTACCAATTCTTACAGTGAGTGGTACTTTTCAATATGATACAGTCATATCTTTGATGCAGATATTTTATGATATAC
AAACCGCCCTCGAGGGAAGGTTTCATAAGTGGGGGTAATGTCGTTAATAGAGCATAACGGATTGAATCAAAGGTCTTACGTGGTTGTTAAAGTTATTACCAAAT
TTCTGAATTTAGTCAAGTGAGAAAAGTGAAACTTTTGGCAGCGGTAGGGAGATGTATATGAGGTAAACGTAGTAACGTACAGGCAGAAATCACATGGCGTCTT
TTCCATTCAGTGTAGGGAATGAAAATGTCATCAAAAAGTATTAATGTAAATATAAACTGGTGCAACCGTGTATTTTGTTATAGATAATATCTAACACGTTATTAGG
TCAAGTACACATACATGTTTAAATGCTTCGCTACGTTTTTGTGTGGGGGGGGGGCGTGGGGCTATGTTTTTATGGCATTTAATACAGATTAGTTTCTCACATTTAA
CATCTATATCAAACTTTTACTCCTAGAATATATAGTTTTCCTTCACCCTCTAGCTTTGTCCTCTACCCATTGCAATGTGTTTTATCATTTATTTAATCAAAATCAATGA
ATCCACACGGGTGCCAGAAATAGTAACTCGAGCCCTGTTTTCTGTAGATACGTGTTATCCCCCTTGCCAGCAGGGCTTAGTTTCAGAACGTGCAGATACGGAATG
CCCAATTAATAATGAGACTCATTCGCGAGCTCCATATTTGTTTCTAACCCCTAACACATCACAATAGATAGCGCGCCGAGAATTATACATAATTGATTACGCAAGG
CCGGCGTTTTTCACAAGACGACATGGCAGAATCGATAAAACCACCATACTCTACATTGCATGTCATTGATTCCAACATGGAAGTCAATGTGGGGGCCTTTCCGGT
TGGGACGGAATTTATTTCCCGCGGGTGTTGCTTTACTAGTCCCGCTGTAACGCCTACGATAACGGCCGCTGTATAAAAAGAATGATGGCGAGAAGGGCGAGAG
AGAGAGTATATCTCGTTTTAGGGCTACAATTTACGGGAAGTAAGCCGATTTCCCTGCCGATTTCCCTGCAGGAATTCTGACACCTGGAGTAATTTCCTGGAAAAG
ACTTTTATGAGGTCACAGCAACACGCCTGTACTTGAGCGACATGAACGATAAGTAACGACGGATTGGCAAAGAGAAGCATCGCTCATTTTGATGGGTTACTTAC
ATCTTGGTAGGACACTTACAAGGACAATAGGGACACAAC 
Sc0000060:261310-262816 (CNRs 17-18-19, intron 1)  
GGAATAGCAACTCCTCGCTGTAAAATATACCCTACTACTACTGAAACAGCGAGGAAACTTGCTGCTCTATGTGCCACTAGGCGCAACAAGGGTCTGAACGAACG
AATTACTTCACTTTGTTTATGTTCCCACACGGCAAGGGTCTAGATTATCTTAAATACTTGCAGTCGTGTTTCTTCGAGATAAGAATAAGACGAGGAAAGAGGCTT
CCATGTCTTAAAGAAATGTTATCAGCTTCATATCATGGCATGTTCTTTTACCGTATTTCATTATTCTCCTACTGTGCATCGAGTGTTATTCAATGAAACCGCCGGCC
TTCAAAGGCACAGCTTGAGGTGAAACAGTACGATCAGTGATCAACCCGTTTGTCAAGGCAATGACTTTAAAATCTTTGCTCTCTTTTACAAGATTATGTATGCCCA
TACGTATAGTAGACCGTTTCTCTTGAAAGGAGCCTACAATAAAGTGATCTTTGACTTTCATTTCTTTTACTCTTTAACTTGGTTTGACAGTGATCCTTTGAGATGCC
AATCAGTTCTTCCCGTGGGTTATTTGTAGGCTTTTCCTTCCAGACCTTTCGGCGTTTGAAAATTTTCAAAACACGCACCGCGAAGCGTCTTCAGCATCCCTCCAATT
AGTTGTCTTTTTACTCCATGACAGAAGACTCCATCTGAAATTTAGATCTCACGTCAGTAGGAATGCGGTTGCTAGGTTCTTGTATTAAATGTGTCTGTTTGAAGAT
TATGTGTTTTGTGGACTCCGAGTCCTGTTTGTTATGTTGGTGAGCGTGGCAGGAAGAACAAAAAGAACTACAAAATGTATTGTCATTAATCGTACATCAGACATG
ACAGGTAGTCCGGGTCATGGGGTCAATGGAAGAGGCTACTACTTCACGGGGAGGTATTGTTTTTGGTCGATCTGTTTGTCTGTGTTTTCGCAGATCTTTATTCTC
CATATGCTAGCCACATTCACCGTACAGCGGTAAAGGGAGTGATAAATTGACATATAAAATGTTAATCAAGCCTTTATTTGCATAAATAATGAACTACAATTAAAG
AGGACATACGGGAAACTTTTAGAATTTCACGAAAGCGAATGGAGGCGAACCCTTATTCTAACTATGAGAAACTTTATCATTTTTGACAGTGTGAAATATGGTTTA
ACCATTCCACGGTGTTTGATACGATTACGAGGCAATCCGTAGTTATGTATCATTACATGAAATGTCAGGTGTAAGGTAGCATTATGGTCAAACTATCACATCTCA
AATCCTCAATGACATTCGCTAGCGAGTTCCGCTGGTTTGTTGCTAATGATGTGAAATCTTACCGGCAGTGATATACAGTTAGCTTGTGGCACGCAGATTCGATTTT
CTTGGTCTTTTAGCAGTGTCTTCAGAACATCATCAAAAGGCGAAGTCAGACTACTCTAGCTGTGACTGGAGTCCGTGCGTGGAATTAAAGCACATAATTACGTCT
ATAGCCTACGACATTCCAGCCTGGTCTTGCAAAGTTCAGTATTTTGTTCATAACGACACCCTAGGTGTGAAGATGGGTAGAGATTGTTCAAAGAATGGTCATGG
ACATGAAATAGCTTTATAGTATGCTACTATAGGCTTGTCCCTGTAGCTCAACTGGTAGCAGCCTCACAGTTGAGCTCCTGGTTCCAAATAATTGCTAGCTGGGAG
ACCCTAGTTCAATCCTGGGTCAATAGAATTTTGTTAGGGCTGCACCTGTCTTTC 
Sc0000060:267947-268277 (CNR 30, intron 2)  
CCAATGTACCCGAGCACTAACTATAAAGTTGTCGTATCGTACCTTGAAGTTAGCCTGCCAGGCCTTTAAGTGTGTGCACACTCTGGGTGTTGTTCTGTAGCTGAG
TGACAACATGCTGTGTGAATGTCCGATCCTCTTCGTCGCACAAAAAGGGGGTCAATGGATGGACAAATGGATCAATACTTAACCCACATTACCTTGAGAACCTGT
CAAGAACACTTATAACCAATTCTGAATCATACACGCGCCCAAGCTACTTAATGATTTATACCAAAACACTGTGCGCCTGCAGTTATTTCCTATCAAGCACCGTATG
TCTTTTTTCTTTCAAGTTAAAAGAAGGTTGATTCGTACTTGTTATCCATCAACCTACGTTTTAAATGTAGTGCTAATGTTGAGGACAGCTATTTTCTGTGAGGACCA
TTCATTTT ATTTATTCATTTATTGGTTCAGCATGTACATGCCAGGGTTGCCCTGTTAG CCGGAGGCTATTACTAAGGACGAACCCG 
Sc0000060:269813-270132 (CNR 33, intron 2) 
CCTCACCGACAAAGACCAAGGTAAGACGTTTCCTCAGAGAAAACGTCGTTCAAGAAAAAAAATTAGATTAACAGAACATTTTCCTTCCTGTGGCTCAAAGGCGTT
GGAGACGATACCTAATAGTTCTGCCCTCTAAAGTAGCAAGTTATTACTCTAGCGTGTAAGAAAGTGGTCGGTTCACACGATACGGCGTTCGCACGGAATCTAAT
TGCGCGTCGATATGGTTTATCAGTCTGGAACAGAGCAATATGAAATGGTGAGATTAGTGTCGGCTTGCTTTTGATGCGGTTTTCACAGAAGGAGATTGACTGGA
GAGCTTTTTATTGAAGAAAAGAAAGCGTTTTTGAGGAGAAAGGAGAACTTTGAAGTATGGGTGCGCAAATCATCCGTCAGAGATGTACAGTCAAACGGGCAAC
GGCCTGGAGAAGGCAACCACCTGCACTCACAA GTCAC 
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The selection criteria used to decide which CNRs will be tested for in vivo transgenesis 
were:  
1) The presence of putative transcription factor binding sites (TFBSs). In order to detect 
potential TFBSs, I used JASPAR database that is an open-access database of annotated, 
high-quality, matrix-based transcription factor binding site profiles for multicellular 
eukaryotes. The profiles were derived exclusively from sets of nucleotide sequences 
experimentally demonstrated to bind transcription factors (Sandelin et al., 2004). In the 
perspective of a comparative analysis of neuronal Nos regulation among chordates, to 
Sc0000060:270836-271288 (CNR 34, intron 2) 
GAGAGGAATAGTTGTGGCCGGGATTTTTTACACTCTCCTCTCTCCCGGACACTCCTACCCCACTCGACCGAAAACTCTAGATCTGCTTGCAGAATACTTTAGACAT
CTCCACGCCTGTCTGAATAGTTCTTTAGCGATGTCGTTGTGTCATAAGTTTCCTTTCAAAGTTTTCGGCTTTGTTGGAAGAAAACATAAATTCCCACTACATAGGG
TGTCGCATGACGCAAATGACCAACTTAACTACAATCATATTGCCAATAACACTGATGAATGTTTTCCGTTTCCTTTGTAAACTTGCGTGTAGGCAAGTGTAACTCG
TTAGATGTGCGAGAGAAATCTTTTTTGTAAAATTGACATGTGCAGCAGAGTGGAAACAATCTTTCTCTAACACAATCGGCTAGCCCCAGGGGGGATCACCATTAT
GACGTTGTTTTGGGCAATAAAGCCACACTGATCCTATTAAGGGTTTGACATTTGCACGCGCACGACTCGTTAATGACGAAAATGCACATCCACACATGTCCATCT
TAAGAAGGCATCAAAAAGCCAACAATACTTCGTATGCATTCACAGACATGTGCATTTAA GGGCCTGATCACATCCGTCATACGAC 
Sc0000060:273236-274482 (CNRs 39-40-41, intron 2) 
CATTGCCTGTGATGTACATTGATGTATTACATATCCTTGAAGCAGGTTTCTTATTGCTTCATTGAGCATGAGCCGGGTGTAGCAAATTGTATGCACGCAGACGCG
GAAGATCTTACAGGCTCAACAGACTCAGTTATTTCATTGAATGCCATTCATATTTTTGTGGATGCTATCTTCATAAGTCACTTGTCTTAGTCGCTTAAGGCCACAGC
AAGTAAATTTTATAGATGACATCCTCCACAGACTCCAAAACTAATGAGATAGGGCGAAAAAAAACAAGGCGGGCAACAACAAAAATAAGATTCCTATATTTTCA
AATTTAGAGATCATAAATCTTTTTAAACAAAAATTGAGGCGAAAAATATGATATCATGACCAACATGTCTTTTATAACTGTATTCAACCAATGAGGCTTCATGCAT
GTATATAATATAAAACATCCTTGATTCAACAGAGGACATGTCCGTGTAGATGTGTATACATCTCAATAGACTAACTACAACAAATGCAGAAAACGGCTTGTTATA
CCATCATGATCAGGAAATACTGGGTATTCATATGCAATGAAACACCTTAGACTGTCAACATGACACTGTCCTTGAAGATGTGTATACAGCTCAGTTAAGTAGAAG
AAATGCAGAAAACAGCTTGTCATACCATCATGGGCATTCGTATTTTTGTTTACGACATATTTGCCAATTTTTGGCATATTGACCACCGTCGGAGGGCAATGAAATT
TCTTGTTTTTGTTTTTTTAATCAGGCGAAAATCAATGAGCGCGCTGATGTCATCCACAAAAATTACTTGCTGTGACCTAAAGGTAAAAACACAGTGCCACCAGAA
GGATCTGCTCTTATGTCTCAACACAAAGGTTGCGAAGGTTCTCAACCGACTTACATGTGTCAAAACCCCTTTGCTATCCACGGCAATCCACATCTAAAGTTTCAAA
GACATCACACGAACATCAAAGCGCACAGAGCCCGCTAAACATACCTTCTCATGCCACCGAGAAATGAAATCTTCTAGAACGGTGTCGTTTATTTTTCTATCACACC
TTTGCCTATAGTTTCTCAACGCCGTGATTTGAAACATTAGATTCAGAACAACCTTGGTTTTATGCACTCGCTGTCGTTGCCGAACGAACGGGCGACAACCCCGTGT
CACGCAAGTCAATTACTCACTTAGTAGCAGCACGCCGCATTATTACTGCCGTGCTTACAAACTGATACCCTCTGATAAACTGATTGATCACATTGGCCAAAGTAAA
GGTTGGCAAAATCAAGTGGTAATAGAAGCGGAGGACGTGGGTGGGTATTGGCAAATACCTATG ATTCAAAAACTTCCTATCGACCAGAGAGTTTGTC 
Sc0000060:277769-278327 (CNR 45, intron 2) 
GACTTACCAACCTGAGGAAGCTATTCACAGAGAACAGATCTAGAAGTTACTAACTTGGGTGGTTTTCCTAATCCGACCACGCCCTGTAGTTCATAGTTCGTGTGT
CTCCATCTCGAAGTGGATGATACGACTAATCGTGAGATAGCGGAAACATGCGTTATTGATGCCCCGTTCACCACGTACGCCCTCGCTCAGAGATGCCTANCCTCG
CTACGAGCGTGCTTCCCAGCCGTTTCCCCCCATATCCTTCATCGGCAAGCACACCGCCGCTTTAATCCCTAAATGAGTGCGTTTACATGCCATCCGTCAGAGTCAA
TCAGGTAGTAATCCTTTCAATGATAAGGCAGCTTGCGCCAATTGATGCGTTGCCATTTCAGCGGCGACAGCCAAGCCCTTTAGGCACGTAGACACACGATGTCG
CTATTACATTTCATCCCTCTAAACGGTAGACAATTGCTGCTAACGTTCCGGAGGGGAATACTCATAAGTGAAGTGAGATATGGTAACGCATAGAGGTCGGAGAC
AGATTACTCGGCCGGAACTTAAGCAAGACACTCGTCATCAACATGCAAGTCGTGACCAATAGGAAATAAACTGGCTTTGACAGCTCTGAAGAGCAAATACATTG
CTGCATAAGCTGATCAAATTTTGGAAAATAGTAAATGGTCGTGCACCACAGTATTTGTAAGATCTTATTCCGCCACGTGTTTGTGTAAATCTACAGTGACTCATTG
ACAGTATG 
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identify the potential TFBSs in the genomic regions of interest I used vertebrates 
JASPAR matrix models with a very high profile score threshold of 99%.  
2) The presence of putative TFBSs already described in human neuronal NOS 
promoters. The CNRs selection based on this criterion can promote the discovery of 
evolutionarily conserved active regulatory regions.  
3) The presence of putative TFBSs for transcription factors (TFs) that co-express with 
NosC in amphioxus embryos.  
 
2.6.2 DNA constructs for transgenesis in Ciona robusta  
DNA digestion with restriction enzymes: analytic and preparative plasmid DNA 
digestions have been performed with the appropriate restriction endonucleases in total 
volumes of 50 µl. The digestion reaction has been prepared as follows: 2,5 µg of DNA 
(GFP-SV40 vector and pGEMT easy vector in which CNR were cloned), suitable 
restriction enzyme buffer 1/10 (Roche), SphI and SalI restriction enzymes (5 unites 
enzyme per 1 μg of DNA) and BSA (1/100, if required). Specific reaction temperatures 
have been used as suggested by manufacturer’s instructions. In order to prevent self-
ligation, a convenient amount of double strand linearized DNA has been incubated with 
1 U of Calf Intestinalis Alkaline Phosphatase enzyme (CIAP; Roche) per 1 pmol 5' ends 
of linearized DNA, in 1x CIP dephosphorylation buffer (Roche), at 37°C for 30 min.  
DNA ligation: each ligation reaction has been carried out in a final volume of 20 µl with 
a mixture containing 1X T4 Ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 
mM dithiothreitol, 1 mM ATP, pH 7.5) and 1 U of T4 DNA Ligase (New England 
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Biolabs). The proportion of plasmid vector and insert DNA was usually kept 1:3, and 
the total amount of DNA was kept within 50-100 ng. The reaction mix has been 
incubated at 16°C overnight or 3 h at R.T. and used to transform competent bacteria. 
 
2.7 NO QUANTIFICATION AND LOCALIZATION 
2.7.1 Griess assay 
NO quantification has been hampered by the physiological short half-life of this 
gaseous free radical, so alternatively integrated nitric oxide production can be estimated 
from determining the concentrations of nitrite and nitrate final products. The 
measurement of nitrate and nitrite concentration or of total nitrate and nitrite (together) 
concentration is routinely used as an index of NO production (Moshage et al., 1995). 
Samples preparation: several samples for each developmental stage were collected and 
homogenized in 500 µl of 1X PBS, subsequently several cycles of sonication were 
performed to obtain the membrane fractionation. The sonication was performed on ice 
with 3 cycles of 1 min, with amplitude of 30%. After the homogenization, a 
centrifugation of 10 min at 13.000 rpm allowed to separate the liquid fraction, in which 
there are proteins.  
Bradford protein assay: Bradford protein assay is a simple and accurate procedure to 
determinate the concentration of solubilized protein. It involves the addition of an acidic 
dye to the protein solution, and subsequent measurement at 595 nm with a 
spectrophotometer or microplate reader. Comparison using a standard curve provides a 
relative measurement of the protein concentration of the sample. To obtain a calibration 
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curve, and subsequently to quantify the protein concentration in the samples bovine 
serum albumin (BSA) was used as standard at three different concentrations: 3, 6 and 9 
µg in PBS 1X. For each sample 200 µl of Biorad solution was added, µl of BSA for 
several concentrations of solutions and up to 1 ml with PBS 1X. After ten minutes of 
incubation the samples were read at the spectrophotometer and the value were used to 
construct the calibration curve; in particular the angular coefficient of the fit line was 
used to calculate the protein concentration of the samples. 
Griess reaction: the reaction described below was first reported by Johann Peter Griess 
in 1879 as a method of the analysis of nitrite (Green et al., 1982). Before measuring the 
concentration of nitrites, all the nitrates were converted to nitrites using the nitrate 
reductase (NaR). To obtain a standard curve useful to quantify nitrite concentration in 
our samples, the Griess reaction was performed on sodium nitrite solutions at different 
molarity: 0 µM (blank); 2,5 µM; 5 µM; and 10 µM in PBS 1X. For this assay, nitrite is 
first treated with a diazotizing reagent, e.g., sulfanilamide (SA), in acidic media to form 
a transient diazonium salt. This intermediate is then allowed to react with a coupling 
rea-gent, N-naphthylethylenediamine (NED), to form a stable azo-compound. The 
intense purple color of the product allows nitrite assay with high sensitivity. The 
absorbance of this adduct at 540 nm is linearly proportional to the nitrite concentration 
accordingly NO concentration in the sample (Sun et al., 2003). Aliquots (50 µg of total 
protein in 150 µl) were incubated for ten minutes in the dark with equal volume of 1% 
(wt/v) SA in 5% H3PO4 and then for ten minutes with equal volume of 0,1% (wt/v) N-
(1-naphthy)- ethylenediaminedihydrochloride. The samples were measured at the 
spectrophotometer and results were expressed as nmol of NO per mg of protein. For the 
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conversion of nitrates to nitrites, 50 µg of total protein were incubated for 2 h at 25°C 
with NaR (0.24 U/ml) and the co-factors FAD and NADPH (final concentration 5 µM 
and 0.2 mM, respectively) in a final volume of 150 µl Then, samples were incubated 
with SA and N-(1-naphthy)- ethylenediaminedihydrochloride, as reported above.  The 
efficacy of nitrate reduction by NaR was tested on known concentrations of nitrate with 
a recovery of nitrite of 90–100%.  
 
2.7.2 DAF-FM diacetate assay 
NO localization was performed using 4-amino-5-methylamino-2',7'-difluorofluorescein 
diacetate (DAF-FM-DA), which is the most sensitive cell permeable and non-
fluorescent reagent that combines with the NO forming benzotriazole, a fluorescent 
compound (Kojima et al., 1999). Embryos at different developmental stages and 
conditions were incubated for 20 min in the dark with 5 μM DAF-FM-DA in FSW. 
After treatment, the animals were washed in FSW for 30 min and quickly fixed in 4% 
PFA. The fluorescence was visualized with ZEISS Axio Imager Z1 fluorescence 
microscope equipped with a filter λEXC = 470 ± 40, λEM = 525 ± 50. 
 
2.8 DIFFERENTIAL TRANSCRIPTOMIC ANALYSIS 
Samples preparation: total RNA for transcriptomic analysis was isolated from TRIM-
treated embryos as described above. The RNA integrity number (RIN) was measured at 
the Genomics and Bioinformatics Services of Genomix4Life (Italy) (See Results 
chapter).  For the sequencing, the embryos chosen started to be treated at 24 hpf and 
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collected at 30 hpf. The experiment was performed in triplicate, for each replicate an 
untreated (control) and a treated sample were sequenced.  
RNA sequencing: Next generation sequencing (NGS) experiments, comprising samples 
quality control, were performed by Genomix4life S.r.l. Indexed libraries were prepared 
from 1 ug/ea purified RNA with Indexed libraries were prepared from 1 ug/ea purified 
RNA with TruSeq Stranded Total RNA Library Prep Kit according to the 
manufacturer’s instructions. Libraries were quantified using the Agilent 2100 
Bioanalyzer (Agilent Technologies) and pooled such that each index-tagged sample was 
present in equimolar amounts, with final concentration of the pooled samples of 2 nM. 
The pooled samples were subject to cluster generation and sequencing using an Illumina 
NextSeq500 System in a 1x75 single read format (30 million of reads) at a final 
concentration of 10 pmol. The raw sequence files generated (.fastq files) underwent 
quality control analysis using FastQC.  
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).  
RNA-seq data analysis: the analysis of sequencing data was performed by the research 
group of Doctor Héctor Escrivà from the Observatoire Océanologique in Banyuls-sur-
mer (France).  It has been used Bowtie2 to map reads against the transcriptome and 
idxstats to do the counting. The package DESeq2 on R has been used to do the 
differential expression analysis (Love, et al., 2014). The package DESeq2 provides 
methods to test for differential expression by use of negative binomial generalized 
linear models; the estimates of dispersion and logarithmic fold changes incorporate 
data-driven prior distributions. The final output was provided as an .xls files containing 
gene-level and transcript-level differential expressions. Gene Ontology and Pathway 
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Enrichment Analysis are performed with an adjusted p-value <0.1 (treated vs 
untreated).  
 
2.9 NOS PHYLOGENETIC ANALYSIS  
B. lanceolatum Nos genes were annotated in the genome draft version Bl71nemr, kindly 
provided by the “Branchiostoma lanceolatum genome consortium”. B. lanceolatum Nos 
genes’ sequences are shown in figures 2.5, 2.6 and 2.7. B. belcheri Nos genes were 
identified from the automated predictions of NCBI. To find A. lucayanum Nos genes, 
we screened a previously published transcriptome assembly (Yue et al., 2014). A. 
lucayanum NosC gene coding sequence which was very fragmented in short contigs. 
Two of these, GESY01098362 and GETC01143078, overlapped and we reconstructed a 
longer sequence, which was used for the phylogenetic analysis. Briefly, we did 
TBLASTN searches using the amino acid sequences of the three NOSA, NOSB and 
NOSC proteins from B. floridae, and the candidate scaffolds, contigs or transcripts were 
further analyzed by means of GeneWise2 as implemented in the EBI website (Birney et 
al., 2000; Li et al., 2015) and manual curation. Other NOS proteins included in the 
phylogenetic analysis were collected from public databases such as Ensembl and NCBI. 
The accession numbers for all the sequences used for phylogenetic analyses are reported 
in Table 2.2. 
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Figure 2.5: Protein and coding sequence (CDS) of the Branchiostoma lanceolatum NosA, come from the 
draft genome sequence. In the protein sequence, the functional domains are highlighted: blue=PDZ; 
grey=heme; green=BH4; red=CaM; light blue=FMN; pink=inhibitory loop; yellow=FAD; 
purple=NAPDH. 
>Bl_NosA_protein 
MEGQQNIIVVGLVKREVDGLGLSAKRREVPGHSAVVIEEVIRGGPADHTGMVQPGDTIVAVNGQDIEGLSYQEATKVIRDIEPGKPVELVLRGPKWF
HTYLETVRLSTGETKTVRVTRPNGPIGALTLLIQRMRGNTFDKRAIRKLENRGEIPLNNRGVANGDVIKSIPSGTIANGCPVTGHRAATVGPSRTRR
PVRLKNWLNERRINDNLHSKANDLNPCNDGRCLGPLMRPRPFTAPGYFRPKEEVLEQAKKFIFEYYASLKSSDAGERDRRWRDVQVQVEEKGVYHLT
YDELLYGAKMSWRNAPRCIGRIQWSKLQLFDARDVTTARGMFEAICRHIKWCTNGGNIRSAITVFPPRTDGRHDYKVWNGQFLKYAAYQLPDGSILG
DPINLEFTEVCQALGWKGEGTRFDLLPMVLSANGEDPEWFDLPKDIVMEVNITHPKYDWFEELGIKWYCVPAVSNMLFDCGGLEFSAAPFSGWYMGT
EVGRDLCDENRLNITEAVGKRMGLDVARSSSLWKDAVFVEVNIAVLHSFQRNNTTIMDHHTASETFMKHLENEQRLRGGCPSDWVWIVPPMSASLTE
VFHQEMANYHVRPSFEYQEDAWLLHLWRKKPEHPVLLKYAYDENPKRKYRLKEVALAVKFAAVLMKKALNKRVKTTILYATETGKSESFASSTLGIF
KHAFDAKMMCMDEYDITNLEKEELVIVVTSTFGNGDPPDNGEAFGQALLHMRHPPGSDKKRSGSVRRVSSISRASYRRQQKLLRQLRDGGALGKVRY
GVFALGSRAYPHFCAFGHAIDTLFESLGAERIHPVGEGDELCGQEESFRAWAKGAFKSACERYDVGHDVNMEEANASLLGSDFSWAPGKFRVLQTKG
LPETDILEGLSKLHRRTVVSSTVISRTQLQAPESSRQTCLVQLETHGAQELRYVPGDHVAVFPANEDRLVQAILDRVEKGTNPDAVIQIEALQEKKI
GAGLVKSWTPHDRLPTCSLRTALSRYLDVTTPPSPQLLLYLAMHATSSRERAELEALGKGGLRYEDWKFEAAPTLPEVLQHYPSLQVPPALLLSQLP
VLQQRYYSISSSPHMYPGQIHATVAVVKYRTRGGQGPEHSXSNWLNTIKSNESVPCFIRTAKNFHLPENSSLPVLMVGPGTGIAPLRSFWQQRQVDI
KAGTASGHPPGDMTLVFGCRQSRVDHIYKEETAQARRDGALTDLYTALSREPGTTKTYVQDIIRQQIPKKVLDLVLKDGGHIYVCGDVTMATDVGET
VQRILVKHGGMSVARAEDFINNMKDNNRYHEDIFGVTLKTHEVEDAARKRSPSFISLSEENTSL 
>Bl_NosA_CDS 
ATGGAGGGACAACAGAACATCATCGTCGTCGGACTGGTCAAGAGGGAGGTTGATGGACTGGGATTATCGGCGAAGCGACGGGAAGTACCCGGTCATT
CTGCGGTGGTCATCGAGGAGGTGATCCGAGGCGGGCCTGCTGACCACACCGGGATGGTGCAGCCAGGGGACACCATCGTCGCTGTAAACGGGCAGGA
CATCGAGGGGTTGTCGTACCAGGAGGCGACCAAGGTCATCAGGGACATCGAGCCAGGGAAGCCGGTCGAGCTCGTCCTCCGCGGACCGAAGTGGTTC
CACACCTACCTGGAGACCGTCCGTCTGAGCACCGGGGAGACCAAAACTGTGCGAGTCACCAGGCCTAACGGGCCCATCGGCGCCCTGACCCTCCTCA
TACAGCGCATGAGAGGCAACACTTTTGACAAGAGAGCCATCCGTAAACTTGAGAATCGCGGCGAAATCCCGCTCAACAACCGTGGTGTGGCGAACGG
TGACGTGATCAAGAGCATCCCCAGCGGCACCATAGCGAACGGCTGTCCGGTCACTGGGCACAGGGCAGCCACGGTGGGACCGTCCAGGACCAGGAGG
CCAGTGCGACTGAAGAACTGGCTGAACGAAAGGAGAATCAATGACAACCTCCACTCGAAGGCAAACGACTTGAACCCGTGCAATGACGGCAGATGTC
TCGGTCCGCTGATGCGACCACGACCGTTCACAGCACCCGGCTACTTCCGACCGAAGGAAGAAGTCCTCGAACAAGCAAAGAAGTTCATCTTCGAGTA
CTACGCCTCTTTGAAGAGTTCGGATGCTGGTGAGCGTGACAGGCGTTGGAGAGACGTCCAGGTGCAGGTTGAGGAGAAAGGTGTGTACCACCTGACG
TACGACGAGCTGTTGTACGGCGCCAAGATGTCGTGGAGGAATGCACCAAGATGCATCGGACGTATCCAGTGGTCCAAACTGCAGCTGTTTGACGCCC
GTGACGTCACAACGGCCAGAGGAATGTTTGAGGCTATCTGCCGACACATCAAATGGTGCACTAACGGCGGGAATATCAGGTCTGCCATTACCGTTTT
CCCGCCACGCACGGACGGTCGCCATGACTACAAGGTGTGGAACGGCCAGTTCCTGAAATATGCCGCCTACCAGCTGCCTGACGGGTCCATCCTCGGC
GATCCCATCAACCTAGAATTCACAGAGGTATGCCAGGCTCTGGGCTGGAAGGGAGAGGGCACACGGTTCGACCTGCTGCCCATGGTTCTGTCTGCTA
ACGGGGAGGACCCGGAGTGGTTCGACCTCCCGAAGGACATCGTGATGGAGGTCAACATCACACATCCCAAGTACGACTGGTTTGAAGAGTTGGGCAT
CAAGTGGTACTGTGTCCCTGCCGTGTCCAACATGTTGTTTGACTGCGGCGGTCTGGAGTTTTCAGCGGCTCCCTTCAGCGGCTGGTACATGGGGACG
GAGGTGGGCAGGGACCTGTGTGACGAGAACAGGCTCAACATCACAGAAGCAGTAGGAAAGAGAATGGGTCTGGACGTCGCAAGAAGCTCCTCCCTCT
GGAAAGACGCCGTTTTCGTGGAGGTCAACATCGCCGTCTTGCACAGCTTCCAGCGCAACAACACGACGATTATGGATCACCACACGGCTTCGGAGAC
CTTCATGAAACACCTGGAGAACGAACAGCGCCTGCGCGGGGGATGCCCTTCTGATTGGGTGTGGATCGTGCCCCCAATGTCGGCGTCTCTCACCGAA
GTTTTCCATCAAGAGATGGCGAACTACCATGTGAGGCCGTCCTTCGAATATCAGGAGGACGCATGGCTGCTTCACCTCTGGAGGAAGAAGCCGGAGC
ACCCAGTCCTTCTGAAGTACGCCTACGATGAAAACCCCAAAAGGAAGTATCGTCTGAAGGAGGTGGCTCTGGCGGTAAAGTTCGCTGCCGTGCTGAT
GAAGAAAGCTCTCAACAAGCGAGTGAAGACCACCATCCTGTACGCCACGGAAACCGGCAAGTCGGAATCATTCGCATCTTCTACACTCGGGATATTC
AAACACGCTTTCGACGCAAAGATGATGTGTATGGATGAGTACGACATAACAAACCTGGAGAAGGAGGAACTCGTCATCGTCGTCACCAGTACCTTCG
GGAACGGAGACCCGCCGGACAACGGAGAGGCTTTTGGTCAGGCTTTGCTCCACATGAGGCACCCACCTGGAAGTGATAAAAAGAGATCCGGCAGTGT
ACGGAGGGTGAGCAGCATCTCCAGGGCCTCCTACCGACGTCAGCAGAAACTGCTGCGACAGCTTCGGGACGGCGGGGCGCTCGGCAAAGTCAGATAC
GGCGTGTTTGCCCTCGGGTCCCGTGCCTATCCACACTTCTGCGCCTTCGGCCACGCCATCGACACGCTGTTTGAGTCGCTGGGAGCGGAACGGATCC
ATCCTGTGGGTGAAGGGGACGAGCTGTGTGGACAGGAGGAGTCCTTCCGGGCCTGGGCCAAGGGCGCCTTTAAGTCCGCATGTGAGAGGTACGACGT
GGGCCATGACGTGAACATGGAGGAGGCGAACGCGTCCCTTCTCGGCAGTGACTTCAGCTGGGCGCCTGGGAAGTTCCGTGTCCTACAGACCAAGGGA
CTGCCGGAGACAGACATCCTGGAGGGTCTGTCCAAGCTGCATCGCAGAACAGTTGTGTCCAGTACAGTCATCTCCAGAACTCAGCTACAAGCTCCGG
AGTCCAGCCGACAGACCTGCCTGGTGCAACTGGAAACTCACGGGGCCCAGGAGCTGAGGTATGTTCCCGGGGATCACGTGGCCGTCTTCCCAGCCAA
TGAGGACCGACTAGTGCAGGCGATTCTGGACAGAGTGGAGAAGGGAACAAACCCCGACGCCGTCATTCAGATAGAAGCGCTGCAAGAGAAAAAAATT
GGAGCTGGTTTGGTCAAATCATGGACGCCCCACGACCGACTGCCGACATGTTCTTTGCGCACGGCACTATCCCGCTATCTTGACGTCACCACCCCAC
CGTCACCACAGCTGCTCCTCTACCTGGCGATGCACGCGACGTCAAGCAGGGAGAGAGCTGAACTCGAGGCTTTGGGCAAGGGAGGACTGAGGTACGA
GGACTGGAAGTTTGAGGCGGCCCCGACTCTGCCCGAGGTGCTGCAGCACTACCCGTCCCTGCAGGTCCCGCCCGCCCTGCTGCTCAGTCAGCTGCCG
GTCCTGCAGCAGCGCTACTACTCCATCAGCTCCTCCCCACACATGTACCCGGGCCAGATCCACGCTACTGTAGCCGTGGTCAAGTACAGGACGCGTG
GTGGCCAGGGTCCTGAGCACAGCGGTGTGTGTTCTAACTGGCTCAACACCATCAAGNTTCTAACTGGCTCAACACTATCAAGAGCAACGAGTCCGTG
CCTTGCTTCATTCGCACGGCCAAGAATTTCCACCTTCCTGAGAACTCCTCCCTCCCTGTCCTGATGGTAGGTCCCGGGACTGGCATCGCCCCTCTCA
GGAGCTTCTGGCAGCAGAGACAGGTGGACATCAAGGCTGGTACCGCGTCCGGACATCCTCCAGGTGACATGACCCTGGTGTTCGGCTGTAGACAGTC
CAGGGTGGACCACATCTACAAGGAGGAGACGGCGCAGGCAAGGAGAGACGGAGCCCTGACAGACCTCTACACTGCACTGTCCAGGGAACCAGGGACA
ACTAAGACCTACGTCCAAGACATCATACGTCAGCAAATTCCCAAGAAGGTGCTGGACCTGGTTCTAAAAGATGGCGGACACATCTACGTGTGTGGTG
ACGTCACCATGGCCACTGACGTCGGCGAGACCGTTCAGCGAATCCTGGTGAAGCACGGAGGGATGTCTGTCGCCAGGGCAGAGGACTTCATCAATAA
CATGAAGGACAACAACCGTTACCATGAGGACATCTTCGGTGTGACACTGAAGACACACGAGGTAGAGGATGCAGCTCGCAAGAGAAGTCCGTCTTTC
ATCAGTCTTTCGGAAGAGAACACGTCTTTGTGA 
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Figure 2.6: Protein and coding sequence (CDS) of the Branchiostoma lanceolatum NosB, come from the 
draft genome sequence. In the protein sequence, the functional domains are highlighted: blue=PDZ; 
grey=heme; green=BH4; red=CaM; light blue=FMN; yellow=FAD; purple=NAPDH. 
 
>Bl_NosB _protein 
MPPVQSRETNDTNSNVTPNGCPFTGSTSTAPRRAQILTDHLRNKHLTDTLHLKATNVAPCSSGKCMGSVVRQREPFPPGYKRPKEEVLEQAKEFIDD
YYASMKKENSAEHERRWIDIQAQVEEKGLYDLEYDELLYGAKMAWRNASRCIGRYQWNNLQVIDYRNVKTAQEMFDAACDHIRYATKDGQMKTAISI
FPMRTDGKHDYKFWNKYLFQYAGYQQPDGSVIGDPANVELTEVCQSLGWKGKGTPYDFLPAIVSANGEDPVIFEWPEDVPLELELRHPKHDWFEELA
IKVNCVPLQGDMLFDVGGMQFPACPITGWFQSTEPVRDLLDENRYNMAEIIAKKLGYDTSRYNSLWKDAAFLEVHIAVIHSFQMKGVMTQDPYTLTE
SFMKHMEREHRVRGGCPSDWVWIVPPSCSSLTPVFHQEMLNYHLRPALEYQEAGWKIHTWKTPPTAPIFTQYIRTKKRCSFKAAAMAVMFASGLMRK
TLNKRVKSTILFASQTGKAETFSNSLCDLHKHAFDAKVVCMDEYDMAQLDKEQLVVIVTSTFGNGDPPDNGETFARALMQMKNKNGQASPRDSPLSS
VRFAVFALGSRAYPHFCAFGHSVDTLLEQLGARRVHAVGEGDELCGQEESFRAWAESAFKSACLSYDVGHGVDMNEATANLLGSDLSWAPDKFRLVQ
AKTKTDTDILQGLSTVHRKNVVPCTFISRTQLQAPDSSRQTILVRLDTKDNEELEFTPGDHLGVFPANEDHLVQAILDRIEGGTKPDDVLEIEALHK
KLTAAVVTKTWMPFERLPPCSLRTALSQYLDITTPPSPQLLGSLSMHTSAPSERAELEELAKGGTKYENWKFERAPTLPEVLQDYPSLQVPPALLLS
QLPVLQQRYYSISSSPHMYPGEIHATLAVVSYRSQGGKGPVHNGVCSSWFNRLEEGETVPCFVRAAKNFHLPADPSMPVLMVGPGTGIAPLRSFWQQ
RQMDIKSGNGQGGNHGDMTLVFGCRQSQIDHIYKDETAQAKTDGALTDIYTAYSREPDTPKTYVQHVLYNQLSERVKELLKNNGHIYVCGDVAMADD
VCTTVQKILEEKSAMTSTESEALIRMLKDSNRYHEDIFGVTLNTKEVREAARSVESAESNAKRHTIGNGQQSGDQLSMH 
>Bl_NosB_CDS 
ATGCCACCGGTACAATCCAGAGAAACGAACGACACCAATTCCAATGTCACCCCGAACGGGTGTCCCTTTACGGGGTCTACCAGCACAGCTCCGCGGA
GAGCCCAGATTCTGACAGACCACCTGCGGAACAAGCACTTGACCGATACCTTACACCTGAAGGCAACCAATGTAGCCCCCTGTAGTTCAGGGAAATG
CATGGGCTCGGTCGTTCGGCAGAGAGAGCCGTTTCCCCCGGGTTACAAGAGGCCGAAGGAAGAAGTTCTGGAACAAGCGAAGGAATTTATCGACGAC
TACTACGCTTCGATGAAAAAGGAAAACAGTGCAGAACATGAGAGGCGGTGGATCGACATACAAGCCCAGGTCGAAGAGAAAGGTTTGTACGACCTGG
AGTACGATGAGCTTCTGTATGGCGCCAAAATGGCCTGGCGGAACGCATCCAGATGTATCGGACGGTACCAATGGAACAACTTACAAGTGATTGACTA
TCGCAACGTCAAGACGGCCCAAGAAATGTTTGACGCCGCCTGCGATCATATTAGGTACGCCACCAAGGATGGGCAGATGAAGACTGCCATCAGCATT
TTCCCAATGCGCACAGATGGAAAACACGACTACAAGTTCTGGAACAAGTACCTGTTTCAGTACGCTGGGTACCAGCAGCCAGACGGTTCAGTCATTG
GAGATCCCGCCAATGTGGAACTTACCGAGGTGTGCCAAAGCCTCGGCTGGAAGGGCAAAGGAACTCCATATGATTTTCTACCCGCCATTGTCTCTGC
TAACGGAGAGGACCCGGTCATCTTCGAATGGCCAGAAGACGTACCCCTGGAACTGGAACTGCGGCATCCAAAGCACGACTGGTTCGAAGAGCTGGCC
ATAAAGGTGAACTGCGTACCGCTGCAAGGGGACATGCTATTCGACGTTGGCGGGATGCAGTTTCCGGCATGTCCAATCACAGGCTGGTTTCAGAGCA
CGGAGCCCGTGCGCGATCTGCTGGACGAAAACAGATACAACATGGCAGAGATCATCGCCAAGAAGTTGGGATATGACACTTCCCGGTACAACTCGCT
GTGGAAGGATGCTGCCTTCCTGGAGGTTCACATTGCAGTTATACACTCTTTTCAGATGAAGGGAGTGATGACCCAGGATCCGTACACCCTGACCGAG
AGCTTCATGAAGCATATGGAGAGGGAACACCGTGTCCGCGGCGGGTGTCCGTCGGACTGGGTCTGGATCGTTCCTCCCTCCTGCTCCTCTCTCACTC
CCGTCTTCCACCAGGAGATGCTGAACTACCACCTCAGGCCCGCTCTGGAGTACCAGGAGGCGGGATGGAAGATACATACATGGAAGACTCCTCCGAC
TGCCCCCATCTTCACACAGTACATCCGCACAAAGAAGCGCTGCAGTTTCAAGGCGGCAGCGATGGCTGTGATGTTTGCTTCAGGGCTGATGAGAAAG
ACTCTGAACAAGAGAGTGAAGTCCACGATCCTCTTCGCCTCTCAGACCGGAAAGGCAGAGACATTCTCCAACTCACTGTGCGACCTCCATAAGCATG
CATTCGATGCAAAGGTGGTGTGTATGGATGAGTATGACATGGCGCAACTCGACAAAGAGCAACTGGTCGTCATAGTGACAAGTACTTTTGGAAACGG
GGATCCCCCGGACAATGGCGAGACCTTCGCTCGTGCTTTAATGCAAATGAAGAACAAGAATGGTCAAGCAAGTCCAAGAGACAGCCCGCTGAGCTCT
GTCAGGTTTGCGGTGTTCGCCCTTGGATCCCGGGCCTACCCGCACTTCTGTGCCTTCGGCCACAGCGTGGACACCCTCCTGGAACAGCTGGGGGCTC
GGCGGGTCCACGCCGTGGGCGAAGGGGACGAACTGTGCGGCCAGGAGGAGTCATTCCGCGCATGGGCAGAGAGTGCATTCAAGTCTGCCTGTTTGAG
TTACGATGTTGGGCACGGTGTCGACATGAACGAAGCCACTGCCAATCTGCTGGGCAGCGATCTGAGTTGGGCGCCGGACAAGTTCCGACTTGTACAG
GCCAAGACTAAGACGGACACTGACATTCTACAAGGTTTGTCCACTGTGCATCGTAAGAATGTTGTGCCTTGTACCTTTATTTCACGGACCCAACTGC
AGGCACCTGACTCAAGTCGACAAACCATCTTAGTTCGGCTGGACACGAAGGACAACGAAGAGTTGGAGTTTACTCCCGGCGATCACCTCGGCGTCTT
CCCGGCCAATGAAGACCACCTTGTTCAGGCGATCTTAGATAGAATCGAGGGTGGAACCAAACCGGATGATGTGCTGGAGATAGAAGCGCTGCACAAG
AAGCTGACGGCAGCTGTGGTGACGAAAACGTGGATGCCTTTCGAGCGTTTGCCGCCATGTTCTTTGCGCACGGCACTCTCCCAGTACCTGGACATCA
CAACCCCACCATCGCCGCAGCTGTTGGGTAGTCTGTCCATGCACACCAGCGCTCCATCAGAGCGAGCAGAGCTGGAGGAACTCGCTAAGGGTGGTAC
AAAGTACGAGAACTGGAAGTTCGAGCGCGCCCCTACCCTACCGGAGGTGCTGCAGGACTACCCGTCCCTACAGGTTCCCCCCGCCCTGCTGCTGAGT
CAGCTGCCTGTCCTGCAGCAGCGCTACTACTCCATCAGCTCCTCCCCACACATGTACCCGGGAGAGATCCACGCTACTTTAGCTGTGGTCAGCTACC
GTTCTCAGGGCGGAAAGGGTCCGGTACACAACGGCGTTTGCTCCTCGTGGTTTAACAGGCTTGAGGAGGGTGAAACGGTCCCCTGCTTCGTCAGAGC
GGCGAAGAATTTCCACCTCCCTGCCGACCCCTCCATGCCTGTGCTGATGGTCGGCCCCGGTACGGGCATCGCCCCGCTGCGCAGCTTCTGGCAGCAA
CGCCAGATGGACATCAAGTCCGGCAACGGTCAGGGAGGTAACCATGGTGACATGACGCTGGTGTTCGGATGTCGACAGTCCCAGATAGACCACATCT
ACAAGGACGAGACGGCCCAGGCCAAGACAGACGGAGCGCTGACGGACATTTATACAGCCTACTCCAGAGAACCGGACACACCAAAGACCTACGTCCA
GCATGTTTTGTACAACCAACTCTCCGAGAGAGTGAAAGAACTCCTGAAGAATAATGGACATATCTATGTCTGTGGTGACGTAGCCATGGCTGATGAC
GTATGCACCACCGTGCAGAAAATACTGGAAGAAAAGTCCGCGATGACGTCGACGGAGAGCGAAGCATTAATCAGAATGTTGAAGGACTCCAATCGCT
ATCACGAGGACATCTTTGGGGTGACTCTCAACACAAAGGAGGTTCGAGAGGCAGCTCGAAGCGTCGAGTCAGCCGAGAGCAATGCAAAACGACACAC
CATCGGAAATGGCCAGCAAAGCGGAGACCAGCTATCTATGCACTAG 
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Figure 2.7: Protein and coding sequence (CDS) of the Branchiostoma lanceolatum NosC, come from the 
draft genome sequence. In the protein sequence, the functional domains are highlighted: blue=PDZ; 
grey=heme; green=BH4; red=CaM; light blue=FMN; pink=inhibitory loop; yellow=FAD; 
purple=NAPDH. 
>Bl_NosC_protein 
MEIRPNVIAVKLMKREGDGLGFLVKQRSCNPPVIVSDVVRGGAADQSGLIQVGDLILSVDGTSLETVPYSDALQVLRAVEVGKPTEIILRGPEGFATKLETTF
TGTGIPKTVRITTAESPLRSLALSPARRLIKRITGNSHVKSIDHINAEALKEKETVSNGPLGTDHSGRTMETPKTCSSIAVQTSPEEPTTKEVNGQCNGNATV
AQLDKTKLTLDTISIALKRESVNGNELGRPIESGPSSRRNSATLSPSAKPRFARMKNWLNDKQMTDTLHNKATPINPCSGTKCLGSLMRPNAAAQAKSARPAG
EARPKDEVLEHAKEFLDEFFASIKRANTQAHKQRWAEAKVQIEEKGWYELTQMELTYGAKLAWRNAPRCVGRIQWSKLQVFDARYVTTARGMYEAICNHIKYA
TNKGNLRSAITIFPARTDGKHDFKVWNSQFVRYAGYKQPDGSVVGDPASVEFTEICQSLGWKGKNGPFDVLPMVLSANGQDPELFELSRDLVLEVELKHPKYA
WFKELGMKWYALPAVANMLFDVGGVEFPAAPFSGWYMCTEIGRDLCDINRYNYTEQIAKRMGLDTGRASSLWRDLAMIEANVAILHSFQTGNVTITDHHTACE
SFMKHMENEQRLRGGCPADWVWIVPPVSASLTPVFHQEMISYYLRPSYEYQEDAWKTHVWKKKEDTKRIMPGKAKRKFGFKEVAKAVKFSAKLMGKALAKRVK
ATILYATETGKSERYAKTXTGKSERYAKTVCEIFKHAFDAKVMCMDDYDIMHLEHETLVIVVTSTFGNGDPPDNGESFGQALLEMRHPPMDNNDNRPPIRRVS
ESSSDGGHTKRLSSISSSATERRRKFSHQMKERDMDSMDLDGGPLSNVRFSAFGLGSRAYPGFCAFAHAVDTLFGELGGERIYKMGEGDELCGQEESFRKWAK
GVFKAACDTFCVGDDLNMSEASSTLLNSDATWSPDKFRLIPAEGVKEFEIWEGLSKVHHRNVVPCRLISRENLQAPDSGRETILVRLDSQGSDDLNYVPGDHL
AVFPANEDHLVQAVLDRLDNAPDPDSIVNMEVLQEKQTPLGAIRTWMTSERLPPCSLRTALSRYFDITTPPSPQLLQHLATQATDEEEKKELEVLGKGDARYE
DWKFERTPNLVEVLEDYPSLKVAPTLLLSQLPFLQQRYYSISSSQRMYPGEIHATVAVVRFATQGGVGPTHNGVCSSWLNRIEKDDIVPCFVRGAQNFHLPED
PTVPLMMVGPGTGIAPFRSFWQHRQMEVTSGDPHHRPKYGQMTLVFGCRQSKMDDIYKHETAQAKEDGALTEVYTALSREPGVPKSYVQNVILDLIPEKVCDL
LMKHNGHFYVCGDVSMAADVCNTLEKAMEKQQGMTPNKAKDFVDKLKDCNRYHEDIFGVTLRTQEVTDRVRSAARKNWVRVKRLRPSTVVPPTRGLSPVRESS
SLSSTPMSTPSATPANSPYSSPLHRPDPTVCANGDLPSLHIEE 
>Bl_NosC_CDS 
ATGGAGATTCGGCCTAACGTGATTGCCGTCAAGTTGATGAAGAGGGAGGGGGATGGACTAGGCTTTCTGGTGAAGCAGCGCTCCTGCAACCCTCCAGTCATCG
TCTCTGACGTGGTGAGAGGCGGGGCGGCAGACCAAAGCGGGTTGATCCAAGTCGGCGACCTTATCCTCTCCGTCGACGGCACGAGTTTGGAGACCGTGCCCTA
CAGCGACGCTCTACAGGTTCTCAGGGCGGTGGAGGTGGGAAAACCGACGGAGATCATCCTCCGCGGGCCCGAAGGTTTTGCGACGAAGCTCGAGACCACCTTC
ACGGGGACTGGCATCCCGAAAACGGTCCGAATAACCACTGCGGAAAGCCCTCTGCGCTCTCTTGCCCTCTCGCCGGCTCGCAGGCTCATCAAGAGGATAACCG
GCAACTCTCACGTCAAATCAATCGACCACATCAACGCAGAAGCGCTCAAAGAGAAAGAAACTGTTTCTAATGGACCGCTAGGCACTGACCACAGCGGCCGAAC
AATGGAGACGCCCAAGACGTGTTCGTCTATCGCTGTACAGACATCACCAGAAGAACCCACCACCAAAGAAGTCAACGGACAGTGCAACGGCAATGCCACGGTT
GCACAGCTAGACAAGACAAAACTGACTCTAGACACGATTTCTATCGCCTTGAAGAGGGAGAGCGTCAACGGGAATGAGCTGGGAAGGCCCATCGAGTCGGGGC
CGTCTTCCCGGCGGAACTCGGCCACGCTGAGCCCGTCCGCAAAACCGAGGTTTGCCCGCATGAAGAACTGGCTGAACGACAAGCAGATGACAGACACCCTGCA
CAACAAAGCTACACCGATAAACCCATGTTCGGGTACAAAGTGTCTGGGCTCGTTGATGCGTCCTAACGCCGCTGCCCAAGCCAAGAGCGCCCGGCCGGCTGGG
GAGGCCAGACCGAAGGATGAAGTCTTAGAGCACGCCAAAGAGTTCCTGGACGAATTTTTCGCGTCAATCAAACGCGCTAACACACAGGCACACAAGCAGAGAT
GGGCGGAAGCGAAGGTGCAGATCGAGGAGAAGGGTTGGTACGAGCTGACGCAGATGGAGCTGACGTACGGAGCCAAGCTCGCCTGGAGGAACGCGCCCAGATG
TGTCGGCAGAATACAGTGGTCTAAGCTACAGGTGTTCGACGCTCGGTACGTGACTACAGCACGAGGCATGTATGAAGCCATTTGCAACCATATCAAGTATGCA
ACCAACAAGGGAAACCTCAGGTCGGCCATCACTATCTTCCCCGCTCGCACCGATGGCAAACACGACTTCAAGGTGTGGAACTCGCAGTTTGTCCGGTATGCCG
GATACAAGCAGCCGGACGGTTCCGTCGTTGGTGACCCAGCAAGCGTGGAGTTCACTGAGATCTGCCAGAGCCTGGGATGGAAAGGGAAGAACGGACCGTTTGA
TGTCCTGCCCATGGTGCTGTCTGCTAACGGTCAGGACCCGGAGCTGTTCGAGCTGTCAAGGGACCTAGTGTTGGAGGTGGAGCTCAAACATCCCAAGTATGCG
TGGTTCAAAGAGCTTGGAATGAAGTGGTACGCCCTGCCGGCGGTGGCTAACATGCTGTTCGACGTGGGCGGAGTCGAGTTCCCGGCAGCGCCCTTCAGCGGCT
GGTACATGTGCACGGAGATCGGCAGAGACCTGTGCGACATCAACAGATACAACTACACAGAGCAAATTGCCAAAAGGATGGGGCTTGATACAGGACGAGCGTC
GTCACTATGGAGAGACCTGGCTATGATCGAGGCAAATGTCGCCATTCTCCATAGCTTTCAGACAGGCAATGTGACCATCACCGATCACCACACCGCGTGTGAG
TCCTTCATGAAGCACATGGAGAACGAACAGCGCCTGCGCGGTGGGTGTCCGGCGGACTGGGTCTGGATCGTCCCGCCTGTCTCTGCTTCTCTCACTCCCGTCT
TCCACCAGGAGATGATCAGCTACTATCTGAGACCGTCGTACGAATATCAGGAGGATGCGTGGAAGACCCACGTGTGGAAGAAGAAGGAGGACACCAAGAGGAT
CATGCCTGGGAAGGCGAAAAGAAAGTTCGGCTTCAAGGAAGTGGCCAAAGCTGTGAAGTTCTCTGCAAAGCTGATGGGAAAAGCGCTGGCCAAGCGGGTGAAG
GCAACCATTCTGTACGCTACAGAGACCGGCAAGTCGGAGCGATACGCTAAGACGGNGACCGGCAAGTCGGAGCGGTACGCCAAAACGGTCTGTGAAATCTTCA
AGCACGCGTTTGATGCCAAGGTGATGTGTATGGATGATTATGACATCATGCACCTGGAACATGAGACACTGGTCATCGTGGTGACCAGCACTTTCGGCAACGG
TGACCCACCGGACAATGGGGAGTCGTTTGGCCAAGCCCTTCTGGAGATGCGACATCCACCAATGGACAACAACGACAACAGACCCCCTATACGGCGGGTTTCT
GAATCAAGCAGCGACGGTGGGCACACGAAGCGGCTGAGCAGCATTTCCAGCAGCGCCACCGAGCGGCGCCGGAAGTTCTCGCACCAGATGAAGGAGCGGGACA
TGGACAGTATGGACCTGGACGGCGGGCCCCTCAGTAATGTCAGGTTTTCGGCCTTTGGGCTTGGTTCTCGGGCCTACCCAGGATTCTGCGCGTTTGCGCATGC
GGTTGACACCCTGTTCGGTGAGCTGGGAGGAGAACGGATCTACAAGATGGGGGAGGGGGACGAGCTGTGCGGACAGGAGGAGTCATTCCGAAAGTGGGCTAAA
GGCGTGTTCAAGGCGGCCTGTGATACTTTCTGTGTCGGTGACGACCTAAACATGAGCGAGGCTAGCTCCACCCTGCTGAATTCGGACGCAACCTGGTCACCGG
ACAAGTTCCGACTCATTCCGGCAGAGGGCGTTAAGGAGTTTGAAATCTGGGAAGGACTATCGAAGGTGCACCATAGAAACGTGGTACCCTGCAGACTCATCTC
CAGAGAAAACCTGCAAGCACCCGACTCTGGCCGGGAGACCATCCTGGTGAGACTAGACTCCCAGGGCTCGGACGATCTGAACTATGTGCCCGGCGACCATCTC
GCCGTCTTCCCGGCCAATGAGGACCACCTTGTGCAAGCCGTGCTGGACCGACTGGACAACGCTCCCGACCCGGACAGTATCGTCAATATGGAGGTTCTCCAAG
AGAAGCAGACGCCGCTAGGAGCCATACGAACATGGATGACGAGCGAGAGACTTCCCCCCTGCTCCCTCCGGACGGCCCTGTCTCGGTACTTTGACATCACGAC
GCCTCCATCGCCTCAGTTACTGCAGCATCTGGCTACACAAGCTACAGATGAGGAGGAGAAGAAAGAACTGGAGGTTTTGGGAAAGGGTGACGCGAGGTATGAA
GACTGGAAGTTTGAGCGTACCCCGAACCTCGTAGAGGTCCTTGAGGACTACCCGTCCCTGAAGGTGGCTCCGACCCTCCTGCTGAGTCAGCTACCCTTCCTGC
AGCAGCGGTACTACTCCATCAGCTCATCACAGAGGATGTACCCGGGAGAAATCCACGCTACGGTCGCAGTGGTCAGGTTTGCCACTCAGGGTGGCGTGGGTCC
TACCCACAACGGAGTCTGCTCATCTTGGTTGAACCGAATCGAGAAGGATGATATCGTACCTTGTTTCGTGCGGGGGGCACAAAACTTCCATCTACCCGAGGAC
CCCACGGTTCCGCTGATGATGGTAGGTCCGGGGACTGGCATCGCGCCGTTCCGCAGCTTCTGGCAGCACAGGCAGATGGAGGTCACTTCTGGTGACCCACATC
ATCGGCCAAAGTACGGCCAGATGACGTTAGTATTCGGCTGTCGGCAGTCTAAAATGGACGACATCTACAAGCACGAGACAGCACAGGCAAAGGAGGACGGCGC
CTTGACTGAGGTCTACACGGCTCTGTCCAGGGAGCCGGGCGTACCAAAGTCGTATGTCCAGAACGTCATCCTGGACCTGATTCCCGAGAAGGTGTGCGACCTC
CTGATGAAGCATAACGGCCATTTCTACGTCTGCGGGGACGTTTCCATGGCAGCAGACGTCTGCAACACGCTGGAGAAGGCCATGGAAAAACAGCAGGGCATGA
CCCCCAACAAGGCCAAGGACTTCGTCGACAAGCTGAAGGACTGCAACCGATACCATGAGGACATCTTTGGGGTAACCTTGAGGACCCAGGAGGTGACTGACCG
TGTGCGCTCGGCCGCACGTAAGAACTGGGTGCGGGTGAAGAGACTGCGGCCCAGCACGGTGGTCCCGCCCACCAGAGGTCTCTCACCGGTACGTGAGAGTTCG
TCCTTGTCATCTACGCCCATGTCCACGCCGTCCGCCACTCCCGCCAACTCCCCCTACTCCTCACCGCTGCACCGGCCCGATCCGACTGTGTGTGCCAACGGCG
ATCTACCCAGTCTACACATTGAGGAATAA 
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Species NOSI NOSII NOSIII NOSA NOSB NOSC 
Homo sapiens AAB49040 AAB60366 AAA36365 - - - 
Asymmetron 
lucayanum 
- - - GESY01069733 
GESY01069734 
GESY01069736 
GESY01069735 
GESY01069737 
GESY01069738 
GETC01128572 
GETC01128573 
GETC01013682 
GETC01013681 
GESY01015049 
GESY01007340 
GESY01007341 
GETC01000005 
GESY01098362 
GETC01143078 
Branchiostoma 
lanceolatum 
- - - Figure 2.7 Figure 2.8 Figure 2.9 
Branchiostoma 
floridae 
- - - XP_002608547 XP_019636970 XP_002605826 
Branchiostoma 
belcheri 
- - - XP_019623080 XP_019636970 XP_019631555 
Ciona robusta XP_009861972 
Ciona savignyi ENSCSAVG00000009725 
Strongylocentrotus 
purpuratus 
XP_003729305 
 
Table 2.2: Accession number of NOS sequences used in the phylogenetic reconstruction. 
 
For the phylogenetic analysis, NOS amino acid sequences were aligned using the 
MUSCLE algorithm (Edgar, 2004) as implemented in MEGA v7, release 7161111-
i38651 with default parameters, and saved in fasta format. The alignment was trimmed 
by trimAl version 1.2rev59, using the '-automated1' parameter. The trimmed alignment 
was then formatted into a nexus file using readAl (Capella-Gutiérrez et al., 2009) 
(bundled with the trimAl package). A Bayesian inference tree was inferred using 
MrBayes 3.2.6 (Ronquist et al., 2012), under the assumption of an LG+I+G 
evolutionary model. Two independent MrBayes runs of 1.000.000 generations, with 4 
chains each, were performed. The tree was considered to have reached convergence 
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when the standard deviation was stabilized under a value <0.01. A burn-in of the 25% 
of the trees was performed to generate the consensus tree (750,000 post-burn trees). 
 
2.10 IMAGING  
Scanning Electron Microscopy (SEM): biological specimen was chemically fixed, 
dehydrated through an ethanol series and then dried at the critical point, a method used 
to minimize specimen distortion due to drying tensions. The samples were mounted on 
a stub of metal with adhesive, coated with 40 ‐ 60 nm of metal such as Gold/Palladium 
and then observed in the microscope. For images acquisition, a Zeiss EVO MA LS 
Scanning Electron Microscope was used. 
Optical microscopy: the embryos were kept in 80% glycerol or they were observed in 
vivo. Then, the samples were placed on the microscope slides with glass spacers on the 
left and the right sides in order to avoid that the cover slip crushed them. For bright field 
and Differential Interference Contrast (DIC) images acquisition, a Zeiss Axio 
Imager.Z2 equipped with a digital camera was used. For fluorescence images, the ad-in 
APOTOME was connected to the microscope. 
 
2.11 STATISTICS 
The statistical analyses of molecular tests were performed with Two-way Student’s t-
test using the Microsoft Office 2010 Excel analysis tool “T-Test: Two-Sample 
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Assuming Equal Variance” where tails = 2 (two-tailed) was applied. Statistical 
significance cut off criteria was set at p<0.05. 
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CHAPTER 3 
RESULTS  
 
 
3.1 CEPHALOCHORDATES INDEPENDENT NOS DUPLICATIONS AND 
AMPHIOXUS NOS EXPRESSION PROFILE 
I have identified the Nos repertoire of different cephalochordate species and analysed 
their evolutionary history in comparison with other chordates. Previous studies have 
showed the presence of three different Nos genes in B. floridae genome derived from 
independent gene duplications (Andreakis et al., 2011). A phylogenetic analysis was 
performed using NOS protein sequences collected from genomic and transcriptomic 
databases in different cephalochordate species, from two different genera: 
Branchiostoma and Asymmetron, which represent the most distantly-related lineages 
within cephalochordates. I found in each of the species analysed three paralogues NOS, 
that resulted to be one to one in orthology with B. floridae NOSA, NOSB and NOSC 
(Fig. 3.1). These results suggested that duplication events that originated the three 
cephalochordate Nos genes occurred in the last common ancestor of extant amphioxus, 
and from our phylogenetic analysis they were not orthologues to vertebrate NOS. This 
implies that they have independently duplicated in the lancelet lineage.  
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Figure 3.1: Phylogenetic relationship among chordate NOS proteins. Sea urchin Strongylocentrotus 
purpuratus was used as outgroup (from Annona et al., 2017; experiment performed by the author). 
 
In addition to identifying the evolutionary scenario of the three amphioxus NOS, I have 
also analysed B. lanceolatum NosA, NosB and NosC expression profile during 
embryonic development and in the adult stage, using the ddPCR methodology, in order 
to better characterize them. This study can help shed light on the diverse range of NO 
physiological roles during amphioxus development, which is the main goal of this PhD 
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thesis project. NosB is significantly expressed at 10 hpf while, later in development, it 
seemed completely turned off (Fig. 3.2a). This result is in agreement with the one 
obtained by the in situ hybridization experiments. NosB mRNA was detected in the 
endoderm at early and middle gastrula stages that correspond to 10 and 12 hpf (Fig 1.23 
b-d) (Annona et al., 2017). Both NosA and NosC were classified as neuronal Nos thanks 
to the presence of the PDZ domain (Andreakis et al., 2011). NosC is expressed during 
embryonic and larval development while NosA is expressed only during the adult stage 
(Fig. 3.2b-c). For B. lanceolatum, NosC transcripts localization pattern was described in 
embryonic and larval stages: it is expressed in neural tube from neurula (24 hpf) to pre-
mouth larva (48 hpf) while at open-mouth larva (72 hpf) the gene is detected in a 
restricted region of the cerebral vesicle and in the club-shaped gland (Fig 1.23g) 
(Annona et al., 2017).  No embryonic or larval expression of NosA was described by 
Annona et al. (2017). Overall, my ddPCR results are in agreement with these in situ 
hybridization data. Such a clear distinction in the temporal expression could be due to a 
different transcriptional regulation of these duplicated neuronal Nos genes (NosA and 
NosC) allowed by the progressive accumulation of changes in their respective 
promoters. To verify this hypothesis, I planned to perform a regulatory mechanisms 
analysis for the amphioxus Nos genes (see later in this chapter) that could shed light on 
the existence of different enhancers in NosA and NosC promoters. 
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Figure 3.2: Branchiostoma lanceolatum Nos genes expression profile analysed by ddPCR. a) NosB; b) 
NosC; c) NosA. For each gene, expression is reported as relative fold change to the stage where the gene 
is less expressed. P-value <0,05 (from Annona et al., 2017; experiment performed by the author). 
 
3.2 INDUCIBLE NATURE OF AMPHIOXUS NOS GENES 
Despite the different Nos genes that have been associated with particular cell types and 
concept of constitutive vs inducible used to classify them, several questions remain 
about whether these associations have been applied too strictly. This issue is still 
controversial but there are some evidences that neuronal and endothelial Nos could be 
inducible under some circumstances, and conversely, inducible Nos can be 
constitutively expressed (Amin et al., 1995; Vaz et al., 2011; Jiang et al., 2013; Mattila 
and Thomas 2014). In amphioxus, NOSA and NOSC have been identified as neuronal 
NOS due to the presence of the PDZ domain and the inhibitory loop sequences, while 
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NOSB has been identified as inducible because it lacks the distinctive feature of a 
constitutive NOS, i.e, the inhibitory loop between the two FMN-binding domains 
(Andreakis et al., 2011) and the PDZ domain. In order to shed light on the possible 
inducible nature of the three amphioxus Nos genes, I performed a stimulation of the 
immune system by means of lipopolysaccharides (LPS) treatments on 72 hpf larvae for 
1, 2, 4, 6, 8 hours and then I analysed the expression levels of the three Nos genes. 
Indeed, LPS is commonly used as an activator of the immune response, and it is known 
that NO production is induced under these conditions. First of all, I conducted toxicity 
tests to choose the right concentration of the drug that would allow me to stimulate the 
immune system of larvae without causing their premature death. After these preliminary 
tests, I selected 10 µg/ml as the LPS concentration to use for my experiments. Then, as 
control, I analysed the AmphiItln239631 expression levels after 1, 2, 4, 6, 8 hours of LPS 
treatment as evidence of the immune system stimulation (Fig. 3.3a), in fact it is known 
that they increase under LPS stimulation in amphioxus (Yan et al., 2013). 
AmphiItln239631 was upregulated after 2 and 8 hours of treatment (Fig. 3.3a), in 
comparison with untreated conditions, demonstrating the immune system stimulation. 
In the same experimental conditions, NosA expression was induced after 8 hours of 
treatment, with a fold change of 14 in comparison with untreated larvae (Fig. 3.3b). The 
NosB expression also increased after 8 hours of LPS stimulation but there was a fold 
change of only 2 times in comparison with untreated conditions (Fig. 3.4c). There was 
no significant variation in NosC expression after LPS stimulation in the time and 
concentration conditions used for this experiment (Fig. 3.3d). 
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Figure 3.3: Branchiostoma lanceolatum Nos genes expression analyses by qPCR after LPS stimulation. 
a) AmphiItln239631 expression in 72 hpf amphioxus larvae after 1, 2, 4, 6 and 8 hours of LPS treatment 
in comparison with un-treated animals. b) NosA, c) NosB, and d) NosC expression levels in 72 hpf larvae 
after 1, 2, 4, 6 and 8 hours of LPS treatment in comparison with un-treated animals. 
 
3.3 REGULATORY MECHANISMS OF AMPHIOXUS NosC  
One of the purposes of this PhD thesis project was to reveal key features of amphioxus 
Nos genes regulation. First of all, I focused my attention on the promoter of NosC, the 
amphioxus neuronal Nos that is expressed during embryonic and larval development 
(Fig. 3.2) (Annona et al., 2017). In order to study the regulation of NosC, I have 
identified putative enhancer sequences in its promoter testing their transcriptional 
activity by transgenesis experiments in C. robusta (invertebrate chordate).  
To find cis-regulatory elements of NosC, I decided to consider the first and second 
intronic regions in which often enhancers are present (Fig. 3.4). I focused on 17 kb 
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upstream (intron 1) and 15 kb downstream (intron 2) genomic regions relative to the 
ATG (respectively Sc0000060:250211-267133 and Sc0000060:267743-282638 in B. 
lanceolatum genome draft (version Bl71nemr) (Fig. 3.4).  
 
Figure 3.4: Branchiostoma lanceolatum NosC genomic locus. In blue is reported the aligned Human 
NOS1 protein. The position of the translation start codon (ATG) on exon 2 is indicated. On the left are 
indicated the alternative first introns. In purple are indicate several predicted NosC isoforms, the boxes 
are the predicted exons spaced by introns. Red arrows indicate the analysed genomic region upstream the 
ATG; green arrows indicate the analysed genomic region downstream the ATG. 
 
The comparative alignment of these genomic regions between three closely related 
amphioxus species - B. floridae, B. belcheri and B. lanceolatum - revealed the presence 
of several conserved non-coding regions (CNR) using PhastCons program (Fig. 3.5, 
blue peaks). In order to identify putative transcription factor (TF) binding motives I 
used JASPAR database. I surveyed exclusively the CNRs highlighted by comparative in 
silico analyses. An early preliminary selection of possible active enhancers was 
performed on the base of the information already present in literature about neuronal 
Nos enhancers. Moreover, I paid more attention to those TFs that from expression 
patterns known in literature could co-localize with amphioxus NosC. The selection 
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process is schematized in the table 3.1. Thank to this sorting, some CNRs were selected 
to be tested in transgenesis experiments and they were cloned in 9 distinct constructs, as 
shown in figure 3.5 (see Methods for constructs preparation).  
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CNRs 
highlighted 
by 
comparative 
in silico 
analyses 
Putative 
TFBSs are 
present 
(JASPAR 
prediction) 
These putative 
TFBSs are 
already 
described in 
human 
neuronal NOS 
promoter 
The TFs 
binding 
these TFBSs 
co-express 
in 
amphioxus 
with NosC  
CNRs 
highlighted 
by 
comparative 
in silico 
analyses 
Putative 
TFBSs are 
present 
(JASPAR 
prediction) 
These putative 
TFBSs are 
already 
described in 
human 
neuronal NOS 
promoter 
The TFs 
binding 
these TFBSs 
co-express in 
amphioxus 
with NosC 
CNR1     CNR 24    
CNR 2       CNR 25    
CNR  3       CNR 26    
CNR 4     CNR 27     
CNR 5     CNR 28     
CNR 6      CNR 29     
CNR 7    CNR 30      
CNR 8    CNR 31    
CNR 9      CNR 32    
CNR 10       CNR 33      
CNR 11    CNR 34       
CNR 12      CNR 35    
CNR 13      CNR 36    
CNR 14      CNR 37    
CNR 15      CNR 38    
CNR 16    CNR 39      
CNR 17       CNR 40       
CNR 18      CNR 41      
CNR 19       CNR 42    
CNR 20    CNR 43    
CNR 21    CNR 44    
CNR 22     CNR 45      
CNR 23    CNR 46    
(see page 92 for the legend) 
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Table 3.1: Selection process schematization for the CNRs to be tested by transgenesis. The ticks indicate 
that the CNRs respect the selection criteria. If at least two of the three criteria were met, the CNR was 
tested by transgenesis.   
Figure 3.5: Amphioxus CRNs tested by transgenesis. a) Magnification of 17 kb upstream the ATG of B. 
lanceolatum NosC showed in figure 3.4. b) Magnification of 15 kb downstream ATG of B. lanceolatum 
NosC showed in figure 3.4. In blue are shown the conservation tracks between B. lanceolatum, B. floridae 
and B. belcheri. Red ovals indicate selected CNRs that were tested in transgenesis analyses.   
 
Preliminary results were obtained in C. robusta using 16 amphioxus NosC CNRs in 9 
constructs (Table 3.2). Embryos were let to grow and larvae were observed in vivo 
under the fluorescent microscope. Constructs 3, 4 and 8 directed expression of GFP in 
C. robusta nervous system. The specificity of the signal, for each experiment, was 
demonstrated using the pSP72 vector containing the TATA box and the GFP reporter 
gene as negative control. This negative control vector was inserted by electroporation in 
C. robusta fertilized eggs simultaneously with other constructs.   
 
Construct name Total number of 
larvae observed* 
Positive GFP 
expression* 
Percentage of 
positive 
Construct 1 190 0 0% 
Construct 2 210 0 0% 
Construct 3 205 58 30% 
Construct 4 200 81 40% 
Construct 5 200 0 0% 
Construct 6 201 0 0% 
Construct 7 196 0 0% 
Construct 8 208 42 20% 
* they were calculated as averages of three distinct experiments  
 
Table 3.2: Summary of results obtained from transgenesis experiments in Ciona robusta using 
amphioxus NosC CNRs. 
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The electroporation of construct 3 allowed me to detect GFP expression in 
approximately 30% of transgenic C. robusta larvae in the motor ganglion (MG) and in 
the dorsal caudal epidermal neurons (DCENs) (Fig. 3.6b-e-f). The motor ganglion is a 
compartment of C. robusta CNS that consists of motor neurons and interneurons. The 
negative control resulted in the absent GFP expression in embryos (Fig. 3.6f). No 
specific GFP expression was detected in earlier developmental stages.  
In the genomic region included in construct 3, different putative TFs binding sites were 
predicted with a relative profile score threshold of 99% using vertebrate matrix models 
from JASPAR database. I carefully studied the literature regarding neuronal Nos 
enhancers, mostly in vertebrates, and I crossed the information found with JASPAR 
prediction and the expression pattern of these predicted TFs in amphioxus. In this way, I 
made a list of the putative enhancers, present in this region, that could regulate 
amphioxus NosC transcription (Fig. 3.6a). The transcription factors able to bind those 
putative enhancers are: Nuclear Factor I (NfI) and Nk2-related homeobox gene 
(Nkx2.1). 
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Figure 3.6: Cross-species regulatory activity in Ciona robusta of the amphioxus CNR14 and CNR15 
cloned together in the construct 3. a) Results of PhastCons analysis of genomic regions called CNR14 and 
CNR15. In the blue boxes are reported the transcription factors binding sites predicted by JASPAR. b) 
Transgenic C. robusta larva using construct 3 (amphioxus CNR14 and CNR15 together). c) Schematic 
representation of C. robusta larva; DCNE: dorsal caudal epidermal neurons. d) GFP expression directed 
by construct 3 in C. robusta motor ganglion. e) GFP expression directed by construct 3 in C. robusta 
DCNE. f) Negative control C. robusta larva electroporated with empty pSP72 vector. 
 
In the experiment with the construct 4 containing amphioxus CNR17, CNR18 and 
CNR19, 40% of larvae showed a clear GFP fluorescent signal in the CNS. Few 
photoreceptor cells of the ocellus were positive (Fig. 3.7c). Negative control larvae did 
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not show any specific GFP fluorescent signal (Fig. 3.7d). No specific GFP expression 
was detected in earlier developmental stages.  Following all the steps described above 
for construct 3, I also identified in this region some putative enhancers that can regulate 
amphioxus NosC transcription (Fig. 3.7a): Nuclear Factor I (NfI), Tcf11 and Gata3.  
 
 
Figure 3.7: Cross-species regulatory activity in Ciona robusta of the amphioxus CNR17, CNR18 and 
CNR19 cloned simultaneously in the construct 4. a) Result of PhastCons analysis of genomic regions 
called as CNR 17, CNR 18 and CNR 19. In the blue boxes are reported the transcription factors binding 
sites predicted by JASPAR. b) Schematic representation of C. robusta larva, head. c) GFP expression 
directed by construct 4 in photoreceptor cells of the C. robusta ocellus. d) Negative control C. robusta 
larva electroporated with empty pSP72 vector. 
 
Also the construct 8 directed the expression of GFP in the C. robusta CNS. GFP 
fluorescent signal was detected in both pigmented sensory organs, the otolith and the 
ocellus, in 20% of transgenic larvae (Fig. 3.8c). The negative control did not show any 
specific GFP fluorescent signal (Fig. 3.8d). No specific GFP expression was detected in 
earlier developmental stages. As described for previous promoter regions already tested, 
also for this one the JASPAR TFs binding sites prediction was carried out. The putative 
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enhancers here contained putative binding sites for: Nuclear Factor I (NfI), Tcf11, Meis, 
and Retinal Homeobox Protein (Rx) (Fig. 3.8a). 
 
 
Figure 3.8: Cross-species regulatory activity in Ciona robusta of the amphioxus CNR39, CNR40 and 
CNR41 cloned simultaneously in the construct 8. a) Result of PhastCons analysis of genomic regions 
called CNR39, CNR40 and CNR41. In the blue boxes are reported the transcription factors binding sites 
predicted by JASPAR. b) Schematic representation of C. robusta larva, head. c) GFP expression directed 
by construct 8 in the ocellus and the otolith. d) Negative control C. robusta larva electroporated with 
empty pSP72 vector. 
 
The results obtained in C. robusta demonstrated that its gene regulatory machinery was 
able to recognize exogenous conserved non-coding elements from amphioxus NosC 
promoter. This allowed me to formulate preliminary hypotheses about the amphioxus 
NosC regulation and the evolutionary conservation of neuronal Nos regulation in basal 
chordates. 
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3.4 ENDOGENUS NO QUANTIFICATION AND LOCALIZATION  
The major pathway for NO metabolism is the stepwise oxidation to nitrite (NO2−) and 
nitrate (NO3−) (Moncada et al., 1991). In the plasma or other physiological fluids, NO is 
quickly oxidized to nitrite, where it remains stable for several hours (Kelm, 1999). NO2− 
derived from NO autoxidation is rapidly converted to NO3− via its oxidation by 
oxyhemoproteins. During low intake of nitrite/nitrate conditions, enzymatic NO 
formation from NOS accounts for the majority of nitrite (Moncada et al., 1991). 
Therefore, the quantification of total nitrite, also the one coming from the reduction of 
nitrate, is a good index to evaluate the NO amount in embryos or tissues, which 
indirectly measures NOS activity. I quantified the total nitrite during amphioxus 
development and in adult animals by Griess assay and I found approximately 5 ng of 
nitrite per mg of proteins in almost every analysed stage (Fig. 3.9). The only exception 
was the 3 days-old larvae in which I detected higher amounts of nitrite corresponding to 
23,5 ng of nitrite per mg of proteins (Fig. 3.9). This peak of NO production, and 
presumably in NOS activity, could be linked with the mouth morphogenesis. 
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Figure 3.9: Nitrite quantification during amphioxus embryonic development and in adult. The results are 
expressed as ng of nitrite/mg of proteins. G: gastrula (10 hpf); N: neurula (24 hpf); PM: pre-mouth larva 
(48 hpf); L3d: larva 3 dpf; A: adult.  
 
The NO localization using DAF-FM-DA revealed that in 48 hpf larvae, NO positive 
cells were abundant along all the neural tube (arrows in Fig. 3.10a) and in the most 
caudal extremity of the larvae, probably the future anal region (tandem arrows in Fig. 
3.10a). Additionally, a strong NO fluorescent signal was observed in the area 
corresponding to the future mouth and gill slits (arrowhead in Fig. 3.10a). At 72 hpf, I 
observed a higher density of NO positive cells around the mouth, in the ventral part of 
the first gill slit and in the club shaped gland (arrowheads in Fig. 3.10b). Afterwards a 
punctuate signal is still present in the rostral area as well as caudally in both the hindgut 
and anus (Fig. 3.10, arrow and tandem arrows, respectively). 
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Figure 3.10: Nitric oxide localization by DAF-FM-DA. (a) 48 hpf and (b) 72 hpf developmental stages 
were analysed. Arrows indicate the nervous system; arrowheads show the pharyngeal area, mouth and gill 
slits; tandem arrows indicate hindgut. a’ and b’ are the negative control embryos that were not treated 
with DAF-FM-DA, exposed at the same laser intensity of the embryos in a and b. Orientation: up = 
dorsal; down = ventral; left: anterior; right: posterior. Scale bars: 50 μm. (from Annona et al., 2017; 
experiment performed by the author). 
 
3.5 NO MODULATION DURING AMPHIOXUS DEVELOPMENT 
The NO system provides opportunities for experimentally enhancing or blocking the 
production of NO and observe specific phenotypes. One of the possible mechanisms for 
NO manipulation is the inhibition of NOS activity through the addition of an inert 
analogous of L-arginine, such as L-NAME or L-nitro arginine (L-NA), or of a molecule 
that avoid the link with important co-factors, such as TRIM. The use of these inhibitors 
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is very useful for in vivo studies to define the physiological role of NO. In my 
experiments, I used both L-NAME and TRIM to decrease NO production during 
amphioxus embryonic development. The drugs were tested at several concentrations 
and added at different developmental stages (Fig. 3.11). L-NAME was used at 100 µM, 
1 and 10 mM while TRIM was used at 25, 50, 75 and 100 µM. L-NAME 100 µM and 
TRIM 25 µM did not affect embryonic development. L-NAME 1 mM, TRIM 50, 75 
and 100 µM affected the development of embryos as described below (Fig. 3.12). L-
NAME 10 mM instead resulted toxic. As a control for L-NAME treatments I used D-
NAME, the inactive D- form enantiomer, at the same experimental conditions. D-
NAME did not affect amphioxus development (Fig. 3.12b). 
 
Figure 3.11: Schematic representation of preliminary L-NAME and TRIM treatments performed on 
Branchiostoma lanceolatum embryos. Black bars indicate the period in which embryos were exposed to 
drug; blue lines indicate the period in which embryos were kept in FSW without drug. 
 
The inhibition of NOS activity, that reflects in lower amounts of endogenous NO, 
caused defects from the early development throughout the whole developmental process 
(complex morphogenetic defects, data not shown), but I did not thoroughly analyse this 
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phenotype. Further studies will be needed to understand if this development defection is 
a specific effect of NO depletion and if NO, in amphioxus, has a role in coordination of 
morphogenetic movements and cell cycle during early development as already 
described for other organisms (Kuzin et al., 1996; Peunova et al., 2007). 
When the treatments were performed later in development at 24 hpf, corresponding to 
5-6 somites neurula, and maintained until 72 hpf, the larvae showed an interesting 
phenotype. The presence of the consistently similar phenotype using both drugs (L-
NAME and TRIM) reassured me that it is a specific effect and not due to the possible 
toxicity of the drug itself. The observed phenotype relates to an alteration of the 
morphology of the mouth and the pharyngeal region (Fig. 3.12 a and c).  
 
Figure 3.12: Amphioxus larvae after drug treatments. a) 72 hpf larva without mouth comes from 1 mM 
L-NAME treatment started at neurula stage. b) 72 hpf larva after 1 mM D-NAME treatment started at 
neurula stage. c) 72 hpf larva without mouth comes from 100 µM TRIM treatment started at neurula 
stage. d) Untreated 72 hpf larva used as control. Orientation: up = dorsal; down = ventral; left: anterior; 
right: posterior.  (from Annona et al., 2017; experiment performed by the author). 
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Phenotypes were divided into three categories: “wild type” (normal pharyngeal and 
mouth morphology), “mild” (malformed mouth and altered pharyngeal morphology) 
and “severe” (complete absence of the mouth and gill slits, altered pharyngeal 
morphology) (Fig. 3.13). Phenotypes with increasing degree of malformation could be 
due to the natural different sensitivity between individuals. The effect of the inhibitors 
was concentration-dependent. In fact, using TRIM 50 µM the proportions of the mild 
and severe phenotypes are almost the same while at 75 and 100 µM TRIM the 
proportions of larvae without mouth increased to 68% and 72%, respectively (Fig. 
3.13).  
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Figure 3.13: SEM images of anterior part of body of amphioxus 72 hpf larvae after TRIM treatments. a) 
untreated larva with a normal phenotype. b) 100 µM TRIM treated larva that shows a mild altered 
phenotype. c) 100 µM TRIM treated larva that shows a severe altered phenotype. Orientation: up = 
dorsal; down = ventral; left: anterior; right: posterior. In correspondence of b and c the proportions of the 
mild and severe altered phenotypes depending on drug concentration are reported. (Adapted from Annona 
et al., 2017; experiment performed by the author). 
 
 
These results allowed me to hypothesize the involvement of NO in the process of mouth 
formation and of the entire pharyngeal region morphogenesis in amphioxus. Moreover, 
the incubation at 48 hpf in the presence of the inhibitor resulted in larvae with a wild-
type phenotype (data not shown). All together these data suggest that in pharynx and 
mouth morphogenesis NO play a key role in the interval from 24 to 48 hpf.  In order to 
understand when exactly NO acts in this process, I performed a series of short-term 
treatment experiments in which TRIM (100 µM) was applied to B. lanceolatum 
embryos for different time periods during development from 24 to 48 hpf, and the 
resulting phenotypes were subsequently observed at the 72 hpf stage. The results of 
treatments that started at 24 hpf and stopped at 30, 36, 42 or 48 hpf were 100% of larvae 
with an altered phenotype (Fig. 3.14), in the proportions between mild and severe 
phenotypes as previously described (Fig. 3.13).  The addition of TRIM at 30 or 36 hpf 
caused alterations in the phenotype in approximately 70% of larvae (Fig. 3.14). From 42 
hpf, NOS inhibition did not affect larvae morphology, in fact 100% of animals showed 
a normal phenotype (Fig. 3.14).  
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Figure 3.14: Schematic representation of 100 µM TRIM treatments performed on Branchiostoma 
lanceolatum embryos in the period 24-48 hpf. On the top, there are reported the developmental stages 
used for the treatments a: 24 hpf; b) 30 hpf; c) 36 hpf; d) 42 hpf; e) 48 hpf. Orientation: up = dorsal; down 
= ventral; left: anterior; right: posterior. In f), there is the scheme of treatment period performed. On the 
left, there are the percentage of altered (red) and wild type (green) phenotype observed for each treatment 
period; n: total number of larvae observed.  
 
These results demonstrated that larval morphology is most susceptible to NO depletion 
during neurulation and probably the pathway downstream NO signal acts in the interval 
from 24 to 42 hpf. In fact, the inhibition of NO production at the beginning of this 
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period brings to the maximum effect on larvae phenotype (100% alteration) while the 
addition of drugs at 30 and 36 hpf allows a small percentage of larvae with a normal 
phenotype (Fig. 3.14). The absence of altered phenotype by adding TRIM to 42 hpf 
means that, at this time, the putative pathway downstream NO is no longer active and 
for this reason NO depletion does not affect it. Moreover, the TRIM-treated larvae 
showed an incomplete formation of the club-shaped gland and the endostyle. The only 
pharyngeal structure that was not affected from the inhibition of NO was the pre-oral pit 
(Fig. 3.15a and b).  
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Figure 3.15: Anterior part of the body of a TRIM-treated larva. a) the pharyngeal area of a larvae after 
TRIM treatment. Orientation: up = right side; down = left side; left: anterior; right: posterior.  On the left 
side, there is only the pre-oral pit indicated by the arrow, on the right side there are incomplete formed 
club-shaped gland and endostyle that are indicated by arrowheads. b) lateral view of the anterior part of 
the body of a larvae after TRIM treatment, left side. The pre-oral pit is indicated by an arrow. Orientation: 
up = dorsal; down = ventral; left: anterior; right: posterior. c-d) schematic representation of the normal 
amphioxus pharyngeal region development, frontal section (Adapted from Goodrich, 1930). Orientation: 
up = right side; down = left side; left: anterior; right: posterior. pp: pre-ora pit; en: endosyle; cgs: club-
shaped gland; m: mouth.  
 
Another effect that I noticed after inhibition of NOS activity was an alteration in larvae 
movement, when TRIM treatment was maintained until larval stage.  The first muscular 
movements appear at the stage of pre-mouth larvae and consist in simple body flexions 
that increase in complexity until they become a complete undulatory (approximately 
sinusoidal) wave in 72 hpf larvae. These movements are similar to adult amphioxus 
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ones (Stoke, 1997). In general, larvae grown in presence of TRIM were less active than 
un-treated ones and, some of them showed jerky movements as shown in Figure 3.16. I 
hypothesized that NO acts in the formation or functioning of the neuromuscular 
junctions and for this reason the absence or decrease of NO can cause alteration in 
locomotion. I did not analyse in detail this phenotype but in the future, further studies 
aimed to clarify the role of NO in this process are necessary.  
 
 
Figure 3.16: Schematic representation of movements in un-treated and TRIM-treated larvae. On the top, 
the undulatory movement of un-treated larva is showed. Down is represented the jerky movement of a 
TRIM- treated larva. The number (0-1-2-3) indicate the steps, the arrows indicate the direction of 
movement. 
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3.6 DIFFERENTIAL TRANSCRIPTOMIC ANALYSIS OF NO-INHIBITED 
EMBRYOS 
To have insights at molecular level of the consequences of the induces NO inhibition 
during embryonic development I performed an RNAseq experiment with three 
biological replicates in each of two conditions, un-treated and TRIM-treated. Embryos 
were treated for 6 hours (from 24 to 30 hpf) before being collected for the assay. 
Samples were assessed after dilution by using Nanodrop spectrophotometer (Fig.3.17A) 
to evaluate purity and TapeStation4200 (Fig. 3.17B-G) to evaluate integrity.  
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Figure 3.17: Quality control of total RNA samples evaluated by using A) a Nanodrop spectrophotometer, 
and B-G) TapeStation4200. FIL1: control female 1; FIL2: treated female 1; FIL4: control female 2; FIL5: 
treated female 2; FIL7: control female 3; FIL8: treated female 3. 
 
Next generation sequencing (NGS) was carried out by Genomix4life (Italy) while the 
analysis of sequencing data was performed in collaboration with the research group of 
Dr Héctor Escrivà from the Observatoire Océanologique in Banyuls-sur-mer (France) 
(for details see Materials and Methods). This analysis showed that, with a P value < 
0,01, 283 genes were up-regulated and 49 genes were down-regulated after TRIM 
treatment in the developmental period 24-30 hpf (Fig. 3.18). 
 
 
Figure 3.18: MA-plot representation of RNA-seq results between TRIM-treated and un-treated samples. 
Red plots are the affected genes with an adjusted P value <0,01. The genes with a logFold-change <0 are 
downregulated. The genes with a logFold-change >0 are upregulated. 
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17 genes among those down-regulated (Table 3.3) and 88 genes among those up-
regulated have already been annotated (Table 3.4). Up- and down-regulated genes were 
subjected to gene ontology (GO) enrichment analysis in order to identify if 
differentially expressed genes were involved in same specific biological processes (BP), 
molecular function (MF) or cellular component (CC). 
The results of GO analysis are summarized in Figure 3.18 for down-regulated genes and 
in Figure 3.19 for up-regulated ones.  
 
 
Figure 3.18: Summary of gene ontology (GO) enriched analysis of down-regulated genes in TRIM-
treated amphioxus embryos in comparison with un-treated ones. a) Proportion between genes not yet 
annotated and genes already annotated. b) Results for the ontology category of biological process; c) 
Results for the ontology category of cellular component; d) Results for the ontology category of 
molecular function. The length of the bars is proportional to the number of genes in the term. Vertical 
axis represents gene ontology while horizontal axis indicates the number of genes in each ontology 
category. 
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Down-regulated genes 
 
Gene name Abbreviation Gene name Abbreviation 
matrix metallo ase-24 
precursor 
MMP24 NK1 transcription factor-
related 1 
NKX1-1 
doublesex- and mab-3-related 
transcription factor 2 isoform 
X1 
DMRT2 angiopoietin-related 7 ANGPTL7 
zinc transporter ZIP10 isoform 
X2 
SLC39A10 matrix metallo ase-14 
precursor 
MMP14 
72 kDa type IV collagenase 
precursor 
MMP2 metallo ase inhibitor 4 
precursor 
TIMP4 
runt-related transcription 
factor 1 
RUNX1 sprouty- EVH1 domain-
containing 3 isoform X3 
SPRED3 
POU class transcription factor 
2 
POU2 matrix metallo ase-9 
precursor 
MMP9 
opsin-5-like OPN5L1 histidine N-
acetyltransferase-like 
NAT 
winged helix transcription 
factor AmphiFoxE4 
FoxE4 platelet derived and 
vascular endothelial growth 
factor receptor 
PDGFR 
zinc transporter ZIP6-like SLC39A6   
 
Table 3.3: List of 17 down-regulated genes already annotated resulted from the differentia transcriptomic 
analysis of TRIM-treated amphioxus embryos in the developmental interval between 24 and 30 hpf. Gene 
nomenclature is based on best BLAST hit and does not imply that the amphioxus gene is a one-to-one 
orthologue of the gene named. 
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Figure 3.19: Summary of gene ontology (GO) enriched analysis of up-regulated genes in TRIM-treated 
amphioxus embryos in comparison with un-treated ones. a) Proportion between genes not yet annotated 
and genes already annotated. b) Results for the ontology category of biological process; c) Results for the 
ontology category of cellular component; d) Results for the ontology category of molecular function. The 
length of the bars is proportional to the number of genes in the term. Vertical axis represents gene 
ontology while horizontal axis indicates the number of genes in each ontology category. 
 
 
UP-REGULATED GENES 
 
GENE NAME ABB. GENE NAME ABB. 
cytochrome P450 CYP450 aldehyde dehydrogenase family 3 member B1 
isoform X2 
 
ALDH3B1 
multidrug resistance-associated 5 
isoform X4 
 
MRP5 alcohol dehydrogenase 6 isoform X3 
 
ADH6 
ATP-binding cassette sub-family A 
member 3 
 
ABCA3 arrestin domain-containing 3 
 
ARRDC3 
fatty acid-binding 12 isoform X3 
 
FABP12 acylcarnitine hydrolase-like isoform X1 
 
Ces2c 
unconventional myosin-XV isoform X2 
 
MYO15A aldo-keto reductase family member C1 
 
AKR1C1 
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1,5-anhydro-D-fructose reductase AKR1E2 E3 ubiquitin- ligase TRIM56 
 
TRIM56 
sulfotransferase family cytosolic 2B 
member 1 isoform X4 
 
SULT2B1 homeobox Meis2 isoform X1 
 
Meis2 
retinol-binding 2 isoform X1 
 
RBP2 very low-density lipo receptor isoform X1 
 
VLDLR 
prostaglandin G H synthase 2 
precursor  
 
PTGS2 frizzled-6 isoform X1 
 
FZD6 
 
DBH-like monooxygenase 1 
 
MOXD1 ammonium transporter Rh type A precursor  
 
RHAG 
3 beta-hydroxysteroid dehydrogenase 
Delta 5 
HSD3B1 betaine--homocysteine S-methyltransferase 1 
 
BHMT 
UDP-glucuronosyltransferase 2B31-
like isoform X1 
 
UGT2B31 epoxide hydrolase 4 isoform X1 
 
EPHX2 
phosphatidylcholine translocator 
ABCB4 isoform X4 
 
ABCB4 choline ethanolaminephosphotransferase 1 isoform 
X1 
 
CEPT1 
retinal dehydrogenase 2 
 
ALDH1A2 phosphotriesterase-related isoform X2 
 
Pter 
alpha-2,8-sialyltransferase 8B 
precursor  
 
ST8SIA2 dehydrogenase reductase SDR family member on 
chromosome X isoform X4 
 
DHRSX 
steryl-sulfatase isoform X1 
 
STS N-acetylated-alpha-linked acidic dipeptidase 2 
isoform X3 
 
NAALAD2 
hexokinase-2 isoform X1 
 
HK2 D-aspartate oxidase  
 
DDO 
pre-B-cell leukemia transcription 
factor 4 isoform X1 
 
PBX1 solute carrier organic anion transporter family 
member 5A1 isoform X1 
 
SLCO5A1 
arylsulfatase E isoform X1 
 
ARSE sterol 26- hydroxylase mitochondrial CYP27A1 
retinoic acid receptor alpha isoform 
X1 
 
RARA NHL-repeat-containing 4 
 
NHLRC4 
myeloperoxidase isoform X1 
 
MPO homeobox Hox-A3 
 
HOXA3 
retinol dehydrogenase 13 precursor  
 
RDH13 hydroxyacylglutathione mitochondrial isoform X1 
 
HAGH 
acetyl- cytosolic-like  
 
ACAT2 carboxylesterase-like precursor  
 
CES1 
estradiol 17-beta-dehydrogenase 11 
isoform X1 
 
HSD17B11 CMP-N-acetylneuraminate- 
beta-galactosamide-alpha-2,3- 
sialyltransferase 1 
ST3GAL1 
oxidative stress-induced growth 
inhibitor 2 isoform X3 
 
OSGIN1 vitamin D 25-hydroxylase  
 
CYP2R1 
homeobox Hox-A1 isoform X1 
 
HOXA1 pyrethroid hydrolase Ces2e-like  
 
CES2 
sulfide:quinone mitochondrial  
 
SQOR butyrophilin subfamily 1 member A1 isoform X1 
 
BTN1A1 
frizzled-2 precursor  
 
FZD2 glycine N-methyltransferase  
 
GNMT 
frizzled-4 precursor  
 
FZD4 peroxisomal acyl-coenzyme A oxidase 2 isoform X2 
 
ACOX2 
spermatogenesis-associated 31A6-like 
isoform X1 
 
SPATA31A6 erythrocyte band 7 integral membrane STOM 
prostaglandin reductase 2 isoform X1 
 
PTGR2 glutathione S-transferase theta-2-like  
 
GSTT2 
neuroligin-1 isoform X1 
 
NLGN1 acyl- dehydrogenase family member 11 
 
ACAD11 
1-aminocyclopropane-1-carboxylate 
synthase 1 isoform X1 
 
ACCSL hypoxanthine-guanine phosphoribosyltransferase  
 
HPRT1 
115 
 
phospholipase ABHD3 
 
ABHD3 homeobox Nkx- NKX- 
leucine-zipper-like transcriptional 
regulator 1 
 
LZTR1 oxysterols receptor LXR-alpha isoform X1 
 
NR1H3 
copper-transporting ATPase 1 isoform 
X1 
 
ATP7A FAD-dependent oxidoreductase domain-containing 
2 isoform X1 
 
FOXRED2 
kelch 18 isoform X4 
 
KLHL18 patched domain-containing 3 
 
PTCHD3 
mitochondrial dicarboxylate carrier 
isoform X1 
 
SLC25A10 haloacid dehalogenase-like hydrolase domain-
containing 2 isoform X1 
 
HDHD2 
leucine-rich repeat and IQ domain-
containing 1 isoform X1 
 
LRRIQ1 ependymin-related protein EPDR 
cellular Retinoic Acid Binding Protein CRABP cell adhesion molecule 2-like CADM2 
ankyrin repeat domain-containing 
protein 1-like 
ANKRD1 amiloride-sensitive sodium channel SCNN1 
serine O-acetyltransferase-like SAT sulfatase-modifying factor 1-like SUMF1 
fibrillin-1-like FBN1 erythrocyte band 7 integral membrane STOM 
plasminogen receptor (KT)-like PLGRKT ADP-dependent glucokinase-like ADPGK 
 
Table 3.4: List of 88 up-regulated genes already annotated resulted from the differentia transcriptomic 
analysis of TRIM-treated amphioxus embryos in the developmental interval between 24 and 30 hpf. Gene 
nomenclature is based on best BLAST hit and does not imply that the amphioxus gene is a one-to-one 
orthologue of the gene named. 
 
The majority of genes resulted up- or down-regulated in our differential transcriptomic 
analysis are involved in metabolic processes, probably implemented as a response to the 
presence of the drug (ie cytoplasmic enzymes). A substantial portion of genes 
differentially expressed between treated and control samples are involved in nervous 
system development. This is coherent with the well-known role of the NO in 
neurogenesis and the NosC expression pattern in amphioxus but these genes are not of 
interest for the phenotype that I described in previous paragraph (3.5, pharyngeal-
altered phenotype). Only few genes can directly or indirectly be involved in the 
development of pharyngeal structures: Runx and MMPs are belong to BMP signaling 
pathway; DMRT regulate the Nodal pathway action; FoxE and PDGFR (VEGFR in 
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amphioxus) are involved in club shaped gland and endostyle development; Raldh, RAR, 
Hox1 and Hox3 are belong to the retinoic acid pathway, known to be involved in the 
correct pharyngeal region development in amphioxus. These genes will be the focus of 
future analyses. 
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CHAPTER 4 
DISCUSSION 
 
 
NO is a small signaling molecule that was identified and described for the first time in 
1989, and in 1992 it was entitled as the “Molecule of the Year” by the journal Science 
(Koshland, 1992). Over the years, a huge number of papers have been published 
regarding several aspects of NO biology with different aims and model organisms, from 
bacteria to mammals (Bryan et al., 2009). It has been shown the involvement of NO in 
several biological processes (both physiological and pathological), like the 
neurotransmission, regulation of blood pressure and immune response. Most of the 
studies were carried out in mammals but the interest of the role that NO plays in non-
mammalian organisms have steadily increased. In this way, the spectrum of known 
processes of NO’s involvement has expanded enormously including, for example, 
response to stress conditions (P. lividus, Migliaccio et al., 2014), apoptosis, epidermis 
development (X. laevis, Tomankova et al., 2017), metamorphosis (C. intestinalis, 
Comes et al., 2007; Lytechinus pictus, Bishop and Brandhorst, 2001) and craniofacial 
development (Xenopus laevis and Danio rerio, Jacox et al., 2014). NOS enzymes are 
the most crucial factor in NO production for their exclusive role in the de novo 
synthesis of NO, and thus decisive in the physiological functions of NO system. 
Therefore, investigating the ancestral role of animal Nos genes and their novel acquired 
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functions during evolution is an issue of broad interest to understand the importance of 
NO system in the evolution of animals. 
The main goal of this PhD project was the investigation of physiological roles of 
amphioxus NO during embryonic and larval development. For this purpose, different 
aspects of the NO system have been considered: 1- the general evolutionary scenario 
and the specific position that amphioxus NOS proteins occupy; 2- a better 
characterization of the three amphioxus Nos genes; 3- the analysis of the phenotype 
deriving by inhibition of NO production during amphioxus embryonic development and 
the differential transcriptomic analysis generated under specific conditions.  
Andreakis and colleagues (2011) highlighted the extraordinary high degree of 
conservation of Nos genes among Metazoan, in particular the domain organization as 
well as intron positions and phases. In B. floridae, three different Nos were identified, 
NosA, NosB and NosC (Andreakis et al., 2011), but the topology of the deuterostome 
NOS phylogeny indicated that the multiple amphioxus Nos genes derived from 
independent duplication events with respect to vertebrates. A deeper comparative 
analysis in the cephalochordate subphylum revealed that not only B. floridae but also 
the other two sister species, B. lanceolatum and B. belcheri, have three paralogues Nos 
genes, that resulted ortologues of B. floridae NosA, NosB and NosC. The same scenario 
was also found for Asymmetron, which was the first to diverge within cephalochordate’s 
group, followed by Epigonichthys and Branchiostoma clades. The comparison between 
Branchiostoma and Asymmetron lineages is highly informative for postulating the 
ancestral condition of all cephalochordates (Kon et al., 2007). This analysis suggested 
that the duplication events that originated the three cephalochordate Nos genes occurred 
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in the last common ancestor of extant amphioxus (Fig. 4.1; Annona et al., 2017). 
Moreover, we demonstrated that it is an independent cephalochordate duplication since 
NosA, NosB and NosC are not orthologues to vertebrates NosI, NosII and NosIII. In the 
case of vertebrate, the fact that Nos duplicates are linked to Hox clusters demonstrated 
that they derive from the two round of genome duplication occurred at the stem of 
vertebrates (Andreakis et al., 2011). 
 
 
Figure 4.1: Schematic representation of duplication events of Nos genes occurred in Chordates. Gene 
duplications in the last common ancestor of cephalochordates gave rise to three distinct amphioxus Nos 
genes. In the vertebrate lineage, instead, Nos genes have a different evolutionary origin because they 
come from two whole genome duplications. 
 
For mammals, NOS are classified in neuronal, endothelial and inducible on the base of 
the presence or absence of following characteristics in the protein sequence: neuronal 
NOS proteins have the PDZ domain which targets the enzyme to synapses, endothelial 
NOS is myristolated and/or palmitoylated on specific aminoacidic residues at the N-
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terminal of the protein which is required for its localization in endothelial cells, while 
inducible NOS lacks any specific localization features. Another classic distinction is 
between constitutive and inducible expressed Nos genes.  The constitutive Nos 
(neuronal and endothelial) are always basal expressed, while inducible Nos expression 
can be stimulated, at transcriptional level, by cytokines, LPS and other agents 
(Förstermann and Sessa, 2012). At the protein level, the difference between constitutive 
and inducible NOS is based on the affinity with CaM and so on the possibility to 
perceive intracellular Ca2+ concentration variations. The constitutive NOS activity is 
regulated by Ca2+ and CaM: it has low affinity to CaM and binds it when the free 
intracellular Ca2+ levels increase to specific micromolar concentrations. Conversely, the 
inducible Nos has greater affinity with CaM and binds it permanently, also at low Ca2+ 
concentrations (Cho et al., 1992).  
Indeed, Nos cannot be clearly classified in terms of these mammalian/vertebrate 
subtypes and the distinction between constitutive and inducible expression is not so 
strict. Metazoan showed multiple events of Nos gene loss and gain in various lineages, 
for example many basal metazoans such as Trichoplax have 3 different Nos while 
insects or tunicates have only one Nos (Andreakis et al., 2011). There are several cases 
in which features observed in distinct genes in vertebrates have been found in a unique 
Nos in invertebrates. For example, the only Nos found in Nematostella share sequence 
features comparable to the iNos-like organization (i.e. without the insertion in the 
reductase domain) while the single Nos found in tunicates presents the PDZ domain as a 
neuronal-like Nos. Further, the presence of any localization feature does not correlate 
with the phylogenetic positions, also suggesting an independent incorporation of those 
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motifs in the basic Nos structure. The possibility to be induced in certain inflammatory 
conditions is not an exclusive feature of the iNos. For example, the scallop Chlamys 
farreri possess only one Nos with both PDZ domain and autoinhibitory loop suggesting 
that it is a typical neuronal Nos (Jiang et al., 2013). Nevertheless, the transcriptional 
activation of C. farreri Nos has been observed after stimulation with PAMPs and TNF-
α causing a range of immune responses, including the responses of NO (Beutler and 
Rietschel, 2003), and therefore it has also inducible features. Interestingly, some 
evidences indicate in vertebrates the inducible character of nNos, in certain 
inflammatory conditions (Amin et al., 1995; Vaz et al., 2011). Amphioxus NosA and 
NosC were identified as neuronal Nos because they have both the PDZ and the 
inhibitory loop, while NosB as inducible (Andreakis et al., 2011). In amphioxus, that for 
many aspects represents a connection between invertebrates and vertebrates, the 
stimulation of the immune system by LPS treatment, performed for this project, caused 
the induction of the NosA and NosB expression (Fig 3.3). Therefore, NosB was found to 
be inducible as expected from its structural features but we demonstrated here that at 
least one of the two amphioxus neuronal Nos (NosA) seems to have characteristics 
typical of inducible genes. These evidences, together with structural ones described 
before, led us to conclude that inducibility is an ancestral feature of Nos genes. The 
possible evolutionary scenario is that the inducible-like Nos is the ancestral prototype of 
the enzyme and the multiple constitutive-like Nos lineage specific could be 
independently derived from iNos-like proteins. The process that leaded this transition 
might include independent events of insertion of the autoinhibitory loop in the Nos 
reductase domain and of the localizations domain at the N-terminal.  
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In addition to the fact that the two amphioxus neuronal genes, NosA and NosC, behave 
differently upon a stress stimulus, they resulted different also from a temporal 
expression point of view. NosA in our experiments was expressed exclusively in 
adulthood (Fig. 3.2c). Indeed, only NosB and NosC were expressed during embryonic 
and larval development, showing a complementary trend (Fig. 3.2a-b). NosB was highly 
expressed during gastrulation and it is interesting to mention that in vertebrates the 
involvement of NO is reported in morphogenetic cell movements that allow convergent 
axial extension. In particular, NO seems to suppress cell division and facilitate cell 
movements during early development (Kuzin et al., 1996; Peunova et al., 2007). These 
evidences, together with the result that I obtained, allowed me to hypothesize that, 
during amphioxus gastrulation, NO produced by NosB could perform a similar function 
in the determination of axial elongation, as previously described for vertebrate. This 
speculation is also supported by the evidence that, inhibition experiments of the Nos 
activity early in development caused complex morphogenetic defects (see later in this 
chapter for more details about Nos activity inhibition experiments). Nevertheless, this 
hypothesis must be confirmed by further in-depth studies. Regarding NosA and NosC, it 
was interesting to understand: 1) what has caused their temporal expression separation 
and different inducible nature, and 2) what this temporal separation means in terms of 
NosA and NosC functions during amphioxus development and physiology. 
The clear distinction in temporal expression and in stress susceptibility of NosA and 
NosC could be due to a different transcriptional regulation probably enhanced by the 
progressive accumulation of changes in their respective promoters. To start clarify this, 
I used C. robusta as experimental tool to study the regulatory activity of amphioxus 
123 
 
NosC promoter. Among many putative CNRs identified in silico, only few of them have 
shown a positive activity in directing the expression of the reporter gene. In particular, I 
have detected positive regulatory activity for the CNR 14, 15, 17, 18, 19 upstream the 
NosC transcription start codon and the CNR 39, 40, 41 downstream the NosC 
transcription start codon. These positive amphioxus CNRs driven GFP expression in C. 
robusta nervous system: in the posterior part of the pigmented sensory organs, in the 
otholite and in the ocellus (CNR 17, 18, 19 and CNR 39, 40, 41; Fig. 4.2b and c 
respectively), in the motor ganglion (MG) and in the dorsal caudal epidermal neurons 
(DCENs) (CNR 14, 15; Fig. 4.2a and f). It was already reported that, in C. robusta 
middle larva (previously indicated as Ciona intestinalis), Nos mRNA was visible in the 
posterior part of the sensory vesicle in a series of cells arranged in a circle and in the 
fibres that originate from the sensory vesicle and arrive to the visceral ganglion passing 
through the neck (Fig. 4.2d; Comes et al., 2007). At late larva in C. robusta, Nos was 
also detected in the central portion of the tail exclusively present in the epidermis (Fig. 
4.2e; Comes et al., 2007).   
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Figure 4.2: Comparison between the Nos expression in Ciona robusta, previously described by Comes 
and colleague in 2007, and the positive enhancer activity for the amphioxus CNRs showed in this thesis 
in the chapter 3. a-b-c-f) Results from the present project (see Chapter 3). d-e) Nos expression in C. 
robusta from Comes et al., 2007. 
 
The results that I obtained testing amphioxus CNRs were mostly comparable with C. 
robusta Nos expression pattern at middle larva stage suggesting not only that these 
genomic regions close to amphioxus NosC transcription start codon (Fig. 3.5b-c) 
contain regulatory elements but also that these elements are evolutionary conserved 
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among basal chordates. Further studies will be necessary to clarify the reasons for the 
slight discrepancies found between my results and the C. robusta Nos expression 
reported in literature (i.e the signal in the DCENs, in the otholite and in the ocellus 
resulted from my transgenetic experiments but that were not detected by Comes and 
colleagues for C. robusta Nos expression). 
During larval development, I observed a peak of NO production at 3 dpf larval stage 
that was mainly localized in the pharyngeal area before and after mouth opening (Fig. 
3.10a-b). The biological function of this high amount of NO in the pharyngeal area, 
when mouth has been already opened, could be linked with the primary antimicrobial 
defense reactions, associated to the feeding and the gut functions, and with the process 
of metamorphosis. In fact, the expression of NosC at 3 dpf larval stage was detected in 
the club-shaped gland (Annona et al., 2017), a transient structure that produce mucous 
secretions that aid in the food capture and processing (Gilmour, 1996). The club-shaped 
gland was also proposed to be source of antimicrobial secretion (Godoy et al., 2006) as 
well as to produce hormones of metamorphosis (Wickstead, 1967). The involvement of 
NO in metamorphosis was already described for other invertebrates such as C. robusta, 
I. obsolete, L. pictus and B. villosa (Bishop and Brandhorst, 2001; Bishop et al., 2001; 
Leise et al., 2004; Comes et al., 2007). In particular, in C. robusta NO acts in 
metamorphosis down-regulating ERK specific phosphatases (MKP1 and MKP3), in this 
way ERK is phosphorylated and active. ERK activation precedes the wave of apoptosis 
necessary for tail regression and metamorphosis (Ercolesi et al., 2012).  Interestingly, it 
has been demonstrated the presence of a highly innervated portion of the pharynx in 
pre- and post-metamorphic larvae, indicating that the club-shaped gland, together with 
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the other pharyngeal structures (the pre-oral pit and the endostyle) probably is involved 
in important morphological processes in amphioxus mouth opening and rostral 
metamorphosis (Kaji et al., 2009).  
In order to clarify the role of NO during amphioxus development, its enzymatic 
production was inhibited by TRIM and the resulting phenotype was described. In my 
experiments, I specifically inhibited the NO production presumably deriving from 
NosC, according to in situ hybridization results in which it is clearly showed that NosC 
is the only Nos gene expressed from neurula to larva stage (Annona et al., 2017). The 
most evident phenotype observed was the alteration of the pharyngeal region formation, 
in particular there was the absence of mouth and gill slits and the not complete 
formation of club-shaped gland and endostyle. Any other body features were apparently 
not affected from the TRIM treatment. A temporal and combinatorial treatment 
approach allowed us to predict that probably the crucial time window for NO action 
during amphioxus development could reasonable be from 24 to 42 hpf. TRIM 
treatments in this window, in fact, resulted active on mouth and gill slits determination, 
while after this time interval the treatment resulted 100% inefficient giving an unaltered 
phenotype.  
The involvement of NO in mouth formation was already suggested in vertebrates. It was 
demonstrated that NO depletion during Xenopus and zebrafish embryonic development, 
in particular during neurulation, causes no mouth opening, with a small stomodeal 
invagination, while the other structures of the extreme anterior domain (EAD) were 
correctly specified (Jacox et al., 2014). Jacox and colleagues also showed that nNOS 
and NO acted as members of the Kinin-Kallikrein pathway in determination of that 
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specific process. In order to understand the pathway in which NO acts in amphioxus for 
the regulation of pharyngeal region formation, I performed a differential transcriptomic 
analysis of amphioxus embryos that were treated with TRIM from 24 to 30 hpf. 
Preliminary results showed a down-regulation of FoxE that, in wild-type amphioxus 
embryos, is expressed towards the right pharyngeal wall and, in larvae, marks the club-
shaped gland (Yu et al., 2002; Soukup et al., 2015). This expression pattern suggests 
the involvement of FoxE in the formation and in the function of the club-shaped gland 
and the absence of this structure in the amphioxus TRIM-treated larvae could be due 
precisely to the down-regulation of this gene. Other interesting results, shown by the 
preliminary analysis of the differential transcriptome, are the down-regulation of some 
genes belonging to BMP signaling pathway (Slc39A10, Slc39A6, Runx, MMPs) and of a 
gene involved in regulation and action of Nodal pathway (Dmrt). (Tables 3.1 and 3.2). 
Moreover, genes coding for Frizzled receptors (Frz2, Frz4, Frz6) were upregulated 
indicating an activation of the WNT pathway. It was reported that this pathway must be 
downregulated to allow the mouth opening (Fig. 4.3, Soukup et al., 2015). In 
amphioxus, it has been demonstrated that Nodal signaling patterns the left-right axis of 
the embryo and in particular it is necessary for the left-side expression of downstream 
genes as well as for left-side morphogenesis (Fig. 4.3; Soukup et al., 2015).  
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Figure 4.3: Scheme of Nodal signaling pathway involved in establishment of the left/right asymmetry in 
amphioxus.  Dotted lines indicate proposed interactions based on the data from other chordates. 
Abbreviations: csg, club-shaped gland; en, endostyle; fgs, first gill slit; m, mouth; pp, pre-oral pit (from 
Soukup et al., 2015).  
 
Soukup and colleagues (2015) observed that the inhibition of Nodal signaling with 
specific drugs caused the loss of left-sided structures, as the mouth and the pre-oral pit. 
Indeed, when I treated amphioxus neurulas with TRIM, I observed developing larvae 
without the mouth but with the pre-oral pit normally formed, indicating that NO may be 
affects only the branch of the Nodal signal pathway which concerns the opening of the 
mouth (pink in Fig. 4.3).  Nevertheless, a more recent study has revealed more details 
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about amphioxus mouth formation (Kaji et al., 2016). Kaji and colleagues suggested 
that during neurulation a mesodermal vesicle, called oral mesovesicle (OMV), forms 
from the left side of the first somite, at the boundary between the first and the second 
somite. Afterwards, the OMV get fused with the epithelium on the left side of the 
pharynx, and through the perforation of the epithelium it gave birth to the mouth (Fig. 
1.18). In agreement with the results reported by Soukup et al. 2015, they showed that 
the formation of the OMV (and of the mouth) was under the control of the Nodal-Pitx 
signal pathway. Moreover, this OMV expressed Dkk1/2/4 (a gene downstream Pitx; Fig. 
4.3), Frzb1 and Pax2/5/8, that have been suggested to have a role in the dissolution of 
basal lamina and so in epithelial perforations (Edelman and Jones, 1995; Kozmik et al., 
1999; Dickinson et al., 2009). In fact, it was proposed that mouth formation arise 
through perforation of ectoderm-mesoderm and endoderm-mesoderm bi-layered 
membranes (Goodrich, 1934). The same process was proposed for gills opening, and for 
this reason gills and mouth formations are comparable. This is also supported by the 
evidence that both mouth and gills formations were affected by perturbation of BMP 
signaling pathway, in fact Dorsomophin caused no opening of mouth and gills in larvae 
(Kaji et al., 2016). It is very interesting that, decreasing NO production with TRIM, I 
obtained a very similar phenotype and that the differential transcriptomic analysis of 
TRIM-treated embryos revealed the down-regulation of genes belonging to BMP 
signaling (Slc39A10, Slc39A6, Runx1). Therefore, it is plausible to hypothesize that both 
mouth and gill slits formation processes are under the control of the BMP pathway and 
that NO plays a crucial regulatory role in it. 
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Figure 4.4: Gene pathways involved in left/right and mouth determination across metazoans. Green text 
marks left/right asymmetric expression; magenta text marks median expression. In protostomes, 
echinoderms and hemichordates, the Nodal-Pitx pathway regulates determination of the right side. In 
chordates, after dorso/ventral inversion, it determines the left side. BMP signaling occurred at the anterior 
neural boundary. BMP signaling suppresses oral development in echinoderms and hemichordates, while 
it promotes oral development, through Pitx, in tunicates and vertebrates. It does not seem to have the 
same role it has in other chordates (from Soukup et al., 2015). 
 
After the dorso/ventral inversion occurred at the base of the chordate phylum, it has 
been demonstrated that Nodal-Pitx signaling controls the development of the left-side 
structures while BMP-Pitx pathway is involved in determination of anterior organs. 
Furthermore, inside this scenario, the position of the mouth changed from an anti-BMP 
and non-Pitx territory (echinoderms and hemichordates) to a pro-BMP and Pitx-
expressing territory (tunicates and vertebrates). Indeed, in olfactores, the mouth 
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develops at the anterior neural boundary (Dickinson et al., 2007; Christiaen et al., 2007; 
Soukup et al., 2013) that is marked by the expression of Pitx factors downstream BMP 
signaling and Otx2 at its most-anterior domain. Cephalochordates have a key position in 
this evolutionary scenario. It was already described the involvement of Nodal-Pitx 
signaling in mouth determination in amphioxus (Soukup et al., 2015), and I also found 
this evidence in my preliminary differential transcriptomic results. On the other hand, it 
is currently unclear if the BMP signaling plays any role in amphioxus mouth 
development, as in other chordates (Fig. 4.4). The peculiar left-sided mouth in 
amphioxus has long been a matter of debate about it is homologous or not to the median 
mouth of vertebrates. The studies carried out for my PhD thesis project could add new 
details about the role of both Nodal and BMP pathways in the amphioxus mouth 
formation, their possible crosstalk and, most of all, the possible role of NO in regulating 
both signaling pathway in such important developmental process.  
Another pathway affected by NOS inhibition resulted that of retinoic acid (RA) (Raldh, 
RAR, and the direct targets Hox1 and Hox3) indicating that NO directly or indirectly 
controls it during amphioxus embryonic development. The RA signaling pathway 
regulates anter-posterior patterning of pharynx in chordates. For many years, in 
vertebrates, the role of the neural crests in organizing pharyngeal development was 
emphasized but it has now been defined the key role of pharyngeal endoderm in the 
patterning of the pharynx (Graham and Richardson, 2012). Evidently, the role of 
pharyngeal endoderm in this process predates the evolution of neural crest. In 
amphioxus RA signaling must be suppressed in the anterior portion of the gastrula for 
the proper specification of the pharynx and it must also be finely regulated during the 
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neurula stage for its correct partitioning (Koop et al., 2014). Normally RAR is not 
expressed in anterior part of amphioxus body while RA-treated embryos show an 
ectopic RAR expression in the pharyngeal area (Escriva et al., 2002) that can affect 
expression of genes involved in its development. It will be necessary to verify whether 
this ectopic expression occurs in the NOS-inhibited embryos and if it can regulate the 
expression of other genes that affected in the differential transcriptomic analysis. 
The inhibition of NO production by TRIM treatment in amphioxus at neurula up to 
larval stage, resulted also in an alteration in locomotion of 3 dpf larvae. It is known that 
NO is a bioactive signaling molecule that is known to affect a wide range of 
neurodevelopmental processes. The treated larvae showed a general inactivity with 
sporadic jerking movements as reported in Figure 3.16. Amphioxus myotomes consist 
of separate sets of superficial and deep muscle fibers that are thought to be responsible 
for slow swimming and escape behavior, respectively (Ruppert, 1997). Therefore, the 
altered behavior observed in TRIM-treated larvae could be due to a disorder in 
neuromuscular junctions (NMJs) formation. However, NO functional relevance to 
NMJs development is not fully understood. In X. laevis NOS activity was localized in 
postsynaptic portions of embryo muscle cells and it was demonstrated that NO 
stimulates agrin-induced aggregation of a complex of proteins, including acetylcholine 
receptors (AChRs) (Schwarte and Godfrey, 2004). In fact, when Xenopus embryos were 
exposed to NOS inhibitors from stage 24, in which the innervation of the myotomes had 
not yet begun, to the stage 31, when rows of functional synapses had formed, the 
postsynaptic differentiation was blocked (Schwarte and Godfrey, 2004). The formation 
of NMJ involves the differentiation of both the presynaptic nerve terminal and the 
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postsynaptic apparatus of the muscle cell, resulting in a functional synapse. NO acts 
also as a retrograde signaling molecule that could play a role into regulating 
differentiation of presynaptic nerve terminals at developing NMJs (Thomas and 
Robataille, 2001). In order to understand if NO in amphioxus is involved in NMJs 
differentiation through the same mechanisms described for vertebrates, a deeper study 
will be necessary in future. Moreover, short-term TRIM treatments could be useful to 
identify the precise interval in which NO acts to define the NMJs, just as I did for the 
pharyngeal structures formation.  
 
FUTURE PERSPECTIVES 
The results obtained during my PhD have opened interesting future research prospects 
and several points need to be deepened and completed:  
- Keeping in mind the results obtained about the inducible nature of the 
amphioxus Nos genes, it would be very interesting to analyze also their 
expression by whole-mount in situ hybridization (WISH) and to study the 
endogenous NO production and localization by Griess assay and DAF-FM-DA 
after LPS treatment. All these analyses should be consistent and they should 
provide comprehensive data not only about the inducible nature of the different 
amphioxus Nos, but also about where (in what tissue or structure) each Nos is 
induced. Unfortunately, to complete such experiments I will have to wait for the 
next amphioxus spawning season. 
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- As regard the amphioxus NosC promoter analysis, the positive regulatory 
activity of the CNRs already tested will be confirmed by immunostaining using 
anti-GFP antibody. In this way, I can be sure that the observed fluorescent signal 
is due to the presence of the GFP construct and activity of the amphioxus CNR. 
The positive CNRs will be divided in smaller fragments that will be tested up to 
identify the regulative elements, which have only been hypothesized so far on 
the basis of the JASPAR analysis (see chapter 3). Finally, these promising CNR 
could be tested in zebrafish to assay the evolutionary conservation of the 
neuronal Nos regulation mechanism in chordates. The same analysis will be also 
performed on the genomic region up- and downstream the NosA TSS in order to 
clarify the possible regulatory differences between the two amphioxus neuronal 
Nos genes that can justify their different inducible nature and temporal 
expression. 
- Starting from the preliminary results obtained from the differential 
transcriptomic analysis after TRIM treatment, the goal is to improve the analysis 
already done and to have a complete view of the NOS inhibition effects. The 
most interesting genes will be analyzed by WISH experiments. The 
characterization of the NO action and the establishment of its molecular 
interactions with other networks, that have been altered after NOS inhibition, 
will be important to clarify the role that NO plays in the process of pharyngeal 
structures formation.  
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CHAPTER 5 
COLLABORATIVE AND RELATED PROJECTS 
 
 
Collaborative project: Eukaryote-specific Ran GTPase controls mitosis in 
Mediterranean amphioxus.  
During the course of my Ph.D., I had the possibility to collaborate with Dr. Filomena 
Ristoratore’ s research group at the Stazione Zoologica Anton Dohrn Napoli. The project 
in which I was involved concerns the study of the Ran evolution in metazoans.  
My contribution in this collaborative project was to perform WISH experiments to reveal 
the Ran expression during amphioxus development (Fig. 5.1a-d). Moreover, I carried out 
whole-mount immunostaining using the mitotic marker Phospho anti-Histone H3 (S10) 
(PHH3) (Fig. 5.1e-h).  
The aim of these experiments was to correlate the Ran expression pattern with the mitotic 
process. I also participated in figures preparation and in the critical discussion of the 
results, moreover I contributed in writing the manuscript that is in preparation at the 
moment of my Ph.D. thesis submission. 
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Figure 5.1: Ran expression profile and mitotic cells (PHH3 immunostaining) in amphioxus embryos and 
larvae. A-D) WISH of Ran during amphioxus development. A) middle neurula; B) late neurula; C) pre-
mouth larva; D) open-mouth larva, in the square on the left there is a focus on the anus. E-H) Whole-mount 
immunostaining using PHH3 during amphioxus development. E) middle neurula; F) late neurula; G) pre-
mouth larva; H) open-mouth larva. 
 
Materials and Methods 
Amphioxus embryo collection 
I used embryos obtained from the local amphioxus species, Branchiostoma lanceolatum, 
from the Gulf of Naples (Italy) that were fixed and stored at -20ºC in 70% ethanol for in 
situ hybridization and immunostaining experiments. 
Whole-mount in situ hybridization 
For this experiment, I followed the WISH protocol reported by Annona et al. (2017). 
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Whole-mount immunostaining 
Embryos were rehydrated in PBT and blocked for 1h at RT in 2 mg/mL BSA, 10% goat 
serum in PBT 1X (Blocking solution). The embryos were incubated over night at 4°C in 
rat Phospho anti-Histone H3 (S10) antibody, diluted 1:250 in blocking solution. After 
rinsed 7x20 min in PBT, the secondary antibody, Alexa Fluor® 555 - Goat Anti-Rat IgG 
H&L, was added (dilution 1:500 in blocking solution) for 2 h at 4ºC, and embryos were 
rinsed again 7x20 min in PBT. Embryos were mounted in 80% glycerol in PBS, and 
observed by Axio Imager used in connection with ApoTome (Zeiss). 
 
Related project: Amphioxus biogeography in Europe. 
During my PhD project, I had the opportunity work in a parallel project on the amphioxus 
Branchiostoma lanceolatum biogeography in Europe. We selected key collection 
locations in Europe and specially in Italy for this analysis (Fig. 5.2). My contribution in 
this project was the selection of discriminative genes to use for the analyses, the 
amplification and sequencing of selected genes for all the samples. In addition to the 
classic markers that are usually used for this type of study, I also used an intronic region 
of the B. lanceolatum NosC since this gene is highly conserved among metazoans 
(Andreakis et al., 2011).  
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Figure 5.2: Map of locations selected for amphioxus biogeography in Europe. In the red square, there is a 
zoom on the Italian peninsula. The red dots indicate the sites already analyzed, the yellow dots indicate the 
sites not yet analyzed. G: Göteborg (SE); E: Edinburgh (UK); R: Roscoff (FR); V: Vigo (ES); F: Faro (PT); 
B: Banyuls-sur-Mer (FR); K: Kefalonia (GR). 
 
 
Materials and Methods 
Genomic DNA extraction 
Genomic DNA was extracted, from a piece of adult amphioxus tail, in 20 μl of 50 mM 
NaOH. The samples were heated for 5 min at 95°C in a thermo-block, followed by 
cooling to 4°C. 100 mM Tris-HCl pH 8.0 was added 1:10. The samples were briefly 
centrifuged to collect the lysate in the bottom of the tube and 2 μl of the supernatant 
containing genomic DNA, used for PCR reactions. 
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Markers 
Different genes were used as marker to analyze the conservation between the samples. 
The list of genes is as follows: 
- Ribosomal genes markers:  Cyclooxygenase 1 (Co1 or Cox1) 
Ribosomal ribonucleic acid 12S (rRNA12S) 
Ribosomal ribonucleic acid 16S (rRNA16S). 
- Nuclear genes markers:  Internal Transcribed Spacer 2 (ITS2) 
Pyruvate dehydrogenase (PDH) 
Neuronal Nitric Oxide Synthase C (NOS-C, 
intron). 
- Microsatellites (in progress):  Branb-4 (GTTT)11 accession number EF583886, 
Branb-3 (TGTGT)8 accession number FJ960511 (Li et al., 2013). 
Sequences and alignments 
DNA sequencing was performed as described in Chapter 2. The alignment was carried 
out using the Multiple Sequence Alignment tool “Clustal Omega” of EMBL. 
 
 
 
 
 
140 
 
REFERENCES 
 
 
ADOLF, B., CHAPOUTON, P., LAM, C. S., TOPP, S., TANNHÄUSER, B., STRÄHLE, U., GÖTZ, M. 
& BALLY-CUIF, L. 2006. Conserved and acquired features of adult neurogenesis in the zebrafish 
telencephalon. Dev Biol, 295, 278-93. 
 
AHERN, G. P., KLYACHKO, V. A. & JACKSON, M. B. 2002. cGMP and S-nitrosylation: two routes for 
modulation of neuronal excitability by NO. Trends Neurosci, 25, 510-7. 
 
ALBUIXECH-CRESPO, B., LÓPEZ-BLANCH, L., BURGUERA, D., MAESO, I., SÁNCHEZ-
ARRONES, L., MORENO-BRAVO, J. A., SOMORJAI, I., PASCUAL-ANAYA, J., PUELLES, 
E., BOVOLENTA, P., GARCIA-FERNÀNDEZ, J., PUELLES, L., IRIMIA, M. & FERRAN, J. 
L. 2017. Molecular regionalization of the developing amphioxus neural tube challenges major 
partitions of the vertebrate brain. PLoS Biol, 15, e2001573. 
 
ALDERTON, W. K., COOPER, C. E. & KNOWLES, R. G. 2001. Nitric oxide synthases: structure, 
function and inhibition. Biochem J, 357, 593-615. 
 
AMIN, A. R., DI CESARE, P. E., VYAS, P., ATTUR, M., TZENG, E., BILLIAR, T. R., STUCHIN, S. A. 
& ABRAMSON, S. B. 1995. The expression and regulation of nitric oxide synthase in human 
osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J 
Exp Med, 182, 2097-102. 
 
ANDREAKIS, N., D'ANIELLO, S., ALBALAT, R., PATTI, F. P., GARCIA-FERNÀNDEZ, J., 
PROCACCINI, G., SORDINO, P. & PALUMBO, A. 2011. Evolution of the nitric oxide synthase 
family in metazoans. Mol Biol Evol, 28, 163-79. 
 
ANDREW, P. J. & MAYER, B. 1999. Enzymatic function of nitric oxide synthases. Cardiovasc Res, 43, 
521-31. 
 
ANNONA, G., CACCAVALE, F., PASCUAL-ANAYA, J., KURATANI, S., DE LUCA, P., PALUMBO, 
A. & D'ANIELLO, S. 2017. Nitric Oxide regulates mouth development in amphioxus. Sci Rep, 7, 
8432. 
 
141 
 
AULAK, K. S., KOECK, T., CRABB, J. W. & STUEHR, D. J. 2004. Dynamics of protein nitration in cells 
and mitochondria. Am J Physiol Heart Circ Physiol, 286, H30-8. 
 
BACHIR, L. K., LAVERRIÈRE, J. N. & COUNIS, R. 2001. Isolation and characterization of a rat nitric 
oxide synthase type I gene promoter that confers expression and regulation in pituitary 
gonadotrope cells. Endocrinology 142, 4631-4642 
. 
BARRINGTON, E. J. W., 1965. Biology of Hemichordata and Protochordata. Science, 149, 49-50. 
 
BERLETT, B. S., FRIGUET, B., YIM, M. B., CHOCK, P. B. & STADTMAN, E. R. 1996. Peroxynitrite-
mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics 
adenylylation: relevance to signal transduction. Proc Natl Acad Sci U S A, 93, 1776-80. 
 
BERTRAND, S., BELGACEM, M. R. & ESCRIVA, H. 2011. Nuclear hormone receptors in chordates. 
Mol Cell Endocrinol, 334, 67-75. 
 
BERTRAND, S. & ESCRIVA, H. 2011. Evolutionary crossroads in developmental biology: amphioxus. 
Development, 138, 4819-30. 
 
BEUTLER, B. & RIETSCHEL, E. T. 2003. Innate immune sensing and its roots: the story of endotoxin. 
Nat Rev Immunol, 3, 169-76. 
 
BIRNEY, E. & DURBIN, R. 2000. Using GeneWise in the Drosophila annotation experiment. Genome 
Res, 10, 547-8. 
 
BISHOP, C. D., BATES, W. R. & BRANDHORST, B. P. 2001. Regulation of metamorphosis in ascidians 
involves NO/cGMP signaling and HSP90. J Exp Zool, 289, 374-84. 
 
BISHOP, C. D. & BRANDHORST, B. P. 2001. NO/cGMP signaling and HSP90 activity represses 
metamorphosis in the sea urchin Lytechinus pictus. Biol Bull, 201, 394-404. 
 
BISHOP, C. D. & BRANDHORST, B. P. 2007. Development of nitric oxide synthase-defined neurons in 
the sea urchin larval ciliary band and evidence for a chemosensory function during 
metamorphosis. Dev Dyn, 236, 1535-46. 
 
BLAIR, J. E. & HEDGES, S. B. 2005. Molecular phylogeny and divergence times of deuterostome animals. 
Mol Biol Evol, 22, 2275-84. 
142 
 
 
BOISSEL, J. P., ZELENKA, M., GÖDTEL-ARMBRUST, U., FEUERSTEIN, T. J., FÖRSTERMANN, 
U. 2003. Transcription of different exons 1 of the human neuronal nitric oxide synthase gene is 
dynamically regulated in a cell- and stimulus-specific manner. Biol Chem 384, 351-362. 
 
BONE, Q. 1992. On the locomotion of ascidian tadpole larvae. J. Mar Biol Assoc UK, 83, 907-919. 
 
BRENMAN, J. E., CHAO, D. S., GEE, S. H., MCGEE, A. W., CRAVEN, S. E., SANTILLANO, D. R., 
WU, Z., HUANG, F., XIA, H., PETERS, M. F., FROEHNER, S. C. & BREDT, D. S. 1996. 
Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-
syntrophin mediated by PDZ domains. Cell, 84, 757-67. 
 
BROOKE, N. M., GARCIA-FERNÀNDEZ, J. & HOLLAND, P. W. 1998. The ParaHox gene cluster is an 
evolutionary sister of the Hox gene cluster. Nature, 392, 920-2. 
 
BROS, M., BOISSEL, J. P., GÖDTEL-ARMBRUST, U. & FÖRSTERMANN, U. 2006. Transcription of 
human neuronal nitric oxide synthase mRNAs derived from different first exons is partly 
controlled by exon 1-specific promoter sequences. Genomics 87, 463-473.  
 
BRUNETTI, R., GISSI, C., PENNATI, R., CAICCI, F., GASPARINI, F., MANNI, L. 2015. Morphological 
evidence that the molecularly determined Ciona intestinalis type A and type B are different 
species: Ciona robusta and Ciona intestinalis. J Zoolog Syst Evol Res, 53, 186–193. 
 
BRYAN, N. S., BIAN, K., MURAD, F., 2009. Discovery of the nitric oxide signaling pathway and targets 
for drug development. Front Biosci, 14, 1-18. 
 
CALABRESE, V., MANCUSO, C., CALVANI, M., RIZZARELLI, E., BUTTERFIELD, D. A. & 
STELLA, A. M. 2007. Nitric oxide in the central nervous system: neuroprotection versus 
neurotoxicity. Nat Rev Neurosci, 8, 766-75. 
 
CANDIANI, S., MORONTI, L., PENNATI, R., DE BERNARDI, F., BENFENATI, F. & PESTARINO, 
M. 2010. The synapsin gene family in basal chordates: evolutionary perspectives in metazoans. 
BMC Evol Biol, 10, 32. 
 
CANDIANI, S., MORONTI, L., RAMOINO, P., SCHUBERT, M. & PESTARINO, M. 2012. A 
neurochemical map of the developing amphioxus nervous system. BMC Neurosci, 13, 59. 
 
143 
 
CAPELLA-GUTIÉRREZ, S., SILLA-MARTÍNEZ, J. M. & GABALDÓN, T. 2009. trimAl: a tool for 
automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics, 25, 1972-3. 
 
CAPPELLETTI, G., TEDESCHI, G., MAGGIONI, M. G., NEGRI, A., NONNIS, S. & MACI, R. 2004. 
The nitration of tau protein in neurone-like PC12 cells. FEBS Lett, 562, 35-9. 
 
CAÑESTRO, C., YOKOI, H. & POSTLETHWAIT, J. H. 2007. Evolutionary developmental biology and 
genomics. Nat Rev Genet, 8, 932-42. 
 
CHEN, D., LIN, Y. & ZHANG, H. 2008. Characterization and expression of two amphioxus DDAH genes 
originating from an amphioxus-specific gene duplication. Gene, 410, 75-81. 
 
CHO, H. J., XIE, Q. W., CALAYCAY, J., MUMFORD, R. A., SWIDEREK, K. M., LEE, T. D. & 
NATHAN, C. 1992. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp 
Med, 176, 599-604. 
 
CHRISTIAEN, L., JASZCZYSZYN, Y., KERFANT, M., KANO, S., THERMES, V. & JOLY, J. S. 2007. 
Evolutionary modification of mouth position in deuterostomes. Semin Cell Dev Biol, 18, 502-11. 
 
COMES, S., LOCASCIO, A., SILVESTRE, F., D'ISCHIA, M., RUSSO, G. L., TOSTI, E., BRANNO, M. 
& PALUMBO, A. 2007. Regulatory roles of nitric oxide during larval development and 
metamorphosis in Ciona intestinalis. Dev Biol, 306, 772-84. 
 
CONKLIN E.G. 1914. Facts and factors of development. New York: Popular Science Pub. Co, 84, 531. 
 
CORBO, J. C., LEVINE, M. & ZELLER, R. W. 1997. Characterization of a notochord-specific enhancer 
from the Brachyury promoter region of the ascidian, Ciona intestinalis. Development 124, 589-
602.  
 
COSTA, O. G. 1834. Cenni zoologici ossia descrizione sommaria delle specie nuove di animali discoperti 
in diverse contrade del regno nell' anno 1834. Naples: Azzolino & Comp.  
 
D'ANIELLO, S., IRIMIA, M., MAESO, I., PASCUAL-ANAYA, J., JIMÉNEZ-DELGADO, S., 
BERTRAND, S. & GARCIA-FERNÀNDEZ, J. 2008. Gene expansion and retention leads to a 
diverse tyrosine kinase superfamily in amphioxus. Mol Biol Evol, 25, 1841-54. 
 
DAVIDSON, B., SHI, W., BEH, J., CHRISTIAEN, L. & LEVINE, M. 2006. FGF signaling delineates the 
144 
 
cardiac progenitor field in the simple chordate, Ciona intestinalis. Genes Dev 20, 2728-2738.  
 
DAVIDSON, B., SHI, W. & LEVINE, M. 2005. Uncoupling heart cell specification and migration in the 
simple chordate Ciona intestinalis. Development 132, 4811-4818.  
 
DAVIDSON, S. K., KOROPATNICK, T. A., KOSSMEHL, R., SYCURO, L. & MCFALL-NGAI, M. J. 
2004. NO means 'yes' in the squid-vibrio symbiosis: nitric oxide (NO) during the initial stages of 
a beneficial association. Cell Microbiol, 6, 1139-51. 
 
DEHAL, P. & BOORE, J. L. 2005. Two rounds of whole genome duplication in the ancestral vertebrate. 
PLoS Biol, 3, e314. 
 
DELSUC, F., BRINKMANN, H., CHOURROUT, D. & PHILIPPE, H. 2006. Tunicates and not 
cephalochordates are the closest living relatives of vertebrates. Nature, 439, 965-8. 
 
DELSUC, F., TSAGKOGEORGA, G., LARTILLOT, N. & PHILIPPE, H. 2008. Additional molecular 
support for the new chordate phylogeny. Genesis, 46, 592-604. 
 
DESDEVISES, Y., MAILLET, V., FUENTES, M. & ESCRIVA, H. 2011. A snapshot of the population 
structure of Branchiostoma lanceolatum in the Racou beach, France, during its spawning season. 
PLoS One, 6, e18520. 
 
DI CRISTO, C., FIORE, G., SCHEINKER, V., ENIKOLOPOV, G., D'ISCHIA, M., PALUMBO, A. & DI 
COSMO, A. 2007. Nitric oxide synthase expression in the central nervous system of Sepia 
officinalis: an in situ hybridization study. Eur J Neurosci, 26, 1599-610. 
 
DICKINSON, A. & SIVE, H. 2007. Positioning the extreme anterior in Xenopus: cement gland, primary 
mouth and anterior pituitary. Semin Cell Dev Biol, 18, 525-33. 
 
DICKINSON, A. J. & SIVE, H. L. 2009. The Wnt antagonists Frzb-1 and Crescent locally regulate 
basement membrane dissolution in the developing primary mouth. Development, 136, 1071-81. 
 
DIOGO, R., KELLY, R. G., CHRISTIAEN, L., LEVINE, M., ZIERMANN, J. M., MOLNAR, J. L., 
NODEN, D. M., TZAHOR, E. 2015. A new heart for a new head in vertebrate cardiopharyngeal 
evolution. Nature, 520, 466-73. 
 
DUFOUR, H. D., CHETTOUH Z, DEYTS C, DE ROSA R, GORIDIS C, JOLY JS, BRUNET JF. 2006. 
Precraniate origin of cranial motoneurons. Proc Natl Acad Sci U S A 103, 8727-8732.  
145 
 
 
EDELMAN, G. M. & JONES, F. S. 1995. Developmental control of N-CAM expression by Hox and Pax 
gene products. Philos Trans R Soc Lond B Biol Sci, 349, 305-12. 
 
EDGAR, R. C. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. 
Nucleic Acids Res, 32, 1792-7. 
 
ERCOLESI, E., TEDESCHI, G., FIORE, G., NEGRI, A., MAFFIOLI, E., D'ISCHIA, M. & PALUMBO, 
A. 2012. Protein nitration as footprint of oxidative stress-related nitric oxide signaling pathways 
in developing Ciona intestinalis. Nitric Oxide, 27, 18-24. 
 
ERICSON, L., FREDRIKSSON, G., OFVERHOLM, T., 1985. Ultrastructural localization of the iodination 
centre in the endostyle of the adult amphioxus (Branchiostoma lanceolatum). Cell Tissue Res. 241, 
267-273. 
 
ESCRIVA, H., HOLLAND, N. D., GRONEMEYER, H., LAUDET, V. & HOLLAND, L. Z. 2002. The 
retinoic acid signaling pathway regulates anterior/posterior patterning in the nerve cord and 
pharynx of amphioxus, a chordate lacking neural crest. Development 129, 2905-2916.  
 
ESPLUGUES, J. V. 2002. NO as a signalling molecule in the nervous system. Br J Pharmacol, 135, 1079-
95. 
 
FIORE, G., MATTIELLO, T., TEDESCHI, G., NONNIS, S., D'ISCHIA, M. & PALUMBO, A. 2009. 
Protein nitration is specifically associated with melanin production and reveals redox imbalance 
as a new correlate of cell maturation in the ink gland of Sepia officinalis. Pigment Cell Melanoma 
Res, 22, 857-9. 
 
FUENTES, M., BENITO, E., BERTRAND, S., PARIS, M., MIGNARDOT, A., GODOY, L., JIMENEZ-
DELGADO, S., OLIVERI, D., CANDIANI, S., HIRSINGER, E., D'ANIELLO, S., PASCUAL-
ANAYA, J., MAESO, I., PESTARINO, M., VERNIER, P., NICOLAS, J. F., SCHUBERT, M., 
LAUDET, V., GENEVIERE, A. M., ALBALAT, R., GARCIA FERNANDEZ, J., HOLLAND, 
N. D. & ESCRIVA, H. 2007. Insights into spawning behavior and development of the European 
amphioxus (Branchiostoma lanceolatum). J Exp Zool B Mol Dev Evol, 308, 484-93. 
 
FÖRSTERMANN, U. & SESSA, W. C. 2012. Nitric oxide synthases: regulation and function. Eur Heart 
J, 33, 829-37, 837a-837d. 
 
146 
 
FREDRIKSSON, G., ERICSON, L. E., OLSSON, R., 1984. Iodine binding in the endostyle of larval 
Branchiostoma lanceolatum (Cephalochordata). Gen. Comp. Endocrinol. 56, 177-184. 
 
GARCIA-FERNÀNDEZ, J. & BENITO-GUTIÉRREZ, E. 2009. It's a long way from amphioxus: 
descendants of the earliest chordate. Bioessays, 31, 665-75. 
 
GHOSH, D. K. & SALERNO, J. C. 2003. Nitric oxide synthases: domain structure and alignment in 
enzyme function and control. Front Biosci, 8, d193-209. 
 
GILMOUR, T. H. J. 1996. Feeding methods of cephalochordate larvae. Israel J. Zool. 42 (Suppl), 87–95. 
 
GIOVINE, M., POZZOLINI, M., FAVRE, A., BAVESTRELLO, G., CERRANO, C., OTTAVIANI, F., 
CHIARANTINI, L., CERASI, A., CANGIOTTI, M., ZOCCHI, E., SCARFÌ, S., SARÀ, M. & 
BENATTI, U. 2001. Heat stress-activated, calcium-dependent nitric oxide synthase in sponges. 
Nitric Oxide, 5, 427-31. 
GODOY, L., GONZÀLEZ-DUARTE, R., ALBALAT, R., 2006. S-nitrosogluthathione reductase activity 
of amphioxus ADH3: insights into the nitric oxide metabolism. Int J Biol Sci., 2, 117. 
 
GOODRICH E.S. 1930. The development of the Club-shaped Gland in Amphioxus. 155-164. 
 
GOODRICH E.S. 1934. The early development of the nephridia in amphioxus: Part II, the paired nephridia. 
Q J Micr Sci, 76, 655–74. 
 
GORETSKI, J. & HOLLOCHER, T. C. 1988. Trapping of nitric oxide produced during denitrification by 
extracellular hemoglobin. J Biol Chem, 263, 2316-23. 
 
GRAHAM, A., RICHARDSON, J. 2012. Developmental and evolutionary origins of the 
pharyngeal apparatus. Evodevo, 3, 24. 
 
GREEN, L. C., WAGNER, D. A., GLOGOWSKI, J., SKIPPER, P. L., WISHNOK, J. S., TANNENBAUM, 
S. R. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem, 126, 
131-8. 
 
GRUMETTO, L., WILDING, M., DE SIMONE, M. L., TOSTI, E., GALIONE, A. & DALE, B. 1997. 
Nitric oxide gates fertilization channels in ascidian oocytes through nicotinamide nucleotide 
metabolism. Biochem Biophys Res Commun, 239, 723-8. 
 
147 
 
HALL A. V., ANTONIOU H., WANG Y., CHEUNG A. H., ARBUS A. M., OLSON S. L., LU W. C., 
KAU C. L. AND MARSDEN P. A. 1994. Structural organization of the human neuronal nitric 
oxide synthase gene (NOS1). J. Biol. Chem. 269, 33 082–33 090. 
 
HATSCHEK, B., 1893. The amphioxus and its development. Swan, Sonnenschein & Company. 
 
HECHT, M., WALLACE, B., PRANCE, G., SCHAEFFER, B. 1987. Deuterostome Monophyly and 
Phylogeny. Evol. Biol. Springer US. 179-235. 
 
HIRAKOW, R., KAJITA, N. 1994. Electron microscopic study of the development of amphioxus, 
Branchiostoma belcheri tsingtauense: the neurula and larva. Kaibogaku Zasshi, 69, 1-13. 
 
HOLLAND, L. Z. & ONAI, T. 2012. Early development of cephalochordates (amphioxus). Wiley 
Interdiscip Rev Dev Biol, 1, 167-83. 
 
HOLLAND, N. D. & HOLLAND, L. Z. 1989. Fine Structural Study of the Cortical Reaction and Formation 
of the Egg Coats in a Lancelet (= Amphioxus), Branchiostoma floridae (Phylum Chordata: 
Subphylum Cephalochordata = Acrania). Bio Bull, 176, 111-122. 
 
HOLLAND, N. D. & HOLLAND, L. Z. 1990. Fine Structure of the Mesothelia and Extracellular Materials 
in the Coelomic Fluid of the Fin Boxes, Myocoels and Sclerocoels of a Lancelet, Branchiostoma 
floridae (Cephalochordata = Acrania). Acta Zool., 71, 225–234. 
 
HOLLAND, N. D. & HOLLAND, L. Z. 1991. The fine structure of the growth stage oocytes of a lancelet 
(= amphioxus), Branchiostoma lanceolatum. Invertebr. Reprod. Dev., 19, 107-122. 
 
HOLLAND, N. D. & HOLLAND, L. Z. 1992. Early Development in the Lancelet (=Amphioxus) 
Branchiostoma floridae from Sperm Entry through Pronuclear Fusion: Presence of Vegetal Pole 
Plasm and Lack of Conspicuous Ooplasmic Segregation. Bio Bull, 182, 77-96. 
 
HOLLAND, N. D. & HOLLAND, L. Z. 1993. Embryos and larvae of invertebrate deuterostomes. Essential 
developmental biology: a practical approach. (Stern CD, Holland PWH, Eds.), Oxford; New York: 
IRL Press at Oxford University Press, 21-32. 
 
HOLLAND, L. Z., HOLLAND, N. D. 2007. A revised fate map for amphioxus and the evolution of axial 
patterning in chordates. Integr Comp Biol, 47, 360-72. 
 
148 
 
HOLLAND, N. D., PARIS, M., KOOP, D., 2009. The club-shaped gland of amphioxus: export of secretion 
to the pharynx in pre-metamorphic larvae and apoptosis during metamorphosis. Acta Zool., 90, 
372-379. 
 
HOLLAND, N. D. & HOLLAND, L. Z. 2010. Laboratory spawning and development of the Bahama 
lancelet, Asymmetron lucayanum (cephalochordata): fertilization through feeding larvae. Biol 
Bull, 219, 132-41. 
 
HORIE, T., NAKAGAWA, M., SASAKURA, Y., KUSAKABE, T.G., TSUDA, M. 2010. Simple motor 
system of the ascidian larva: neuronal complex comprising putative cholinergic and 
GABAergic/glycinergic neurons. Zool Sci, 27, 181-190. 
 
HOU, Y. C., JANCZUK, A. & WANG, P. G. 1999. Current trends in the development of nitric oxide 
donors. Curr Pharm Des, 5, 417-41. 
 
IGAWA, T., NOZAWA, M., SUZUKI, D. G., REIMER, J. D., MOROV, A. R., WANG, Y., HENMI, Y. 
& YASUI, K. 2017. Evolutionary history of the extant amphioxus lineage with shallow-branching 
diversification. Sci Rep, 7, 1157. 
 
IKUTA, T. & SAIGA, H. 2007. Dynamic change in the expression of developmental genes in the ascidian 
central nervous system: revisit to the tripartite model and the origin of the midbrain-hindbrain 
boundary region. Dev Biol 312, 631-643.  
 
IMAI, J. H. & MEINERTZHAGEN, I. A. 2007. Neurons of the ascidian larval nervous system in Ciona 
intestinalis: II. Peripheral nervous system. J Comp Neurol 501, 335-352.  
 
JACOX, L., SINDELKA, R., CHEN, J., ROTHMAN, A., DICKINSON, A., SIVE, H. 2014. The extreme 
anterior domain is an essential craniofacial organizer acting through Kinin-Kallikrein signaling. 
Cell Rep, 8, 596-609.  
 
JAFFREY, S. R., BENFENATI, F., SNOWMAN, A. M., CZERNIK, A. J. & SNYDER, S. H. 2002. 
Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and 
CAPON. Proc Natl Acad Sci U S A, 99, 3199-204. 
 
JEONG, Y., WON, J., KIM, C. & YIM, J. 2000. 5'-Flanking sequence and promoter activity of the rabbit 
neuronal nitric oxide synthase (nNOS) gene. Mol Cells 10, 566-574.  
 
149 
 
JIANG, Q., ZHOU, Z., WANG, L., YUE, F., WANG, J. & SONG, L. 2013. A scallop nitric oxide synthase 
(NOS) with structure similar to neuronal NOS and its involvement in the immune defense. PLoS 
One, 8, e69158. 
 
JOHNSON, D. S., DAVIDSON, B., BROWN, C. D., SMITH, W. C. & SIDOW, A. 2004. Noncoding 
regulatory sequences of Ciona exhibit strong correspondence between evolutionary constraint and 
functional importance. Genome Res 14, 2448-2456. 
 
KAJI, T., HOSHINO, Y., HENMI, Y., YASUI, K., 2013. Longitudinal Observation of Japanese Lancelet, 
Branchiostoma japonicum, Metamorphosis. Dataset Pap Biol. 2013, 6. 
 
KAJI, T., REIMER, J. D., MOROV, A. R., KURATANI, S. & YASUI, K. 2016. Amphioxus mouth after 
dorso-ventral inversion. Zoological Lett, 2, 2. 
 
KAJI, T., SHIMIZU, K., ARTINGER, K. B. & YASUI, K. 2009. Dynamic modification of oral innervation 
during metamorphosis in Branchiostoma belcheri, the oriental lancelet. Biol Bull, 217, 151-60. 
 
KATZOFF, A., BEN-GEDALYA, T. & SUSSWEIN, A. J. 2002. Nitric oxide is necessary for multiple 
memory processes after learning that a food is inedible in aplysia. J Neurosci, 22, 9581-94. 
 
KELM, M. 1999. Nitric oxide metabolism and breakdown. Biochim Biophys Acta, 1411(2-3), 273-89. 
 
KNOWLES, R. G. & MONCADA, S. 1994. Nitric oxide synthases in mammals. Biochem J, 298 (Pt 2), 
249-58. 
 
KOJIMA, H., URANO, Y., KIKUCHI, K., HIGUCHI, T., HIRATA, Y. & NAGANO, T. 1999. Fluorescent 
Indicators for Imaging Nitric Oxide Production. Angew Chem Int Ed Engl, 38, 3209-3212. 
 
KON, T., NOHARA, M., YAMANOUE, Y., FUJIWARA, Y., NISHIDA, M. & NISHIKAWA, T. 2007. 
Phylogenetic position of a whale-fall lancelet (Cephalochordata) inferred from whole 
mitochondrial genome sequences. BMC Evol Biol, 7, 127. 
 
KOOP, D., CHEN, J., THEODOSIOU, M., CARVALHO, J. E., ALVAREZ, S., DE LERA, A. R., 
HOLLAND, L.Z., SCHUBERT. M. 2014. Roles of retinoic acid and Tbx1/10 in pharyngeal 
segmentation: amphioxus and the ancestral chordate condition. Evodevo 5, 36.  
 
KOSHLAND, D. E., JR., 1992. Editorial: The Molecule of the Year. Science. 258, 1861. 
150 
 
 
KOZMIK, Z., HOLLAND, N. D., KALOUSOVA, A., PACES, J., SCHUBERT, M. & HOLLAND, L. Z. 
1999. Characterization of an amphioxus paired box gene, AmphiPax2/5/8: developmental 
expression patterns in optic support cells, nephridium, thyroid-like structures and pharyngeal gill 
slits, but not in the midbrain-hindbrain boundary region. Development, 126, 1295-304. 
 
KOZMIKOVA, I., CANDIANI, S., FABIAN, P., GURSKA, D. & KOZMIK, Z. 2013. Essential role of 
Bmp signaling and its positive feedback loop in the early cell fate evolution of chordates. Dev 
Biol, 382, 538-54. 
 
KRÖNSTRÖM, J., DUPONT, S., MALLEFET, J., THORNDYKE, M. & HOLMGREN, S. 2007. 
Serotonin and nitric oxide interaction in the control of bioluminescence in northern krill, 
Meganyctiphanes norvegica (M. Sars). J Exp Biol, 210, 3179-87. 
 
KUO, R. C., BAXTER, G. T., THOMPSON, S. H., STRICKER, S. A., PATTON, C., BONAVENTURA, 
J. & EPEL, D. 2000. NO is necessary and sufficient for egg activation at fertilization. Nature, 406, 
633-6. 
 
KUZIN, B., ROBERTS, I., PEUNOVA, N. & ENIKOLOPOV, G. 1996. Nitric oxide regulates cell 
proliferation during Drosophila development. Cell, 87, 639-49. 
 
LACALLI, T. C. 1996. Frontal eye circuitry, rostral sensory pathways and brain organization in amphioxus 
larvae: evidence from 3D reconstructions. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 351, 243-263. 
 
LACALLI, T. C. 2006. Prospective protochordate homologs of vertebrate midbrain and MHB, with some 
thoughts on MHB origins. Int J Biol Sci, 2, 104-9. 
 
LAMARCK, J.B. 1816. Histoire Naturelle Des Animaux Sans Vertèbres. Verdière, Paris. 
 
LANKESTER, E.R. Memoirs: notes on the embryology and classification of the animal kingdom: 
comprising a revision of speculations relative to the origin and significance of the germ-layers. Q 
J Microsc Sci, 2, 399-454. 
 
LECKIE, C., EMPSON, R., BECCHETTI, A., THOMAS, J., GALIONE, A. & WHITAKER, M. 2003. 
The NO pathway acts late during the fertilization response in sea urchin eggs. J Biol Chem, 278, 
12247-54. 
 
151 
 
LEISE, E. M., KEMPF, S. C., DURHAM, N. R. & GIFONDORWA, D. J. 2004. Induction of 
metamorphosis in the marine gastropod Ilyanassa obsoleta: 5HT, NO and programmed cell death. 
Acta Biol Hung, 55, 293-300. 
 
LI, W., COWLEY, A., ULUDAG, M., GUR, T., MCWILLIAM, H., SQUIZZATO, S., PARK, Y. M., 
BUSO, N. & LOPEZ, R. 2015. The EMBL-EBI bioinformatics web and programmatic tools 
framework. Nucleic Acids Res, 43, W580-4. 
 
LI, W., ZHONG, J. & WANG, Y. 2013. Genetic diversity and population structure of two lancelets along 
the coast of China. Zoolog Sci, 30, 83-91. 
 
LI, Q., RITTER D, YANG N, DONG Z, LI H, CHUANG JH, GUO S. 2010. A systematic approach to 
identify functional motifs within vertebrate developmental enhancers. Dev Biol 337, 484-495.  
 
LI, Y. ZHAO, Y., LI, G., WANG, J., LI, T., LI, W., LU, J. 2007. Regulation of neuronal nitric oxide 
synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma 
cells. J Neurochem 101, 1194-1204.  
 
LIN, Y., CHEN, D., ZHANG, W., CAI, Z., CHEN, Z., ZHANG, N., MAO, B. & ZHANG, H. 2011. 
Characterization of the immune defense related tissues, cells, and genes in amphioxus. Sci China 
Life Sci, 54, 999-1004. 
 
LOVE, M. I., HUBER, W. & ANDERS, S. 2014. Moderated estimation of fold change and dispersion for 
RNA-seq data with DESeq2. Genome Biol, 15, 550. 
 
MACMICKING, J., XIE, Q. W. & NATHAN, C. 1997. Nitric oxide and macrophage function. Annu Rev 
Immunol, 15, 323-50. 
 
MARTÍNEZ-RUIZ, A. & LAMAS, S. 2009. Two decades of new concepts in nitric oxide signaling: from 
the discovery of a gas messenger to the mediation of nonenzymatic posttranslational 
modifications. IUBMB Life, 61, 91-8. 
 
MATTIELLO, T., FIORE, G., BROWN, E. R., D'ISCHIA, M. & PALUMBO, A. 2010. Nitric oxide 
mediates the glutamate-dependent pathway for neurotransmission in Sepia officinalis 
chromatophore organs. J Biol Chem, 285, 24154-63. 
 
MATTILA, J. T. & THOMAS, A. C. 2014. Nitric oxide synthase: non-canonical expression patterns. Front 
152 
 
Immunol, 5, 478. 
 
MATSUOKA, T., AWAZU, S., SHOGUCHI, E., SATOH, N. & SASAKURA, Y. 2005. Germline 
transgenesis of the ascidian Ciona intestinalis by electroporation. Genesis 41, 67-72.  
 
MIGLIACCIO, O., CASTELLANO, I., ROMANO, G. & PALUMBO, A. 2014. Stress response to 
cadmium and manganese in Paracentrotus lividus developing embryos is mediated by nitric oxide. 
Aquat. Toxicol. 156, 125-134. 
 
MOHRI, T., SOKABE, M. & KYOZUKA, K. 2008. Nitric oxide (NO) increase at fertilization in sea urchin 
eggs upregulates fertilization envelope hardening. Dev Biol, 322, 251-62. 
 
MONCADA, S., PALMER, R. M. & HIGGS, E. A. 1991. Nitric oxide: physiology, pathophysiology, and 
pharmacology. Pharmacol Rev, 43, 109-42. 
 
MOROZ, L. L., MEECH, R. W., SWEEDLER, J. V. & MACKIE, G. O. 2004. Nitric oxide regulates 
swimming in the jellyfish Aglantha digitale. J Comp Neurol, 471, 26-36. 
 
MOSHAGE, H., KOK, B., HUIZENGA, J. R. & JANSEN, P. L. 1995. Nitrite and nitrate determinations 
in plasma: a critical evaluation. Clin Chem, 41, 892-6. 
 
NISHIDA, C. R. & ORTIZ DE MONTELLANO, P. R. 1999. Autoinhibition of endothelial nitric-oxide 
synthase. Identification of an electron transfer control element. J Biol Chem, 274, 14692-8. 
 
NOBREGA, M. A., OVCHARENKO, I., AFZAL, V. & RUBIN, E. M. 2003. Scanning human gene deserts 
for long-range enhancers. Science 302, 413.  
 
NOHARA, M., NISHIDA, M., MIYA, M. & NISHIKAWA, T. 2005. Evolution of the mitochondrial 
genome in cephalochordata as inferred from complete nucleotide sequences from two 
epigonichthys species. J Mol Evol, 60, 526-37. 
 
OBERBÄUMER, I., MOSER, D. & BACHMANN, S. 1998. Nitric oxide synthase 1 mRNA: tissue-specific 
variants from rat with alternative first exons. Biol Chem 379, 913-919. 
 
OHNO, S. 1970. Evolution by gene duplication. London: George Alien & Unwin Ltd. Berlin, Heidelberg 
and New York: Springer-Verlag. 
 
153 
 
OLSSON, R. 1983. Club-shaped gland and endostyle in larval Branchiostoma lanceolatum 
(Cephalochordata). Zoomorphology, 103, 1-13. 
 
PALLAS, P. S. 1767. Limax lanceolatus: descriptio Limacis lanceolaris. Spicilegia Zoologica, quibus 
novae imprimus et obscurae animalium species iconibus, descriptionibus. 9-14. 
 
PALUMBO, A. 2005. Nitric oxide in marine invertebrates: a comparative perspective. Comp Biochem 
Physiol A Mol Integr Physiol, 142, 241-8. 
 
PARIS, M., ESCRIVA, H., SCHUBERT, M., BRUNET, F. D. R., BRTKO, J., CIESIELSKI, F., 
ROECKLIN, D., VIVAT-HANNAH, V. R., JAMIN, E. L., CRAVEDI, J.-P., 2008. Amphioxus 
postembryonic development reveals the homology of chordate metamorphosis. Curr Biol., 18, 
825-830. 
 
 PARIS, M., HILLENWECK, A., BERTRAND, S. P., DELOUS, G., ESCRIVA, H., ZALKO, D., 
CRAVEDI, J.-P., LAUDET, V., 2010. Active metabolism of thyroid hormone during 
metamorphosis of amphioxus. Integr Comp Biol., 50, 63-74. 
 
PASCUAL-ANAYA, J., ADACHI, N., ALVAREZ, S., KURATANI, S., D'ANIELLO, S. & GARCIA-
FERNÀNDEZ, J. 2012. Broken colinearity of the amphioxus Hox cluster. Evodevo, 3, 28. 
 
PASCUAL-ANAYA, J., D'ANIELLO, S. & GARCIA-FERNÀNDEZ, J. 2008. Unexpectedly large number 
of conserved noncoding regions within the ancestral chordate Hox cluster. Dev Genes Evol, 218, 
591-7. 
 
PASCUAL-ANAYA, J., D'ANIELLO, S., KURATANI, S. & GARCIA-FERNÀNDEZ, J. 2013. Evolution 
of Hox gene clusters in deuterostomes. BMC Dev Biol, 13, 26. 
 
PASINI, A., AMIEL, A., ROTHBÄCHER, U., ROURE, A., LEMAIRE, P., DARRAS. S. 2006. Formation 
of the ascidian epidermal sensory neurons: insights into the origin of the chordate peripheral 
nervous system. PLoS Biol 4, e225.  
 
PENNACCHIO, L. A., AHITUV N., MOSES A.M., PRABHAKAR S., NOBREGA M.A., SHOUKRY 
M., MINOVITSKY S., DUBCHAK I., HOLT A., LEWIS K.D., PLAJZER-FRICK I., AKIYAMA 
J., DE VAL S., AFZAL V., BLACK B.L., COURONNE O., EISEN M.B., VISEL A., RUBIN 
E.M. 2006. In vivo enhancer analysis of human conserved non-coding sequences. Nature 444, 
499-502.  
154 
 
 
PEUNOVA, N., SCHEINKER, V., RAVI, K. & ENIKOLOPOV, G. 2007. Nitric oxide coordinates cell 
proliferation and cell movements during early development of Xenopus. Cell Cycle, 6, 3132-44. 
 
POLYCHRONOPOULOS, D., KING, J. W. D., NASH, A. J., TAN, G. & LENHARD, B. 2017. Conserved 
non-coding elements: developmental gene regulation meets genome organization. Nucleic Acids 
Res 45, 12611-12624.  
 
POLLOCK, V. P., MCGETTIGAN, J., CABRERO, P., MAUDLIN, I. M., DOW, J. A., DAVIES, S. A., 
2004. Conservation of capa peptide-induced nitric oxide signalling in Diptera. J Exp Biol. 207, 
4135-45. 
 
PRABHAKAR, S., POULIN, F., SHOUKRY, M., AFZAL, V., RUBIN, E.M., COURONNE, O., 
PENNACCHIO, L. A. 2006. Close sequence comparisons are sufficient to identify human cis-
regulatory elements. Genome Res 16, 855-863.  
 
PUTNAM, N. H., BUTTS, T., FERRIER, D. E., FURLONG, R. F., HELLSTEN, U., KAWASHIMA, T., 
ROBINSON-RECHAVI, M., SHOGUCHI, E., TERRY, A., YU, J. K., BENITO-GUTIÉRREZ, 
E. L., DUBCHAK, I., GARCIA-FERNÀNDEZ, J., GIBSON-BROWN, J. J., GRIGORIEV, I. V., 
HORTON, A. C., DE JONG, P. J., JURKA, J., KAPITONOV, V. V., KOHARA, Y., KUROKI, 
Y., LINDQUIST, E., LUCAS, S., OSOEGAWA, K., PENNACCHIO, L. A., SALAMOV, A. A., 
SATOU, Y., SAUKA-SPENGLER, T., SCHMUTZ, J., SHIN-I, T., TOYODA, A., BRONNER-
FRASER, M., FUJIYAMA, A., HOLLAND, L. Z., HOLLAND, P. W., SATOH, N. & 
ROKHSAR, D. S. 2008. The amphioxus genome and the evolution of the chordate karyotype. 
Nature, 453, 1064-71. 
 
RIFE, T. K., XIE, J., REDMAN, C. & YOUNG, A. P. 2000. The 5'2 promoter of the neuronal nitric oxide 
synthase dual promoter complex mediates inducibility by nerve growth factor. Brain Res Mol 
Brain Res 75, 225-236. 
 
ROBERTSON, J. D., BONAVENTURA, J., KOHM, A. & HISCAT, M. 1996. Nitric oxide is necessary 
for visual learning in Octopus vulgaris. Proc Biol Sci, 263, 1739-43. 
 
ROBINSON, L. J. & MICHEL, T. 1995. Mutagenesis of palmitoylation sites in endothelial nitric oxide 
synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci 
U S A, 92, 11776-80. 
 
155 
 
RONQUIST, F., TESLENKO, M., VAN DER MARK, P., AYRES, D. L., DARLING, A., HÖHNA, S., 
LARGET, B., LIU, L., SUCHARD, M. A. & HUELSENBECK, J. P. 2012. MrBayes 3.2: efficient 
Bayesian phylogenetic inference and model choice across a large model space. Syst Biol, 61, 539-
42. 
 
RUPPERT E.E. 1997. Cephalochordata (Acrania). In: Harrison FW, Ruppert E.E., editors. Microscopic 
anatomy of invertebrates, 15. New York: Wiley-Liss, 349–504. 
 
RYAN, K., LU, Z. & MEINERTZHAGEN, I. A. 2016. The CNS connectome of a tadpole larva of. Elife 
5.  
 
SALLEO, A., MUSCI, G., BARRA, P. & CALABRESE, L. 1996. The discharge mechanism of acontial 
nematocytes involves the release of nitric oxide. J Exp Biol, 199, 1261-7. 
 
SANDELIN, A., ALKEMA, W., ENGSTRÖM, P., WASSERMAN, W. W. & LENHARD, B. 2004. 
JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic 
Acids Res 32, D91-94.  
 
SASAKI, M., GONZALEZ-ZULUETA M, HUANG H, HERRING WJ, AHN S, GINTY DD, DAWSON 
VL, DAWSON TM. 2000. Dynamic regulation of neuronal NO synthase transcription by calcium 
influx through a CREB family transcription factor-dependent mechanism. Proc Natl Acad Sci U 
S A 97, 8617-8622. 
 
SAUR, D., SEIDLER, B., PAEHGE, H., SCHUSDZIARRA, V. & ALLESCHER, H. D. 2002. Complex 
regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of 
Sp and ZNF family members of transcription factors. J Biol Chem 277, 25798-25814. 
 
SCHIPP, R. & GEBAUER, M. 1999. Nitric oxide: a vasodilatatory mediator in the cephalic aorta of Sepia 
officinalis (L.) (Cephalopoda). Invert Neurosci, 4, 9-15 
 
SCHOPFER, F. J., BAKER, P. R. & FREEMAN, B. A. 2003. NO-dependent protein nitration: a cell 
signaling event or an oxidative inflammatory response? Trends Biochem Sci, 28, 646-54. 
 
SCHUBERT, M., ESCRIVA, H., XAVIER-NETO, J. & LAUDET, V. 2006. Amphioxus and tunicates as 
evolutionary model systems. Trends Ecol Evol, 21, 269-77. 
 
SCHWARTE, R. C. & GODFREY, E. W. 2004. Nitric oxide synthase activity is required for postsynaptic 
156 
 
differentiation of the embryonic neuromuscular junction. Dev Biol, 273, 276-84. 
 
SCHWARTZ, S., ZHANG Z, FRAZER KA, SMIT A, RIEMER C, BOUCK J, GIBBS R, HARDISON R, 
MILLER W. 2000. PipMaker--a web server for aligning two genomic DNA sequences. Genome 
Res 10, 577-586.  
 
SHIMELD, S. M., PURKISS, A. G., DIRKS, R. P., BATEMAN, O. A., SLINGSBY, C. & LUBSEN, N. 
H. 2005. Urochordate betagamma-crystallin and the evolutionary origin of the vertebrate eye lens. 
Curr Biol, 15, 1684-9. 
 
SIEPEL, A., BEJERANO G, PEDERSEN JS, HINRICHS AS, HOU M, ROSENBLOOM K, CLAWSON 
H, SPIETH J, HILLIER LW, RICHARDS S, WEINSTOCK GM, WILSON RK, GIBBS RA, 
KENT WJ, MILLER W, HAUSSLER D. 2005. Evolutionarily conserved elements in vertebrate, 
insect, worm, and yeast genomes. Genome Res 15, 1034-1050.  
 
SOUKUP, V., HORÁCEK, I. & CERNY, R. 2013. Development and evolution of the vertebrate primary 
mouth. J Anat, 222, 79-99. 
 
SOUKUP, V., KOZMIK, Z. 2016. Zoology: A New Mouth for Amphioxus. Curr Biol, 26, R367-8. 
 
SOUKUP, V., YONG, L. W., LU, T. M., HUANG, S. W., KOZMIK, Z. & YU, J. K. 2015. The Nodal 
signaling pathway controls left-right asymmetric development in amphioxus. Evodevo, 6, 5. 
 
STAMLER, J. S., SINGEL, D. J. & LOSCALZO, J. 1992. Biochemistry of nitric oxide and its redox-
activated forms. Science, 258, 1898-902. 
 
STEFANO, G. B. & OTTAVIANI, E. 2002. The biochemical substrate of nitric oxide signaling is present 
in primitive non-cognitive organisms. Brain Res, 924, 82-9. 
 
STEINERT, J. R., CHERNOVA, T. & FORSYTHE, I. D. 2010. Nitric oxide signaling in brain function, 
dysfunction, and dementia. Neuroscientist, 16, 435-52. 
 
STOKES, M. D., HOLLAND, N. D. 1995. Embryos and larvae of a lancelet, Branchiostoma floridae, from 
hatching through metamorphosis: growth in the laboratory and external morphology. Acta Zool. 
76, 105-120. 
 
SUN, J., ZHANG, X., BRODERICK, M., FEIN, H. 2003. Measurement of nitric oxide production in 
157 
 
biological systems by using Griess reaction assay. Sensors. 3, 276-284. 
 
TAKAHASHI, T. & HOLLAND, P. W. 2004. Amphioxus and ascidian Dmbx homeobox genes give clues 
to the vertebrate origins of midbrain development. Development, 131, 3285-94. 
 
TAKATORI, N., BUTTS, T., CANDIANI, S., PESTARINO, M., FERRIER, D. E., SAIGA, H. & 
HOLLAND, P. W. 2008. Comprehensive survey and classification of homeobox genes in the 
genome of amphioxus, Branchiostoma floridae. Dev Genes Evol, 218, 579-90. 
 
TAQATQEH, F., MERGIA, E., NEITZ, A., EYSEL, U. T., KOESLING, D. & MITTMANN, T. 2009. 
More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal 
long-term potentiation. J Neurosci, 29, 9344-50. 
 
TEDESCHI, G., CAPPELLETTI, G., NONNIS, S., TAVERNA, F., NEGRI, A., RONCHI, C. & RONCHI, 
S. 2007. Tyrosine nitration is a novel post-translational modification occurring on the neural 
intermediate filament protein peripherin. Neurochem Res, 32, 433-41. 
 
TENG, Y., GIRARD, L., FERREIRA, H. B., STERNBERG, P. W. & EMMONS, S. W. 2004. Dissection 
of cis-regulatory elements in the C. elegans Hox gene egl-5 promoter. Dev Biol 276, 476-492.  
 
TENGAN, C. H., RODRIGUES, G. S., GODINHO, R. O. 2012. Nitric oxide in skeletal muscle: role on 
mitochondrial biogenesis and function. Int J Mol Sci, 13, 17160-84. 
 
THOMAS, S. & ROBITAILLE, R. 2001. Differential frequency-dependent regulation of transmitter 
release by endogenous nitric oxide at the amphibian neuromuscular synapse. J Neurosci, 21, 1087-
95. 
 
TITHERADGE, M., HEMMENS, B., MAYER, B. 1998. Enzymology of Nitric Oxide Synthases. Nitric 
Oxide Protocols, 100. Humana Press, 1-32. 
 
TOMANKOVA, S., ABAFFY, P., SINDELKA, R. 2017. The role of nitric oxide during embryonic 
epidermis development of Xenopus laevis. Biol Open, 6, 862-871. 
 
VAZ, A. R., SILVA, S. L., BARATEIRO, A., FERNANDES, A., FALCÃO, A. S., BRITO, M. A. & 
BRITES, D. 2011. Pro-inflammatory cytokines intensify the activation of NO/NOS, JNK1/2 and 
caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin. Exp 
Neurol, 229, 381-90. 
158 
 
 
VIERRA, D. A. & IRVINE, S. Q. 2012. Optimized conditions for transgenesis of the ascidian Ciona using 
square wave electroporation. Dev Genes Evol 222, 55-61.  
 
VIZI, E. S., FEKETE, A., KAROLY, R. & MIKE, A. 2010. Non-synaptic receptors and transporters 
involved in brain functions and targets of drug treatment. Br J Pharmacol, 160, 785-809. 
 
WADA, H., GARCIA-FERNÀNDEZ, J. & HOLLAND, P. W. 1999. Colinear and segmental expression 
of amphioxus Hox genes. Dev Biol, 213, 131-41. 
 
WANG Y., NEWTON D. C., ROBB G. B., KAU C. L., MILLER T. L., CHEUNG A. H., HALL A. V., 
VANDAMME S., WILCOX J. N. AND MARSDEN P. A. 1999. RNA diversity has profound 
effects on the translation of neuronal nitric oxide synthase. Proc. Natl Acad. Sci. 96, 12 150–12 
155. 
 
WICHT, H., LACALLI, T. C. 2005. The nervous system of amphioxus: structure, development, and 
evolutionary significance. Can J Zool. 83, 122-150. 
 
WICKSTEAD, J. H. 1967. Branchiostoma lanceolatum larvae: some experiments on the effect of thiouracil 
on metamorphosis.  J. Mar. Biol. Assoc. U. K., 47, 49–59. 
 
WINCHELL, C. J., SULLIVAN, J., CAMERON, C. B., SWALLA, B. J. & MALLATT, J. 2002. 
Evaluating hypotheses of deuterostome phylogeny and chordate evolution with new LSU and SSU 
ribosomal DNA data. Mol Biol Evol, 19, 762-76. 
 
WINK, D. A., HINES, H. B., CHENG, R. Y., SWITZER, C. H., FLORES-SANTANA, W., VITEK, M. 
P., RIDNOUR, L. A. & COLTON, C. A. 2011. Nitric oxide and redox mechanisms in the immune 
response. J Leukoc Biol, 89, 873-91. 
 
WLLLCY, A., 1891. The later larval development of amphioxus. Q J Microsc Sci. 32, 183. 
 
WOOLFE, A., GOODSON M, GOODE DK, SNELL P, MCEWEN GK, VAVOURI T, SMITH SF, 
NORTH P, CALLAWAY H, KELLY K, WALTER K, ABNIZOVA I, GILKS W, EDWARDS 
YJ, COOKE JE, ELGAR G. 2005. Highly conserved non-coding sequences are associated with 
vertebrate development. PLoS Biol 3, e7.  
 
XU, W., LIU, L. Z., LOIZIDOU, M., AHMED, M. & CHARLES, I. G. 2002. The role of nitric oxide in 
159 
 
cancer. Cell Res, 12, 311-20. 
 
YAN, J., ZHANG, C., ZHANG, Y., LI, K., XU, L., GUO, L., KONG, Y. & FENG, L. 2013. 
Characterization and comparative analyses of two amphioxus intelectins involved in the innate 
immune response. Fish Shellfish Immunol, 34, 1139-46. 
 
YARRELL, W. 1836. A history of British fishes. London: John Van Voorst. 
 
YOON, Y., SONG, J., HONG, S. H. & KIM, J. Q. 2000. Plasma nitric oxide concentrations and nitric oxide 
synthase gene polymorphisms in coronary artery disease. Clin Chem, 46, 1626-30. 
 
YU, J. K. & HOLLAND, L. Z. 2009. Cephalochordates (amphioxus or lancelets): a model for 
understanding the evolution of chordate characters. Cold Spring Harb Protoc, 2009, pdb.emo130. 
 
YU, J. K., HOLLAND, L. Z., JAMRICH, M., BLITZ, I. L. & HOLLAN, N. D. 2002. AmphiFoxE4, an 
amphioxus winged helix/forkhead gene encoding a protein closely related to vertebrate thyroid 
transcription factor-2: expression during pharyngeal development. Evol Dev, 4, 9-15. 
 
YUE, J. X., YU, J. K., PUTNAM, N. H. & HOLLAND, L. Z. 2014. The transcriptome of an amphioxus, 
Asymmetron lucayanum, from the Bahamas: a window into chordate evolution. Genome Biol 
Evol, 6, 2681-96. 
 
ZHANG, S. C., HOLLAND, N. D. & HOLLAND, L. Z. 1997. Topographic changes in nascent and early 
mesoderm in amphioxus embryos studied by DiI labeling and by in situ hybridization for a 
Brachyury gene. Dev Genes Evol, 206, 532-535. 
 
ZHOU, L., ZHU, D. Y. 2009. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, 
and clinical implications. Nitric Oxide, 20, 223-30.  
1Scientific RepoRts | 7: 8432  | DOI:10.1038/s41598-017-08157-w
www.nature.com/scientificreports
Nitric Oxide regulates mouth 
development in amphioxus
Giovanni Annona1, Filomena Caccavale1, Juan Pascual-Anaya  2, Shigeru Kuratani2,  
Pasquale De Luca3, Anna Palumbo1 & Salvatore D’Aniello  1
The development of the mouth in animals has fascinated researchers for decades, and a recent study 
proposed the modern view of recurrent evolution of protostomy and deuterostomy. Here we expanded 
our knowledge about conserved traits of mouth formation in chordates, testing the hypothesis that 
nitric oxide (NO) is a potential regulator of this process. In the present work we show for the first time 
that NO is an essential cell signaling molecule for cephalochordate mouth formation, as previously 
shown for vertebrates, indicating its conserved ancestral role in chordates. The experimental decrease 
of NO during early amphioxus Branchiostoma lanceolatum development impaired the formation of the 
mouth and gill slits, demonstrating that it is a prerequisite in pharyngeal morphogenesis. Our results 
represent the first step in the understanding of NO physiology in non-vertebrate chordates, opening 
new evolutionary perspectives into the ancestral importance of NO homeostasis and acquisition of 
novel biological roles during evolution.
Nitric oxide (NO) is a small and highly diffusible signal molecule that is known to be involved in a wide range of 
important biological processes. Since its initial discovery as a modulator of vascular activities in mammals, NO 
has been found to participate in numerous physiological and developmental functions in a wide spectrum of 
organisms1. Our understanding of NO signaling has profoundly changed over recent decades. It was originally 
considered solely as a toxic substance, but nowadays, although harmful at high concentration, NO is believed 
to be an essential signaling molecule for living organisms. The function of this ambivalent gas depends on the 
precise balance between its production and consumption. When produced at high levels, for example during 
inflammation, NO may interact with cellular components, such as DNA, RNA, lipids, and proteins, leading to 
mutations and altered cell physiology that may lead to carcinogenesis2–4. On the other hand, NO deficiency can 
cause disorders of endocrine5, cardiovascular6, musculoskeletal7 and immune systems8.
The biosynthesis of NO is catalysed by the nitric oxide synthase enzymes (NOS), through two successive 
mono-oxygenation reactions, from L-Arginine to L-Citrulline with Nω-hydroxy-L-arginine (NOHLA) as an 
intermediate9. Mammalian genomes have three paralogous Nos genes with distinct expression patterns and 
specific functions10, 11: NosI or neuronal Nos (nNos); NosII or macrophage inducible Nos (iNos), and NosIII or 
endothelial Nos (eNos). All Nos genes share a very similar gene structure, with highly conserved intron num-
ber, position and phases. At the protein level, they only differ in the presence of the protein-interaction domain 
(PDZ) in NOSI, which is absent in both NOSII and NOSIII, and in the absence of the inhibitory loop in the 
region of FMN-binding domain exclusively in NOSII12, 13. Two of these genes, NosI and NosIII, are typically 
constitutively expressed, while NosII expression levels increase upon microbial infection, generating high and 
sustained amounts of NO14. Despite their given names indicating a tissue-specificity, all three Nos genes are, in 
fact, expressed in most tissues and organs. Therefore, we prefer to use the NosI-II-III nomenclature. In the central 
nervous system (CNS) the NO produced by NOSI is implicated in neurogenesis, synaptic plasticity, learning and 
memory15, while in the peripheral nervous system it is involved in the control of blood pressure, gut peristalsis 
and vasodilatation14, 16. NO derived from NOSII, primarily from macrophages, is essential for the control of 
inflammatory processes induced by intracellular bacteria or parasites14. Lastly, NO produced by NOSIII, which 
is the best characterized of the NOS proteins, is a homeostatic regulator of numerous essential cardiovascular 
functions, such as vasodilatation, inhibition of platelet aggregation and adhesion to the vascular wall, as well as 
inhibition of vascular inflammation14.
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Nos genes are found in all living organisms, including bacteria17 and plants18, 19. During evolution, an ancestral 
proto-Nos gene was duplicated independently in several metazoan lineages, with a remarkable conservation in 
amino acid sequence and functional domains. Among chordates, the urochordate Ciona intestinalis possesses a 
single NosI-like gene containing a PDZ domain, and NO is a critical endogenous regulator of metamorphosis, 
apoptosis and ERK signaling20–22. As mentioned above, in tetrapod genomes, including mammals, three Nos par-
alogs have been identified23–25, while bony fish possess a variable Nos gene repertoire23–25.
Although the role of Nos genes is well established in urochordates and vertebrates (so-called olfactores), infor-
mation available on cephalochordates (sister group of olfactores) is scattered in the literature. Presence of NOS 
was demonstrated prevalently in adult Branchiostoma belcheri tissues, mainly cerebral vesicle, muscle, endostyle 
and anus26, as well as nerve cord, wheel organ, epithelial cells of gut and midgut diverticulum, gill blood vessels, 
endostyle and ovary27. Later, NOS involvement in the immune system was demonstrated by Lin et al.28. The only 
attempt to study NOS during amphioxus development showed that the protein is present in the developing intes-
tine (midgut and hindgut) and in the club-shaped gland of Branchiostoma floridae larvae29.
The foregoing studies were performed before the identification of the complete set of three Nos genes in the 
B. floridae genome: two NosI-like (NosA and NosC) and one NosII-like, so-called NosB23. However, phylogenetic 
analyses showed that they are not one-to-one orthologs of the three vertebrate Nos genes, but they derived from 
an independent duplication in the cephalochordate lineage23. A comprehensive study aimed at discovering the 
different biological roles of all Nos genes during amphioxus embryogenesis was still missing.
In the present study, we have identified the Nos gene repertoire of three cephalochordate species and analysed 
their evolutionary history in comparison with other chordates. In addition, we have analysed the expression pro-
files of Nos genes in the European amphioxus, Branchiostoma lanceolatum. Lastly, we have investigated the nitric 
oxide localization as well as its biological functions during embryonic development in B. lanceolatum. We have 
found that NO is involved in the formation of the amphioxus mouth, acting in a sharp temporal window at early 
embryonic stages.
Results
Nos genes have independently duplicated in the lancelet lineage. Previous studies have high-
lighted the occurrence of several independent lineage-specific Nos gene duplications in metazoan evolution, 
including amphioxus B. floridae23. In order to unravel whether the Nos expansion observed in B. floridae was 
present in other amphioxus species and to better define the Nos evolutionary history within the cephalochordates, 
we searched both genomic and transcriptomics databases for Nos genes in different cephalochordate species, from 
two different genera: Branchiostoma and Asymmetron (see Methods). We found three NOS paralogs in each of 
the analysed species: B. belcheri, B. lanceolatum and Asymmetron lucayanum. To confirm the orthologous rela-
tionships between cephalochordate Nos genes, we performed a phylogenetic analysis (Fig. 1). All B. lanceolatum, 
B. belcheri and A. lucayanum NOS proteins were closely related with high bootstrap values with the previously 
characterized B. floridae NOSA, NOSB and NOSC proteins, suggesting that the duplication events that resulted in 
the three cephalochordate Nos genes occurred in the last common ancestor of extant amphioxus (Fig. 1).
Complementary Nos gene expression patterns during amphioxus development. To examine 
whether Nos genes have a role in amphioxus development we characterized the temporal and spatial expression 
pattern of the three B. lanceolatum Nos genes. Droplet digital PCR (ddPCR) experiments showed a temporal com-
plementary expression between the B. lanceolatum NosB and NosC genes (Fig. 2h-h’). During early developmental 
stages, strong NosB gene expression was detected. Initially NosB is expressed at gastrula stage [10 hours post 
fertilization (hpf)], followed by a decrease in expression levels at neurula stage (24 hpf) (Fig. 2h). At later stages 
of development NosB seems to completely switch off (Fig. 2h). NosC expression starts at pre-mouth larval stage 
(48 hpf) with the highest level of expression occurring at 3 days post-fertilization (dpf) larva (72 hpf) (Fig. 2h’). 
NosC expression levels decrease at 5 dpf larva (120 hpf) (Fig. 2h’). We were not able to detect discernible levels of 
NosA during the embryonic and larval stages analysed, but we observed expression in adult specimens (Fig. 2h”).
Expression patterns in whole-mount in situ hybridization preparations, were mostly in agreement with the 
trend observed in the ddPCR experiments: NosB was the first to be detected and its expression was limited to a 
few developmental stages. NosB expression was detected at early- (Fig. 2b) and mid-gastrula stage (Fig. 2c,d) in 
the endoderm, however it was absent in the area surrounding the blastopore, in the ectoderm and the dorsal mes-
oderm (Fig. 2b–d). We did not find any specific NosB signals at later developmental stages in whole-mount in situ 
hybridization experiments. Afterwards, following NosB down-regulation, we detected NosC expression from the 
mid-neurula stage onwards, which was specifically restricted to a few cells in the anterior part of the neural plate, 
slightly posterior to the neural pore (Fig. 2e). At the pre-mouth larval stage, NosC transcripts were detected in the 
anterior half of the neural tube, from the rostral part to the pigment spot (Fig. 2f). In 3 dpf larvae, the expression 
in the neural tube disappeared almost completely, remaining only in a few cells located in the most ventral and 
posterior part of the cerebral vesicle (Fig. 2g). At this stage, we also detected NosC expression in the club-shaped 
gland, which is closely connected to the pharyngeal area (Fig. 2g). The low levels of NosA expression revealed by 
ddPCR experiments were confirmed by the lack of any in situ hybridization signal in the developmental stages 
examined.
Inhibition of the NO signaling prevents the formation of amphioxus mouth and gill slits. 
Amphioxus Nos genes are expressed in different tissues during development. We assumed therefore that NO sig-
naling could have an important role during embryogenesis of some, if not all, of those tissues. First, we measured 
endogenous NO levels during B. lanceolatum development by monitoring nitrite formation (Griess assay) to 
finely detect the exact localization of NO, independently of Nos transcript expression. From early to late develop-
ment, we first observed a concentration of 6 nmol nitrite/mg protein at gastrula (10 hpf), followed by a decrease at 
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neurula stage (24 hpf) and pre-mouth larvae (48 hpf), with 5 and 4.7 nmol nitrite/mg protein, respectively. At 72 
hpf NO levels increased to 23.5 nmol nitrite/mg protein, decreasing again to average levels of 4.6 nmol nitrite/mg 
protein in adults (Fig. 3a). Next, using DAF-FM-DA, we detected where NO was localized in 48 and 72 hpf larvae. 
At 48 hpf larva, NO positive cells were abundant along all the neural tube (arrows in Fig. 3b) and in the most cau-
dal extremity of the larvae, probably the future anal region (tandem arrows in Fig. 3b). Additionally, a strong NO 
fluorescent signal was observed in the corresponding area of the future mouth and gill slits (arrowhead in Fig. 3b). 
At 72 hpf, we observed a higher density of NO positive cells around the mouth, in the ventral part of the first gill 
slit and in the club-shaped gland (arrowheads in Fig. 3c). Later a punctate signal is still present in the rostral area 
as well as caudally in both the hindgut and anus (arrow and tandem arrows, respectively). In order to exclude the 
previously described endogenous GFP fluorescence in amphioxus30, 31, we checked green fluorescence emission 
in untreated B. lanceolatum larvae (negative control), showing a negligible non-specific signal at the same laser 
intensity as used for DAF-FM-DA experiments (Suppl. Fig. S1).
We next investigated the role of NO during development, and thus the ontogenetic importance of NOS pro-
teins. We experimentally reduced the endogenous NOS-produced NO with treatments using two different NOS 
inhibitors: Nω-Nitro-L-arginine methyl ester (L-NAME) and 1-(α,α,α-trifluoro-o-tolyl)-Imidazole (TRIM) at 
different temporal windows22, 32, 33 (see Methods; Suppl. Fig. S2 and Fig. 4). Treatments with a concentration of 
100 μM of L-NAME resulted in normal larvae in each of the experimental times assayed, indistinguishable from 
wild type control treatments (Fig. 4d). Experiments with 1 mM L-NAME added at neurula stage (24 hpf) and 
maintained to 3 dpf larva stage resulted in larvae in which the mouth and gill slits did not form, without affect-
ing the other morphological features (Fig. 4a). In the experiments performed in other temporal windows, the 
L-NAME treatment did not induce any body malformations, except when present throughout development from 
gastrula to larva, giving rise to an abnormal body plan (Suppl. Fig. S2). Increasing the L-NAME concentration to 
10 mM produced larvae with an abnormal body plan, presumably due to the toxicity of high drug concentrations 
rather than a specific effect. As a control for L-NAME treatments we used D-NAME, the inactive D- form enanti-
omer, at the same experimental conditions. D-NAME did not affect amphioxus development (Fig. 4b).
To understand whether the observed alteration of the buccal area was due to the toxicity of the L-NAME or to 
a specific inhibition effect on NOS activity, we performed a second independent series of in vivo treatments using 
a different NOS inhibitor (TRIM). Treatments with 50, 75 and 100 µM TRIM from neurula stage until day 3 of 
development causes alterations mainly in the mouth and gill slits area of the amphioxus larvae (Fig. 4c, compare 
Figure 1. Phylogenetic analyses of NOS proteins in chordates. Bayesian inference-based phylogenetic tree 
of chordate NOS proteins. Numbers on nodes represent posterior probabilities values. The red box includes 
cephalochordate proteins, including 3 closely related species of Branchiostoma (B. lanceolatum, B. floridae and 
B. belcheri), plus Asymmetron lucayanum. The blue box contains two ascidian species, Ciona intestinalis and 
Ciona savignyi. Vertebrate NOS, represented here by Homo sapiens, are highlighted by the yellow box. The NOS 
protein of the sea urchin Strongylocentrotus purpuratus (Ambulacraria) was used as an outgroup.
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with Fig. 4a). There was a significant increase in the proportion of larvae with severe phenotype (no mouth 
opening) in a dose dependent manner (50 to 100 μM) (Fig. 4h). To better characterize the head malformation, we 
treated larvae with 100 μM TRIM and then examined by scanning electron microscopy (SEM). While the general 
animal morphology was unaffected, mouth and gill slits structures were malformed. We classified this phenotype 
according to its severity, as either mild (reduction of the mouth opening, Fig. 4f) or severe (absence of the mouth 
opening, Fig. 4g). We further investigated if these morphological alterations positively correlated with a decreased 
intracellular NOS-produced NO. NO localization detection by DAF-FM-DA in TRIM treated embryos showed 
that the mouth absence was associated with the disappearance of NO fluorescent signal (arrowheads in Fig. 4k), 
which in contrast is present in the untreated animals (arrowheads in Fig. 4j).
Discussion
NO has probably played a crucial role in the early history of life on Earth providing protection to primitive 
microorganisms, neutralizing the aggressive oxidative effect of rising ozone levels in the atmosphere. NO does 
not require carrier molecules to cross cell membranes, and can easily reach intracellular targets by diffusion even 
over large body distances. During animal evolution, NO has acquired several novel functions beyond the mere 
enhancement of survival34. With this in mind, we tried to gain insight into the evolutionary history of Nos genes 
in chordates, particularly studying in detail both the Nos genes repertoire and putative functions of NO in the 
cephalochordate amphioxus B. lanceolatum. Although we previously studied amphioxus Nos gene relationships 
with other metazoan Nos genes23, their evolution within the cephalochordate clade was still unclear. We have 
confirmed the presence of three Nos genes, NosA, -B and -C, in other Branchiostoma species, B. lanceolatum and 
Figure 2. Nos genes expression patterns during Branchiostoma lanceolatum embryonic development. (a) 
Scheme of gastrula territory organization; (b) NosB expression at early gastrula stage, lateral view, (c) mid-
gastrula stage, lateral view and (d) blastopore view [arrowheads indicate the limits of the positive signal]. (e) 
NosC gene expression at mid-neurula stage in neuropore (arrowhead); (f) at pre-mouth larva in brain vesicle 
(arrowhead) and in neural tube (posterior limit, arrow); (g) at larva 3 dpf in the brain vesicle (arrowhead) and 
club-shaped gland (arrow). In (h-h”) the ddPCR results of the three Nos genes in embryonic development are 
represented; P-value <0,05. Embryos orientation: anterior to the left (except 2d), dorsal to the top. Scale bars: 
50 μm.
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B. belcheri, as well as in an Asymmetron species, A. lucayanum. Branchiostoma and Asymmetron represent line-
ages diverged directly from the last common ancestor of extant cephalochordates35, and therefore comparisons 
between them are informative to determine the condition of the latter (Fig. 1). Our phylogenetic analysis clearly 
shows that both Branchiostoma and Asymmetron Nos paralogs are one-to-one orthologous Nos genes, suggesting 
that the duplication events that originated cephalochordate NosA, -B and -C paralogous genes, happened in their 
last common ancestor (Fig. 1).
While we did not detect NosA expression, we found a complementary expression of NosB and NosC 
(Fig. 2h-h’). NosB was highly expressed during gastrulation (Fig. 2b–d). Interestingly, NO is thought to be 
involved in cell division and cell motility during gastrulation in Drosophila and Xenopus36, 37. Therefore, it is 
tempting to hypothesize that also in amphioxus NOSB may exert important roles during gastrulation. NO lev-
els in whole embryos were in general concordant with Nos expression levels, suggesting that NOS likely exert 
their roles by means of NO production and, importantly, in a regulated fashion during amphioxus development. 
NosC expression starts at the neurula stage in a few cells in the most anterior part of the neural plate (Fig. 2e), 
then expands from this most anterior region to the pigmented spot at pre-mouth larvae (Fig. 2f) and later gets 
restricted to a few cells of the cerebral vesicle and to the club-shaped gland at 3 dpf larvae (Fig. 2g). Although 
direct comparison between Nos expression patterns in nervous systems between vertebrates and cephalochor-
dates is difficult38, it seems that a similarity exists between zebrafish NosI gene (expressed at 24 hpf in differenti-
ating neurons and then in the major areas of the brain) and amphioxus NosC gene expression39, 40. Moreover, our 
NO localization experiments showed that NO partially coincides with the expression patterns of NosC gene at 
pre-mouth larvae, like in the cerebral vesicle and neural tube. Altogether, these results suggest a putative involve-
ment of NosC in amphioxus CNS function, although further experiments are needed to find out what this func-
tion might be.
Besides the expression in the CNS, we observed a peak of NosC transcript levels (Fig. 2h’) that was mainly local-
ized, together with significant amounts of NO, in the pharyngeal area in 3-dpf larvae (compare Figs 2g and 3c). 
This stage represents a pre-metamorphic developmental phase possessing an already formed neural tube, func-
tional muscles and an open mouth on the left side of the body, in addition to other embryonic transitory organs: 
endostyle, pre-oral pit and club-shape gland. Interestingly, the presence of an intensively innervated portion of 
the pharynx in pre- and post- metamorphic larvae has been demonstrated, indicating that the club-shaped gland, 
the pre-oral pit and the endostyle are probably involved in important morphological processes in amphioxus 
Figure 3. Nitrite quantification and nitric oxide detection in amphioxus embryos. The graph (a) shows the 
nitrite quantification during embryonic development and in adult obtained by Griess assay, the results are 
expressed as nmol of nitrite/mg of proteins. Nitric oxide localization by DAF-FM-DA at (b) 48 hpf and (c) 72 
hpf. Arrows indicate nervous system; arrowheads show pharyngeal area, mouth and gill slits; tandem arrows 
indicate hindgut. Embryos orientation: anterior to the left, dorsal to the top. Scale bars: 50 μm.
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mouth opening and rostral metamorphosis41. Here we showed NosC expression in the club-shaped gland, there-
fore we assume a possible involvement of this organ in the morphogenesis of pharyngeal structures.
NO is the final product of the Kinin-Kallikrein pathway, which in adult vertebrates usually participates in 
inflammation processes, as well as in the regulation of blood pressure. Recently, this pathway has been proposed 
to be active in the so-called “extreme anterior domain” of Xenopus and zebrafish embryos and to be essential for 
craniofacial development42. NosI-morphants and TRIM treated frog embryos at neurula stage developed abnor-
mal cranio-facial structures with a complete absence of the mouth42. Addition of a NO donor led to a complete 
rescue of the facial development, demonstrating that NO is necessary for mouth development in vertebrates42. 
Decreasing endogenous NO levels in amphioxus upon NOS inhibition, similarly to vertebrates, has led to the 
development of amphioxus larvae with a compromised pharyngeal structure, showing severely reduced or absent 
mouth and gill slits (Fig. 4). Interestingly, this developmental abnormality was observed only when the NO deple-
tion was carried out during a sharp temporal window. The capability of the embryo to recover the correct mor-
phology after the removal of the drug at 36 hpf (that is after 12 hours of treatment) allowed us to demonstrate 
the precise time interval in which NO is likely to have a role in mouth and pharynx formation: between 36 and 
48 hpf. This suggests that also in amphioxus the embryonic origin of the prospective chordate primary mouth is 
under direct NO control during the neurula stage. Because of its characteristics, the amphioxus mouth still repre-
sents a longstanding enigma with regards to its evolutionary origin, homology relationships and differences with 
other chordate mouths. Recently, Nodal signaling in amphioxus has been shown to control left-right asymmetric 
Figure 4. Drug treatments of amphioxus embryos. Amphioxus embryos were treated with L-NAME, D-NAME 
and TRIM, then the phenotype of 72 hpf larvae was observed. 1 mM L-NAME induces malformations in the 
mouth and gill slits area (a), not observed in the case of 1 mM of the D- enantiomer (D-NAME) (b). 100 µM 
TRIM-treated larvae show a phenotype similar to that observed with L-NAME (c). Control untreated larva 
kept in FSW (d). Next, 100 µM TRIM-treated larvae were observed by SEM. Control larvae in DMSO/FSW 
(e). TRIM-treated larvae with mild and severe phenotype (f–g). Percentages of larvae with mild and severe 
phenotypes at increasing drug concentrations, and the respective number of larvae observed (h). NO detection 
by DAF-FM-DA in untreated larvae mouth and gill slits are shown by arrowheads in (j). The absence of NO in 
mouth and gill slits of TRIM-treated larvae is indicated by arrowheads (k). Scale bars: 50 μm in (a–d) and (k–j).
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development, in which the mouth is a prominent feature43. An independent study proposed that a mesodermal 
vesicle becomes intimately juxtaposed to the nascent mouth at the early larval stage under the control of several 
genes belonging to the Nodal-Pitx signaling pathway44.
In conclusion, the results of the present study showed for the first time the crucial role of NO as an endoge-
nous regulator of mouth formation in amphioxus (Fig. 5). The balance of NO levels in the pharynx-surrounding 
area is likely to be a prerequisite for the correct morphogenesis of the mouth. Future studies are needed to inves-
tigate if there is any relationship between NO and Nodal-Pitx pathway in amphioxus mouth morphogenesis, and 
to clarify whether the Kinin-Kallikrein signaling, discovered in vertebrates, is conserved in amphioxus.
Methods
Ethics Statement. Adult amphioxus specimens (B. lanceolatum) were collected from an endemic popula-
tion of the Gulf of Naples (Italy), according to the authorization of Marina Mercantile (D. Lgs. 09/01/2012, n.4). 
All procedures were in compliance with current available regulations for the experimental use of live animals in 
Italy.
Animal care and embryo collection. Animals were kept in an open circulating system reproducing natu-
ral thermal and light conditions, development of the gonads was periodically monitored. Ripe males and females 
were induced to spawn and the embryos were cultured at 18 °C as described in literature45. Embryos used for total 
RNA extraction were collected and fixed in EUROzol (Euroclone) and stored at −80 °C until used. For in situ 
hybridization experiments embryos were transferred into 4% paraformaldehyde (PFA) in MOPS/EGTA solution 
(0.1 M MOPS pH 7.5; 2 mM MgSO4; 1 mM EGTA; 0.5 M NaCl in DEPC-H2O) and dehydrated in ice-cold 70% 
EtOH in DEPC water and kept at −20 °C until used.
Identification of lancelet Nos genes and phylogenetic analysis. B. lanceolatum Nos genes were 
annotated in the genome draft version Bl71nemr, kindly provided by the “Branchiostoma lanceolatum genome 
consortium”. B. lanceolatum Nos gene sequences are available in the Suppl. Fig. S3. B. belcheri Nos genes were 
identified from the automated predictions of NCBI (corresponding accession numbers in Suppl. Table S4). To 
find A. lucayanum Nos genes we screened a previously published transcriptome assembly46, 47 (DDBJ/EMBL/
NCBI accession numbers GESY00000000 and GETC00000000). Accession numbers of A. lucayanum transcripts 
corresponding to each Nos paralog are available in Suppl. Table S4. Briefly, we performed TBLASTN searches 
using amino acid sequences of the three NOSA, NOSB and NOSC proteins from B. floridae, and candidate scaf-
folds, contigs or transcripts were further analysed by means of GeneWise2 as implemented in the EBI website48, 49  
and manual curation. Other NOS proteins included in the phylogenetic analysis were collected from public data-
bases such as Ensembl and NCBI (see Suppl. Table S4 for accession numbers).
For the phylogenetic analysis, NOS amino acid sequences were aligned using the MUSCLE algorithm50 as 
implemented in MEGA v7, release 7161111-i38651 with default parameters, and saved in FASTA format. The 
alignment was trimmed by trimAl version 1.2rev5952, using the ‘-automated1’ parameter. The trimmed align-
ment was then formatted into a nexus file using readAl50 (bundled with the trimAl package) (Suppl. File S5). A 
Bayesian inference tree was inferred using MrBayes 3.2.653, under the assumption of an LG + I + G evolutionary 
model. Two independent MrBayes runs of 1,000,000 generations, with 4 chains each, were performed. The tree 
was considered to have reached convergence when the standard deviation was stabilized under a value of <0.01. 
A burn-in of the 25% of the trees was performed to generate the consensus tree (750,000 post-burn trees).
Cloning and riboprobes preparation. Total RNA, from B. lanceolatum adult tissues (for NosA) or embryos 
(for NosB and NosC), was extracted using EUROzol (EuroClone) reagent and chloroform, and precipitated from 
Figure 5. Nitric Oxide role during amphioxus larval development. Schematic representation of the rostral part 
of amphioxus larvae indicates possible involvement of NO in mouth development. The conspicuous depletion 
of endogenous NO by NOS inhibition (TRIM-treated larvae) leads to an abnormal phenotype without a mouth.
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the aqueous phase with isopropyl alcohol. cDNA was synthesized from 0.5–1 µg of total RNA using the SMART 
PCR cDNA Synthesis Kit (Clontech). Different fragments corresponding to the three B. lanceolatum Nos genes 
were amplified using specific primers, designed in order to avoid cross-hybridization among the three paralo-
gous genes (Suppl. Table S6), and cloned into the pGEM-T Easy Vector (Promega). Antisense Digoxygenin-UTP 
riboprobes were synthesized using the SP6 or T7 RNA polymerases and the (DIG) RNA Labeling Kit (Roche).
Droplet digital polymerase chain reaction (ddPCR). Expression profiles of B. lanceolatum Nos genes 
were analysed by Droplet digital PCR (ddPCR) in biological triplicates. Total RNA was extracted from embryos 
at different developmental stages: gastrula (10 hpf), middle neurula (24 hpf), pre-mouth larva (48 hpf), 3 dpf 
and 5 dpf larvae. Approximately 500 ng of total RNA extracted from each time point was reverse transcribed to 
cDNA using Super Script Vilo kit (Invitrogen). cDNA (approx. 3 ng) was mixed with 10 µl of 2X ddPCR Evagreen 
Supermix, 0.5 pM of each primer and nuclease-free water to a total reaction volume of 20 µl, then loaded into a 
sample well of a DG8 Cartridge for the QX200/QX100 droplet generator, according to the QX200/QX100 Droplet 
Generator Instruction Manual. Thermal cycling was then performed on the droplets using the C1000 Touch 
Thermal Cycler with 96-deep well reaction module according to the following protocol: enzyme activation at 
95 °C for 10 min (1 cycle), denaturation at 94 °C for 30 sec followed by annealing/extension at 60 °C for 30 sec (40 
cycles), enzyme deactivation at 98 °C for 10 min (1 cycle) followed by hold at 4 °C. All reagents and equipment 
used for ddPCR were from Bio-Rad Laboratories. The absolute gene expression level per well for the probes and 
reference genes were quantified using QuantaSoft software. The gene expression values for each sample were nor-
malized to the housekeeping gene Ribosomal protein L32 (RPL32)54 and reported as relative quantity compared to 
the lowest expression level of each Nos gene, respectively. The results for the three Nos genes at each developmen-
tal stage were subjected to Student t-test; a P-value of less than 0.05 was considered significant.
Whole-mount in situ hybridization. For whole-mount in situ hybridization, embryos were re-hydrated in 
1X PBT, treated with proteinase K (5 µg/ml) to facilitate riboprobe penetration; the reaction was stopped by add-
ing 4 μl of 10% glycine and then washed with 2 mg/ml glycine in a phosphate buffered saline solution containing 
0.1% Tween-20 (PBT). The embryos were re-fixed in PBT containing 4% PFA for 1 h at RT, subsequently washed 
in 0.1 M triethanolamine and then with 0.1 M triethanolamine plus acetic anhydride, to prevent non-specific 
background staining. Embryos were washed with PBT several times, pre-hybridized at 60 °C for 1 h and finally 
hybridized by shaking at 65 °C overnight, in DEPC-H2O hybridization buffer (50% deionized formamide; 100 μg/
ml Heparin; 5X SSC; 0.1% Tween-20; 5 mM EDTA; Denhardt’s 1 mg/ml; yeast RNA 1 mg/ml). The day after 
post-hybridization, washes were performed in decreasing concentrations from 5X to 2X of SSC 50% formamide/
dH2O at hybridization temperature and then at room temperature in decreasing concentrations of SSC, from 2X 
to 0.2X in dH2O. An RNAse step at 37 °C was included. Embryos were incubated overnight in primary antibody 
(anti-DIG AP, Roche), pre-adsorbed at 1:3000, with rocking at 4 °C. The signal was revealed at room temperature 
using BM-Purple substrate (Roche). Afterwards embryos were washed several times in PBT, postfixed in 4% PFA 
for 20 min, mounted in 80% glycerol in PBS, and photographed under Axio Imager 2 (Zeiss).
NO measurement assay (Griess). The endogenous NO concentration was measured indirectly from the 
nitrite content using the Griess reagent, according to Green and collaborators55. Adult specimens and embryos 
at different developmental stages were homogenized in PBS and centrifuged at 20000 g for 30 min at 4 °C. Total 
protein concentration was determined by the Bradford assay using a Bio-Rad Protein Assay Reagent (Bio-Rad), 
bovine serum albumin was used as a standard. The supernatant of each sample was then analysed for nitrite con-
tent using a spectrophotometer (λ = 540) and reported as nmol of nitrite per mg of protein. The experiment was 
performed on biological triplicates for each sample.
In vivo NO modulation assays with L-NAME and TRIM. We decreased the NO production dur-
ing amphioxus development using two types of drugs that alter the NOS activity: an analog of arginine, 
Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME, Sigma Aldrich, stock solution in filtered sea 
water, FSW) and 1-(α,α,α-trifluoro-o-tolyl)-Imidazole (TRIM, Cayman Chemical, stock solution in DMSO) 
which interferes with binding of both L-arginine and tetrahydrobiopterin to their respective sites on the NOS 
enzymes. Untreated control larvae were raised in FSW. Additional controls included: inactive enantiomer 
Nω-Nitro-D-arginine methyl ester hydrochloride (D-NAME, Sigma Aldrich) for L-NAME, and DMSO for 
TRIM. The treatments were started and blocked at different developmental stages and the phenotype was always 
observed at 3 dpf larvae (Suppl. Fig. S2). All the experiments shown in Suppl. Fig. S2 were performed with 100 µM, 
1 mM and 10 mM L-NAME at 18 °C as pilot experiments. We repeated the in vivo experiments adding the TRIM 
at the neurula stage, which proved to be the most sensitive stage to drug treatment. Therefore, 24 hpf embryos 
(neurula stage) were treated with 50, 75 and 100 µM TRIM for the time periods indicated in Suppl. Fig. S2. Larvae 
at 72 hpf were fixed in 4% PFA, dehydrated and stored in 70% ethanol, and the morphology was initially analysed 
using a stereoscope and then, for image acquisition, using a Zeiss EVO MA LS Scanning Electron Microscope.
In vivo NO localization assay. NO localization was performed using 4-amino-5-methylamino-2′,7′
-difluorofluorescein diacetate (DAF-FM-DA), the most sensitive cell permeable and non-fluorescent reagent that 
combines with NO forming benzotriazole, a fluorescent compound56. Embryos at different developmental stages 
were incubated for 20 min in the dark with 5 μM DAF-FM-DA in FSW. After treatment the animals were washed 
and incubated in FSW for 30 min and quickly fixed in 4% PFA. The fluorescence was visualised with ZEISS Axio 
Imager Z1 fluorescence microscope equipped with a λEXC = 470 ± 40, λEM = 525 ± 50 filter.
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